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A study of two models of primary mental health care provisions in Yogyakarta, Indonesia 
Background 
The World Health Organization (WHO) defines health as a state of complete physical, mental, and 
social well-being and not merely the absence of disease or infirmity. Despite its importance, mental 
health provisions are often limited. In 2015, Indonesia had only 773 psychiatrists for 250 million 
residents. This shortage of specialist mental health professionals is shared by most Low- and Middle-
Income Countries (LMICs) and is reflected in the Treatment Gaps in this region indicating the very 
small proportion of people who receive adequate mental health care for their needs. While the median 
worldwide Treatment Gap for psychosis is 32.2% (Kohn et al., 2004), in Indonesia it is more than 90%. 
Experts suggested integrating mental health care into primary care, to help bridge this gap (Mendenhall 
et al., 2014). The systematic introduction of the World Health Organization Mental Health Gap Action 
Programme into primary care clinics across Indonesia and the presence of a 15-year-old co-location of 
Clinical Psychologists in Yogyakarta province’s primary care clinics presented an opportunity to assess 
the clinical and cost-effectiveness of both frameworks.  
Methods 
This research (“the trial”) set out to develop an approach, and then implement it, to compare the adapted 
WHO mhGAP framework with the existing specialist framework within primary mental health services 
in Yogyakarta, Indonesia, through a pragmatic, two-arm cluster randomised controlled non-
inferiority trial. This design enabled an examination of patients derived from whole populations in a 
‘real world’ setting. The trial involved two phases: a pilot study in June 2016 with the objectives to 
refine data collection procedures and to serve as a practice run for clinicians involved in the trial; as 
well as a substantive trial beginning in December 2016. The 12-item General Health Questionnaire 
(GHQ-12) was established as a ‘fairly accurate’ screening tool using a Receiver Operating Curve study. 
Using the GHQ scoring method of 0-0-1-1, a threshold of 1/2 was identified for use in clinical setting, 
i.e. the context of the trial. The primary outcome was the health and social functioning of participants 
as measured by the Health of the Nation Outcome Scale (HoNOS) and secondary outcomes were 
disability as measured by WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), quality of life as 
measured by European Quality of Life Scale (EQ-5D-3L), and cost of intervention evaluated from a 
health services perspective, which aimed to determine the clinical effectiveness and cost-effectiveness 
of both frameworks at six months.  
Results 
During the recruitment period, 4944 adult primary care patients attended 27 participating primary care 
centres. Following screening (n=1484) and in-depth psychiatric interviews (n=394), 174 WHO mhGAP 
arm and 151 Specialist arm participants received a formal diagnosis and were recruited into the trial. 

























bilateral significance value of 0.05 was estimated to be 96. A total of 153 participants of the WHO 
mhGAP arm and 141 of the Specialist arm were followed-up at six months, representing 90.8% of all 
participants diagnosed. At follow-up, 82% (n=126) participants of the WHO mhGAP arm indicated 
they had attended at least one treatment session during the trial, significantly more than in the Specialist 
Arm (69%; n=97), c2 = 7.364, p=0.007. 
The WHO mhGAP arm was proven to be statistically not inferior to the Specialist arm in reducing 
symptoms of social and physical impairment, reducing disability, and improving health-related quality 
of life at six months. Cost-effectiveness analyses show that the Specialist arm was dominant for a unit 
of improvement in patient outcomes at six months. While the framework is more expensive for the 
Health System, participants in the Specialist arm were found to have larger improvements. 
Conclusion 
Given that both frameworks yielded positive patient outcomes, there is no immediate need to increase 
the absolute number of specialist mental health professionals in community psychiatry (i.e. replicate 
the specialist framework outside Yogyakarta). As most psychologists and psychiatrists in Indonesia 
reside in large cities, the current systematic roll-out of the adapted WHO mhGAP framework might 
address the need to strengthen non-stigmatising mental health care within community contexts, 
reflecting the preferences of primary care patients. In districts or provinces which could afford the 
additional cost, however, the Specialist framework was shown to be better at improving patient 
outcomes than the adapted WHO mhGAP framework. Existing resources for specialist care can be 
arranged in a hub-and-spoke (step-up care) model where higher-level interventions are provided for 
those with greater needs. The proposed model would free-up resources for advanced clinical training of 
the specialist workforce in key areas of need while keeping specialist services accessible.  
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Psychiatric disorders are increasingly considered to be killer diseases, reducing life expectancy. In high-
income countries, this gap has been estimated to be from 8.0 to 14.6 life years in men and 9.8 to 17.5 
life years lost in women, with a reported 20-year mortality gap for men and 15 years for women with 
psychiatric disorders compared to the general population. This mortality gap is attributed mainly to a 
combination of lifestyle risk factors, higher rates of unnatural deaths, and poorer physical health care 
(Thornicroft, 2011). This excess mortality is even higher in low- and middle-income countries (LMICs) 
(Fekadu et al., 2015). It is generally recognised that most people with psychiatric disorders in LMICs 
do not receive treatment based on the best current knowledge, if at all. Solutions to this problem, which 
may be tailored to various contexts, are necessary.   
This Chapter begins by defining health, mental health and global mental health before explicitly 
reviewing the current Indonesian mental health system based on a thorough narrative review of the 
literature that was undertaken. Search terms included: “mental health system” AND “Indonesia”. The 
originally planned systematic review did not successfully gather relevant grey literature and was 
subsequently abandoned in favour of a narrative approach, although relevant journal articles were 
retained and supplemented in this review by personal correspondence, online reports, and newspaper 
articles.  
Within the investigation into the Indonesian mental health system and landscape, particular attention 
will be given to Human Rights violations towards people with mental health issues as well as the role 
that geography plays in strengthening primary care (and mental health within primary care) in the 
country. Subsequently, the topic of Treatment Gap is discussed, and the various proposed reasons why 
Treatment Gap remains enormous in Indonesia. Lastly, Indonesia’s new Mental Health Law (2014) will 
be scrutinised and discussed. This chapter concludes with the proposed aims and objectives of the thesis, 
detailing research activities which were to be undertaken and the rationale behind them. 
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1.1 Global Mental Health 
What is health? While the Oxford Dictionaries defines health as “the state of being free from illness or 
injury,” the World Health Organization (WHO) defines health as a state of complete physical, mental, 
and social well-being and not merely the absence of disease or infirmity. There are many critiques 
regarding this 1948 definition, deemed to have contributed to over-medicalisation of society and no 
longer relevant given the rise of chronic diseases, among others. Recent critiques include the absence 
of consideration towards spiritual health and environmental health. While those critiques are beyond 
the scope of this thesis to discuss, one should note that in many cultures and for many people, spiritual 
health is an integral part of wellbeing. For almost seven decades since the WHO definition, health has 
been acknowledged to have multiple domains, which contribute to the holistic wellbeing of an 
individual, community and society.  
The three primary domains of health (physical, mental and social) are not equally regarded. Mental 
health is less understood (and often less valued), as the biological bases for many disorders remain and 
the interaction between mental health and environmental factors better understood. Mental disorders 
remain mysterious to many as is the realisation that mental health conditions can influence one’s 
physical health (and vice versa), help-seeking behaviours, detection of physical health conditions, 
adherence to treatment, and overall prognosis (Prince et al., 2007). Both physical and mental health 
contribute to social health, which is the capacity to fulfil one’s potential and obligations, the ability to 
manage one’s life with a degree of independence, and the ability to participate in meaningful social 
activities, such as work (McDowell, 2006).  
Mental health is “a state of well-being in which every individual realises his or her own potential, can 
cope with the normal stresses of life, can work productively and fruitfully, and is able to make a 
contribution to her or his community” (WHO, 2014). Psychiatric disorders have been found to be the 
leading cause of disability worldwide, with 28.5% years lost to disability (YLD), 2.3% years of life lost 
(YLL), and 10.4% of disability-adjusted life years (DALY) attributed to psychiatric and substance use 
disorders (Whiteford et al., 2015).  
Psychiatric disorders reduce life expectancy by between 8.0 to 14.6 life years lost for men and 9.8 to 
17.5 life years lost for women as described in a London study (Chang et al., 2011). Other studies have 
found a 20-year mortality gap for men and 15 years for women with psychiatric disorders, owing to a 
combination of lifestyle risk factors, higher rates of unnatural deaths, and poorer physical health care 
(Thornicroft, 2011). This mortality gap is even greater in low and middle-income countries (LMICs) 
(Fekadu et al., 2015).  
Even more alarming, 800,000 people die through suicide each year worldwide (WHO, 2014). There are 
indications that for every successful suicide attempt, there are 20 unsuccessful attempts. Interestingly, 
75% of global suicides occur in LMICs. Suicides, suicide attempts, and self-harm are often linked to 
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psychiatric disorders, pointing to the inability to cope with a given situation or realise one’s potential. 
It has been estimated that 14.3% of premature deaths worldwide, or approximately 8 million deaths 
annually, are attributable to psychiatric disorders (Walker et al., 2015). 
Discrepancies in health status between countries lead to the development of a new field within health 
research: global health. It is defined as “an area for study, research, and practice that places a priority 
on improving health and achieving equity in health for all people worldwide” (Koplan et al., 2009). 
Global mental health, in particular, is the application of these principles to the specific domain of 
mental, neurological, and substance use disorders (MNS) with the primary focus of reducing mental 
health inequalities within and between countries, particularly High-Income Countries vs LMICs (Patel 
and Prince, 2010).  
There is indeed growing evidence for effective, locally feasible and affordable treatments for depression 
and schizophrenia in LMICs; the two conditions being the most commonly studied perhaps due to their 
relatively higher prevalence, compared to other conditions (Tiller, 2013). Systematic reviews have 
shown that non-specialist health worker interventions for mental health care in LMICs are clinically 
effective (Caulfield et al., 2018, van Ginneken et al., 2011). Other ways of managing mental disorders 
with less established efficacy information include traditional healers, religious exorcisms, and the 
removal of people with mental health issues from the community. Awareness of mental disorders, 
avenues to seek help, and the desire to get better, are all determinants of help-seeking efforts. 
Often, mental health care is separate from physical health care. Compartmentalisation underestimates 
the overall burden of mental disorders, much of which is mediated through links with other conditions. 
It also misses the salience of mental health to mainstream health and human development. Separating 
mental health care from physical health care entrenches isolation and emboldens stigma towards those 
affected. Moreover, psychiatric disorders are linked to a cycle of disadvantage, including poverty, 
violence, and social exclusion (Lund et al., 2010). The social care systems of many countries perpetuate 
this inequity. While the impact of poverty alleviation on mental health is inconclusive, mental health 
interventions have been shown to improve economic outcomes (Lund et al., 2011). 
In many LMICs, people with mental and psychosocial disorders continue to experience this wide range 
of human rights violations. These include stigma, social exclusion within families or communities, and 
discrimination in employment, education, housing, and broader society (WHO, 2001). Often, they are 
denied the opportunity to exercise legal capacity and civil, social, and political rights (Drew et al., 
2011). People with severe mental health problems may experience the denial of basic entitlements, such 
as freedom of movement and the right to receive care (Patel et al., 2011). Abuse, inhumane and 
degrading treatment are commonplace, and these violations may happen in hospitals, private 
institutions, community facilities, or even at home (Drew et al., 2011). Discrimination, low social 
support, and negative self-image contribute to suicidality (Farrelly et al., 2015). Moreover, laws and 
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practices in many countries systematically deny people with mental disorders the right to exercise their 
legal capacity and make decisions, regardless of the severity of the disorders and usually without prior 
competency assessment. Instead, third parties such as health professionals, government officials, or 
family members make all decisions in their place, including decisions on treatment, living arrangement, 
as well as other personal, administrative and financial matters. These infringements of human rights 
have been referred to as a “failure of humanity” (Kleinman, 2009). 
1.2 Indonesia State of Mind 
Modern-day Indonesia is the largest economy in Southeast Asia. With a population of over 267 million 
in 2018, it is the world’s fourth most populous country after China, India, and the United States (World 
Population Review). Geographically, Indonesia is an archipelago of 17,508 islands, 6,000 of which are 
inhabited. More than 700 languages are spoken in Indonesia, with the lingua franca being Bahasa 
Indonesia (CIA, 2015). While the majority (87%) of its population are Muslims, Indonesia is also home 
to Christians, Hindus, and Buddhists. Religious minorities are often targeted by militant Muslims in 
their campaign to Islamise Indonesia (Davis, 2002). During the global financial crisis, Indonesia 
outperformed its regional neighbours and joined China and India as the only G20 members posting 
growth. Despite this, around 11% of Indonesia’s population lives below the poverty line (OECD, 2013). 
Indonesia still struggles with poverty and unemployment, inadequate infrastructure, corruption, a 
complex regulatory environment, and unequal resource distribution across regions. Health expenditures 
amounted to only 3.1% of GDP in 2013 (WHO, 2015), 1% of which was allocated to mental health 
care.  
The health infrastructures and workforce are reflections of relatively small health expenditures. 
Ministry of Health data in 2015 recorded 2,447 hospitals exist in Indonesia, 17% of which are privately 
owned. These hospitals supply a total of 304,902 beds, a ratio of 1.22 beds per 1,000 population. The 
global average is three beds per 1,000, and the OECD average is five beds per 1,000. Indonesia has 0.4 
medical doctors per 1,000 people, under a third of the global average of 1.4 doctors (OECD average is 
3.2). There are five nurses per 1,000 population, 60% of whom are educated to high school level only 
(Hennessy et al., 2006). Jamsostek, the national insurance system which paid for basic healthcare before 
the implementation of Universal Health Coverage (BPJS) from 1 January 2014, covered approximately 
60% of Indonesians. With BPJS, demand for medical care is predicted to increase steadily, placing a 
more significant strain on existing health infrastructures. The figure below illustrates the recorded use 
of BPJS between 2014-2016. 
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Figure 1. Increased demand for medical care between 2014-2016 (in millions), BPJS Data via Dr 
Maya Rusady, Director of Medical Services, 1 March 2017 
 
Geography and health are intrinsically linked (Dummer, 2008) as reflected in the adjustment of the 
health system to consider population density, demographic profile, and accessibility. Approximately 
57% of Indonesians live on the Island of Java, making it the most populous island in the whole world. 
Most (65%) medical doctors in Indonesia practice in Java. The island is home to ethnic Javanese (41.7% 
of Indonesia’s population) and Sundanese (15.4%) although larger cities in Java, like Jakarta, are home 
to other ethnicities that have migrated. Indonesia has more than 300 distinct ethnic and linguistic groups, 
although the largest and most dominant politically are the Javanese. Ethnic Chinese Indonesians account 
for only 3% of the population but control most of the country’s wealth and commerce, the by-product 
of the segregation of roles and living quarters during the 350-year Dutch colonial rule (Suryadinata, 
1999). Presently, ethnic Chinese Indonesians continue to experience discrimination, ranging from the 
additional citizenship documents, limited quotas in state universities and civil service, as well as being 
the political scapegoat (Winarta, 2008). As economic growth in the country centres in Java, citizens 
living outside the island often complain about unequal access to development budget and infrastructures 
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Figure 2. Map of Indonesia and neighbouring countries (Source: Ezilon Maps) 
 
It is more difficult to access health services outside Java as hospitals are few in number, despite broad 
geographical coverage (Shields and Hartati, 2003). On the other hand, it is not economically feasible to 
develop and maintain hospitals where population density is very low. The Indonesian government relies 
on community health centres or Pusat Kesehatan Masyarakat (Puskesmas), to provide citizens with 
primary health services given the lack of feasibility to develop hospitals in areas with low population 
density (Mahendradhata et al., 2017). The majority (63%) of Puskesmas are outside Java. Recognising 
their role in filling the gaps in primary health services, many Puskesmas in Indonesia offer basic 
inpatient facilities. The healthcare system of the country, therefore, adapts to the geographical 
challenges. Table 1 details the number of government-owned, independent Puskesmas in the provinces.   
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Table 1. Number of Puskesmas in Indonesia, by Province (Shaded Provinces are in Java) 
NO Province 
PUSKESMAS (Community Health Centres) 
Inpatient Outpatient TOTAL 
1 ACEH 142 194 336 
2 SUMATERA UTARA 164 406 570 
3 SUMATERA BARAT 91 173 264 
4 RIAU 79 132 211 
5 JAMBI 68 108 176 
6 SUMATERA SELATAN 95 226 321 
7 BENGKULU 45 135 180 
8 LAMPUNG 106 184 290 
9 KEPULAUAN BANGKA BELITUNG 20 41 61 
10 KEPULAUAN RIAU 28 44 72 
11 DKI JAKARTA 30 310 340 
12 JAWA BARAT 176 874 1,050 
13 JAWA TENGAH 318 557 875 
14 D I YOGYAKARTA 42 79 121 
15 JAWA TIMUR 505 455 960 
16 BANTEN 56 175 231 
17 B A L I 34 86 120 
18 NUSA TENGGARA BARAT 109 49 158 
19 NUSA TENGGARA TIMUR 134 236 370 
20 KALIMANTAN BARAT 95 143 238 
21 KALIMANTAN TENGAH 73 122 195 
22 KALIMANTAN SELATAN 45 183 228 
23 KALIMANTAN TIMUR 95 79 174 
24 KALIMANTAN UTARA 32 16 48 
25 SULAWESI UTARA 92 95 187 
26 SULAWESI TENGAH 79 105 184 
27 SULAWESI SELATAN 228 218 446 
28 SULAWESI TENGGARA 86 183 269 
29 GORONTALO 25 68 93 
30 SULAWESI BARAT 44 50 94 
31 M A L U K U 62 135 197 
32 MALUKU UTARA 27 100 127 
33 PAPUA BARAT 40 109 149 
34 PAPUA 104 290 394 
TOTAL   3,369 6,360 9,729 
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The Indonesian government has adopted the WHO definition of mental health. In 2013, the 15-year 
prevalence of depression and anxiety according to Basic Health Research was 6% (15 million people). 
Within-country surveys have revealed a significant cross-sectional association between depression and 
chronic heart disease, asthma, and arthritis (National Health Survey, 2009). Besides, the 15-year 
prevalence of severe psychosis is 0.17% (estimated number affected nearly half a million people, 
425,000). Users of narcotic substances in the last year amounted to 2.2% of the population (4 million 
people), with a quarter of them being regular users (Badan Narkotika Nasional, 2001). In 2011, there 
were 1,170 recorded cases of suicide, or 0.5 per 100,000 people (National Police, 2012). Post-disaster 
prevalence of depression and anxiety is estimated to be 40% as assessed after the 2004 Boxing Day 
Tsunami and 2010 Mount Merapi Eruption (Irmansyah et al., 2010). While prevalence might seem 
lower than global averages, the enormous population of Indonesia, coupled with inadequate service 
infrastructure, impose a heavy burden on the mental health care system, judicial system, and the society 
in general. Furthermore, to date, there is no existing formal social care system. 
Mental health services in Indonesia are arranged in primary, secondary, and tertiary levels of care. Since 
2004 in Aceh, then in other parts of Indonesia, Puskesmas provide primary mental health care at the 
community level, including public education to individual patients, counselling, basic psychiatric 
services, house visits, community outreach, and referral to secondary care. This is in line with the task-
shifting or task-sharing approach to primary mental health services recommended for low-resource 
settings (Barrett et al., 2009, Bruckner et al., 2011, Burns and Tomita, 2014, Mirza et al., 2006, 
Padmanathan and De Silva, 2013, Petersen et al., 2012, van Ginneken et al., 2011). In 2015, 30% of all 
Puskesmas in Indonesia (approximately 3,000) provided basic mental health services. Approximately 
47% of Puskesmas have at least one staff member, usually a general practitioner or practice nurse, who 
has attended task-sharing mental health training, Community Mental Health Nursing (Rifaskes, 2011). 
Secondary care (outpatient psychiatric care) is available in less than half (41%) of general hospitals in 
the country. Patients are provided with emergency psychiatry, policlinic psychiatry (specialist 
outpatient), and liaison psychiatry (through A&E or hospital inpatient referral). At the tertiary level, 
psychiatric hospitals provide emergency psychiatry, inpatient facilities, and sub-specialist care. Not all 
provinces in Indonesia have a psychiatric hospital.  
The World Psychiatric Association recently refocused efforts on attracting medical graduates to 
psychiatry training, as the number of medical doctors pursuing specialist training in psychiatry has 
declined markedly over the years resulting in a greater burden in the mental health care system both in 
developed countries and LMICs (Farooq et al., 2014). It has been noted that there is a 1.2 million mental 
health labour force shortage in LMICs and the scale-up costs are predicted to be around US$840 million 
(Kakuma et al., 2011).  
In 2015, Indonesia was home to only 773 psychiatrists for its 250 million residents (ratio of 0.32 
psychiatrist for 100,000 residents or 0.1 per 30,000) (Nasional, 2016). A ratio of below one psychiatrist 
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per 30,000 indicates an insufficient supply of qualified mental health care professionals (Koran, 1979). 
In January 2019, the Indonesian Clinical Psychology Association recorded 980 verified members and 
approximated the presence of 1587 clinical psychologists in the country (anon., 2019).. Even prevalence 
using frequency of service contact is unlikely to be indicative of actual demand, yet there has not been 
a country-wide population-based study with reasonable response rates and rigorous methodology. 
Culture, stigma, geographical accessibility, and insurance status, among others, affect the utilisation of 
specialist services. Notably, Indonesia’s Ministry of Health Director for Mental Health confirmed in a 
private conversation that most psychiatrists in Indonesia work in the private sector, except for a handful 
working in tertiary psychiatric facilities and psychiatrists in government hospitals. The fee-for-service 
healthcare system previously denied specialist psychiatric treatment opportunities for those without the 
means to afford private medical care. Similarly, few psychiatrists in other developed countries have 
been reported to accept state-insured patients (Bishop et al., 2014).  
1.3 Abomination in Paradise 
Many Indonesians with symptoms of mental illness are shackled in practice called pasung (Minas and 
Diatri, 2008).  Their families often restrain people with mental illness due to their history of chronic or 
relapsing disease, lack of access to mental health services, family burden and/or financial issues, lack 
of response towards pharmacotherapy, and most importantly lack of knowledge and understanding of 
mental health (conference presentation at ASEAN mental health conference by, Diah Setia Utami, past 
Director of Mental Health Ministry of Health, Republic of Indonesia). Those in restraint are usually 
held in one place for many years (even up to their deaths). While some in pasung experience all-around 
neglect, most are chained nearby their relatives and continue to receive regular meals and family 
contact. Family members, therefore, believe that restraints protect their loved ones from trouble with 
the law, getting lost, or harming themselves. The Ministry of Health estimated around 57,000 
Indonesians had previously been or are currently living under restraint in their lifetime (chain, wooden 
block, cage, among others). This phenomenon primarily appears in places with limited mental health 
resources and is seen as a breach of human rights (Freeman & Pathare, 2005). The Human Rights Watch 
published an online article on this phenomenon on 21 March 2016, titled “Living in Hell: Abuses 
Against People with Psychosocial Disabilities in Indonesia,” 
https://www.hrw.org/report/2016/03/20/living-hell/abuses-against-people-psychosocial-disabilities-
indonesia. 
For almost five decades, Indonesia has acknowledged the problem of pasung in its public policy. As 
early as the 1920s, nearly a hundred years ago and before independence, Dutch psychiatrists wrote 
extensively about the problem of pasung. In accordance with the 1966 law on mental health (Law No. 
23, 1966), patients with mental disorders must receive care and treatment in healthcare facilities, and 
their human rights must be safeguarded. The Minister of Home Affairs Decree number PEM.29/6/15, 
dated 11 November 1977, addressed to the Governors of the Indonesian Provinces, stated that mentally 
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ill people must not be shackled or restrained and that there should be awareness raising programmes 
about mental health at all levels to be delivered by local governments. However, this policy was not 
enforced, and no effort was made to ensure compliance.  
Subsequently, Indonesia has ratified international conventions such as the UN Convention Against 
Torture (CAT) in 1998, the Convention on the Elimination of Racial Discrimination (1999), and the 
International Covenant on Civil and Political Rights (ICCPR) in 2006, indicating intention to support 
human rights protection of those who are mentally ill within multi-ethnic Indonesia (Irmansyah et al., 
2009a). Among over 300 recognised ethnic groups in Indonesia, ethnic Chinese has been targeted in 
several political uprisings, most notably in the May Riots of 1998, where they were blamed for the 
Asian Financial Crisis, resulting in the looting and burning of Chinese-owned businesses and homes, 
as well as torture and rape of Chinese women and girls (Kusno, 2003). 
Furthermore, in 2010, the Indonesian Government, supported by Universitas Indonesia and the 
University of Melbourne, established its 'Free From Pasung' programme, which includes human rights 
advocacy, public education of mental illness, and training of mental health professionals. Indonesia’s 
Ministry of Health is committed to eliminating pasung practices by the end of 2019 (after moving the 
deadline twice from 2014 to 2017 and now to 2019). While this target is again likely to be delayed, the 
movement also indicates the level of commitment from academia, community organisations, volunteers, 
and local health authorities to promote mental health awareness and practices. Civil society 
organisations such as Schizophrenia Care Community of Indonesia (KPSI) and the Suryani Institute are 
working on raising awareness at the grassroots level in Java and Bali. Most recent data from 2013 
estimates that around 18,800 Indonesians are in pasung and in 2015, 4,393 victims had been ‘rescued’ 
from this state (3,399 of them received psychiatric therapy). Professor Harry Minas from the University 
of Melbourne, a lead academic on the Free From Pasung programme, noted that in 2015, 20 out of 34 
provinces in the country had adopted the Free From Pasung programme.  
1.4 Treatment Gap 
Low supply of mental health professionals and low demands for psychiatric services due to stigma, 
contribute to the wide Treatment Gap as illustrated in the figure below. While the median worldwide 
Treatment Gap for psychosis is 32.2% (Kohn et al., 2004), the Treatment Gap in Indonesia is estimated 
to be more than 90% (Ministry of Health data), reaching 96.5% in the village of Leuwiliang, West Java 
(WHO-SEARO, 2004). This enormous Treatment Gap means that only one in twenty patients with 
severe psychosis currently receives treatment. While this is in part due to the stigma of mental health 
issues, traditional beliefs often point to magic or demon possession as reasons for the alteration of a 
person’s character or behaviour (Irmansyah et al., 2009b). Besides, commonly held beliefs that people 
with psychiatric disorders are incurable also led to the finality of their being locked up and hidden from 
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society. Relatively few Indonesians refer to psychiatric disorders as an illness with the potential for 
recovery. 
 
Figure 3. The Vicious Cycle of Indonesian Mental Health Service Utility 
 
It is possible that the lack of public awareness of mental health issues actively fosters stigma towards 
mental illness. This stigma, in turn, is a barrier to help-seeking (Clement et al., 2015) resulting in low 
demand for psychiatric services. This low demand may in turn influence the number of medical 
professionals interested in psychiatry (supply creation/inhibition). As the number of psychiatrists in 
Indonesia remains small, Treatment Gap remains enormous. Psychiatrists in Indonesia are also expected 
to provide public mental health education. In a vicious cycle, the very small number of psychiatrists has 
contributed to low levels of public awareness, as illustrated in Figure 1. Increasing the number of 
psychiatrists is slow and costly. Going beyond this role for psychiatrists (shaded arrow in Figure 3) it 
is likely that a wider-reaching and more sustainable approach can and should be considered.  
A comprehensive meta-analysis of randomised controlled trials looking at the effectiveness of stigma 
reduction programmes found that social distance interventions have small positive effects (Griffiths et 
al., 2014). Contact with persons with psychiatric disorders or educational interventions has been found 
helpful. For American adults, social contact is better than education at reducing stigma, and for 
adolescents, the opposite pattern was found (Corrigan et al., 2012). While Indonesian studies on stigma 
are limited, it is believed that a long-term approach to improving public awareness for mental health 
issues is through the education system. In addition, accounts from people with lived experiences can be 
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1.5 Indonesia’s New Mental Health Law 
On 30 November 2011, Indonesia ratified the Convention on the Rights of Persons with Disabilities 
(CRPD). Against this backdrop, tackling human rights abuses of people with mental health problems 
has become an urgent policy priority. Increasingly, the provision of mental health care is being viewed 
as a fundamental human right. The World Health Organisation has made tackling human rights abuse a 
crucial part of their Mental Health Action Plan 2013–2020 (WHO, 2013). Considering widespread 
human rights violations and discrimination experienced by people with mental illness, the WHO argues 
that a human rights perspective is essential in responding to the global burden of mental disorders. The 
Mental Health Action Plan emphasises the need for mental health strategies, actions, and interventions 
for treatment, prevention and promotion to be compliant with the CRPD and other international and 
regional human rights instruments. The vision of the action plan is to create “a world in which mental 
health is valued, promoted and protected, mental disorders are prevented and persons affected by these 
disorders are able to exercise the full range of human rights and to access high quality, culturally-
appropriate health and social care in a timely way to promote recovery, in order to attain the highest 
possible level of health and participate fully in society and at work, free from stigmatization and 
discrimination” (WHO, 2013). 
Within this context, mental health service legislation in countries that have ratified the CRPD must 
consider these main themes: (1) the right to adequate standard of living (Article 28 of the CRPD); (2) 
the right to enjoy the highest attainable standard of physical and mental health (Article 25 of the CRPD); 
(3) the right to exercise legal capacity; (4) the right to personal liberty and the security of person 
(Articles 12 and 14 of the CRPD), freedom from torture or cruel, inhuman or degrading treatment or 
punishment and from exploitation, violence and abuse (Articles 15 and 16 of the CRPD); (5) the right 
to live independently and be included in the community (Article 19 of the CRPD). 
In July 2014, Indonesia’s House of Representatives (Dewan Perwakilan Rakyat) approved a new 
Mental Health Law following advocacy and lobbying by a psychiatrist Member of Parliament, Dr Nova 
Riyanti Yusuf. The new law promised better treatment of people with mental ill-health and intellectual 
disabilities, including outlawing shackling. In line with the principles of freedom and social justice in 
the 1945 constitution, the new Mental Health Law built upon previous mental health legislations largely 
in line with the CRPD. This law was approved a year after India’s Mental Health Care Bill (2013) and 
two years after China’s National Mental Health Law (2012). By 2014, three of the world’s most 
populous Middle-income Countries have their own mental health legislation. China, however, began its 
mental health reforms before the law was passed by the National Assembly (Ma, 2012). In contrast, 
Indonesia remains waiting for a top-down directive on how to implement the law. 
Based on the principles of human rights and recovery, and in line with the WHO Mental Health Action 
Plan, Indonesia’s new Mental Health Law is based on the following premises: justice, humanity, 
beneficial impact, transparency, accountability, comprehensiveness, protection, and non-
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discrimination. Its layout reflects a public mental health model, with a specific focus on health 
promotion, prevention, intervention, and rehabilitation (Figure 4). The four-fold model is built upon the 
three-fold principles of prevention, intervention, and rehabilitation from the 1966 Mental Health Law, 
recognising the need for public education on mental health and efforts to reduce stigma.  
 
Figure 4. Public Health Model of Mental Health Care Embedded in the 2014 Law 
 
The new law also comes with a set of regulations governing the provision of mental health services, 
including explicitly banning the practice of pasung and stating the requirements for provincial 
governments to manage and provide primary, secondary, and tertiary care and rehabilitation of people 
with mental health issues. By 2018, only one province (West Java) had introduced local regulations 
regarding the provision of mental health services (Arisanti et al., 2018).  As it is impossible to meet the 
required number of qualified mental health professionals within the next few years, provincial 
governments must consider other solutions to provide mental health care adequately.  
In light of the political and structural makeup of Indonesia’s current health system, the management of 
psychiatric disorders seems to require a concerted effort combining deliberate top-down with grassroots 
initiatives to circumvent the stigma and human rights violations ingrained in traditional beliefs towards 
mental health disorders. The subsequent process of developing national policies around mental health 
is an opportunity to bridge cutting-edge research and public policy. Action plans and case studies should 
accompany the mandate given to provincial governments to finance and provide mental health services. 
Recognising the general lack of specialist knowledge regarding mental health service frameworks 
among civil servants in regional government offices, a lag between policy-making and ground-level 
service provision is expected. This situation presents a golden opportunity for the development of an 
evidence-base for the clinical and cost-effectiveness of various service frameworks. 
1.6 Proposed Solutions  
Experts suggested integrating mental health care into primary care, to help bridge this gap (Mendenhall 
et al., 2014). Recent research established that primary care clinics are the first port-of-call for most 
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problems in primary care is difficult for several reasons. Firstly, most patients present with physical 
ailments (Allen, 2002, Kessler and Stafford, 2008). Secondly, underlying psychiatric morbidity may 
not be diagnosed given the time constraint during the consultation (Coyne et al., 2000). Patients may 
not be familiar with articulating their symptoms, and therefore the onus is on primary care physicians 
to provide a thorough clinical interview, which may be time-consuming. Thirdly, the majority of 
primary care physicians report that they could not refer patients on for secondary care (Sorel and 
Everett, 2011). In addition, when referrals are made, no appointment is ever made for up to 90% of 
referrals made to offsite practitioners (Callahan et al., 2002, Katon, 1995, Kessler and Stafford, 2008). 
These problems are worse in Low and Middle-Income Countries (LMICs) as poverty has been linked 
to the increased prevalence of mental health problems (Arcury and Quandt, 2007, Rios-Ellis, 2005), 
and decreased likelihood of access to treatment (Borowsky et al., 2000, Hovey and Seligman, 2006, 
Miranda and Cooper, 2004, Wang et al., 2005). Despite this, there is good evidence for effective, locally 
feasible, and affordable treatments for mental health problems in LMICs. Systematic reviews have 
shown that non-specialist health worker interventions for mental health care in LMICs are clinically 
effective (Caulfield et al., 2018, van Ginneken et al., 2011). Several studies have shown the provision 
of mental health services in primary care is both effective and efficient (Bao et al., 2013, Katon et al., 
2002, Sorel and Everett, 2011). 
In the integration of mental health care into primary care, the multimorbidity of mental and physical 
illnesses is unavoidable. A cross-sectional study in Scotland found 23.2% point prevalence rate of 
multimorbidity among primary care patients (Barnett et al., 2012). The same study found that the 
presence of a mental health disorder increased as the number of physical morbidities increased. The 
rate of multimorbidity increased along with economic deprivation, and separately, age. This is relevant 
for Puskesmas-attending patients, as the free (or heavily subsidised) medical treatment attract patients 
from lower socio-economic status. For multimorbidity, the integration of mental health into primary 
care is a feasible solution to its own problem. A trial conducted in in North West England found good 
evidence supporting a collaborative care model integrating physical and mental health treatment in 
primary care for multimorbidity, resulting in mental health symptom reduction and better self-
management of chronic diseases (Coventry et al., 2015).   
Embedding a screening procedure into primary care could help early identification, intervention, and 
prevention of common mental disorders, including anxiety and depression (Baksheev et al., 2011). For 
a screening procedure to be effective, a reliable screening instrument is necessary, and its optimal 
threshold needs to be determined. Resources for effective intervention must also be in place.  
Though many academic articles, white papers, and media attention focus on the human rights violations 
towards people with mental health issues in Indonesia, only a handful focus on providing potential 
solutions. Two primary mental health service frameworks currently running in Indonesia should be 
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considered: the task-shifting framework and the specialist framework. Both frameworks have not been 
evaluated in the Indonesian context, despite their potential to be the framework of choice for other 
provincial and district governments to adopt.  
The task-shifting framework was pioneered in Aceh following the Boxing Day tsunami, and has 
undergone an evolution since 2004. As there was a lack of qualified mental health professionals who 
could provide post-disaster psychiatric intervention, cadres of health workers were trained to identify 
mental health issues, and general practitioners and nurses were trained to provide mental health services. 
The task of managing psychiatric disorders, traditionally the remit of specialist mental health 
professionals, is shifted to primary care clinicians, including general practitioners and nurses. The 
Ministry of Health, under the Directorate of Mental Health, subsequently managed the training of 
general practitioners and nurses. In 2015, 47% of Puskesmas in the country had at least one staff 
member who have been given additional mental health training: Community Mental Health Nursing 
(CMHN).  
The WHO Mental Health Gap Action Programme (WHO mhGAP) was launched in 2008. The 
programme aims to support countries in the scaling up of services for mental, neurological, and 
substance use disorders (MNS). The programme focuses on the delivery of pharmacological and 
psychosocial interventions in non-specialised healthcare settings. The WHO mhGAP manual contains 
the following modules: depression, psychoses, epilepsy, child and adolescent mental and behavioural 
disorders, dementia, disorders due to substance use, self harm/suicide, as well as other significant 
mental health complaints. Both the Intervention Guide and the Training Manual are freely available on 
the WHO website.    
In 2015, the Ministry of Health revised the curriculum for the training of Puskesmas GPs and Nurses to 
follow the adapted WHO mhGAP Training Manual. Since then, the Directorate of Mental Health has 
been systematically conducting adapted WHO mhGAP training in various provinces, to pairs of 
Puskesmas GPs and Nurses, with training costs covered by the country’s health budget. A sample 
training schedule is available in Appendix A. There was no study on the effectiveness of the task-
shifting programme in Indonesia, prior to the attempt described in this thesis. Additionally, to date there 
is no attempt to determine adherence to the intervention guide. This reflects the practicality decision-
making for public policy: available funds were directed to what policy-makers considered crucial which 
in this case is training. 
While the first WHO mhGAP Intervention Guide (mhGAP-IG) has been used by over 80 countries and 
translated into more than 20 languages, few research studies had directly addressed the utility of the 
mhGAP framework in LMICs, highlighting the pressing need for evidence (Dua et al., 2016). Studies 
on barriers and facilitators to mhGAP-IG use, adherence, and patient outcomes are particularly required, 
to inform local, regional, national, and global improvements. A recent systematic review of the WHO 
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mhGAP evidence from LMICs found 33 published literature reporting training courses (15 articles), 
clinical implementations (9 articles), country contextualisation (3 articles), economic models (3 
articles), uses as control interventions (2 articles) and use in developing a rating scale (Keynejad et al., 
2018). The same review underlined the pressing need for an understanding of contextual challenges in 
the field, detailed protocols, qualitative studies, as well as randomised controlled trials – all of which 
would be attempted by this thesis and other studies conducted alongside, for the Indonesian context. 
On the other hand, integrating psychology in primary care is in line with current thinking which 
conceptualises primary care as a biopsychosocial rather than a biomedical field (Bluestein and Cubic, 
2009). The presence of psychologists in primary care setting combines the underlying concepts of the 
Chronic Illness and Integrated Care models through facilitating shared decision making between 
primary care providers and behavioural care providers, addressing the realities of primary care 
(Bluestein and Cubic, 2009). An integrated care model in high income countries has been shown to be 
cost-effective (Liu et al., 2003), matches patients’ preference (especially older patients) (Areán et al., 
2002) leading to increased utilisation of mental health care (Hedrick et al., 2003) and results in higher 
treatment adherence and better clinical outcomes (Katon et al., 2002).  
From on an interview with Professor Laksono Trisnantoro, former Dean of Medical School, Universitas 
Gadjah Mada, In 2004, the Sleman District Health Office (within Yogyakarta province), in 
collaboration with the Centre for Public Mental Health (Universitas Gadjah Mada), initiated the 
integration of clinical psychologists within primary care (Retnowati, 2011). The presence of clinical 
psychologists in Sleman district was for the first five years (2005-2010) fully funded by Professor 
Trisnantoro’s grant from World Vision, and for the next five years (2010-2015), the presence of clinical 
psychologists in Sleman and Kota districts was 50% funded by the grant, and 50% funded by the district 
health budget. By 2016, all 43 Puskesmas in the Sleman and Kota districts (two out of five districts in 
the Province Yogyakarta), had employed a Clinical Psychologist to provide basic mental health services 
at community level. Their salaries are now 100% funded by the district health budget. These 
psychologists submit two reports annually to the Centre for Public Mental Health, a specialised unit 
within the Faculty of Psychology at Universitas Gadjah Mada, which also manages their continual 
professional development. In 2017, this programme was also rolled out to a third district within the 
province, Bantul district.  
While the resources of individual provinces across Indonesia are different, both service provision 
frameworks above can be adapted to local contexts. Both frameworks increase the accessibility of 
mental health services by providing it at a non-stigmatised, affordable, and local setting, such as primary 
care clinics. The task-shifting framework is a top-down initiative, but the specialist framework is an 
example of a bottom-up initiative. The high rate of service utilisation of Puskesmas across the country 
shows that community health centres are potentially feasible tools in the effort to bridge the Treatment 
Gap.  
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1.7 The Case for Screening 
While there is momentum to improve the mental health system, including integrating mental health 
services within primary care, there remains the worldwide problem of timely and accurate identification 
of psychiatric disorders. Illness has been defined as the subjective experience of symptoms by the 
patient and their social network, which Arthur Kleinman terms “the innately human experience of 
symptoms and suffering… how the sick person and the members of the family or wider social network 
perceive, live with, and respond to symptoms of disability” (Kleinman, 1988). Clinicians bridge the gap 
between a patient’s subjective experience of illness and the biomedical model of diseases – an especially 
challenging task in mental health.  
The process of identifying mental (psychiatric) disorders is complex and is recognised as one of the 
critical issues for healthcare. Limited understanding of the underlying physiological mechanisms behind 
mental disorders and the very nature of their definitions mean diagnoses must rely primarily on 
observations and self-reports. The current (and perhaps enduring) lack of a biomedical model for many 
of these disorders means that clinicians as a group are still dependent on subjective report for their 
definition of pathology, which may or may not transcend cultural boundaries. The subjective experience 
of the patient, the symptoms of the illness, are therefore the signs of the disease. 
Under-diagnosis of psychiatric disorders has been partly attributed to the reluctance of clinicians to 
move away from their conviction that diagnoses should be based on underlying physiological 
mechanisms, rather than symptoms of illness (Kupfer et al., 1989). Given the lack of studies in 
Indonesia and other LMICs, available studies from high-income countries are instead presented to 
illustrate potential mechanisms behind this phenomenon. Several studies report that primary care 
physicians are especially reluctant to diagnose depression and do not recognise it, resulting in an 
average delay in diagnosis in high-income countries for major depression of approximately five years 
(Mitchell et al., 2009, Tyrer, 2009). In a review of 23 studies, Mitchell and colleagues (2009) found that 
General Practitioners could identify the mild signs of depression in only 1 of 3 cases. Inherent stigma 
among clinicians based on discomfort regarding the lack of understanding of the biological basis of 
mental health conditions could inhibit General Practitioners’ ability to diagnose (Hyde et al., 2005). In 
a European qualitative study examining doctors’ attitudes towards different illnesses, Haldar and 
colleagues found that many medical practitioners across disciplines viewed mental disorders as 
“illegitimate” or less prestigious than physical illnesses (Haldar et al., 2015). Legitimacy here refers to 
Parson’s sick role (1951), which is combined with the idea of stigma (Goffman, 1963) and seriousness 
as the three elements of a sociological classification of diseases (Freidson, 1970). Borrowing from the 
labelling theory model, Freidson argues that diseases which come closest to the ideal sick role are 
serious, often acute, without stigma, and (therefore) highly legitimate.  
Though lacking in “legitimacy”, psychiatric disorders are estimated to be present in around 20-36% of 
patients attending primary care settings globally, and when untreated, result in significant suffering and 
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growing healthcare costs (Schmitz et al., 1999a, Spitzer et al., 1994).  Improving ways to identify people 
at risk of psychiatric disorders is a feasible strategy to help bridge the Treatment Gap and reduce 
suffering experienced by people with psychiatric disorders (Lund et al., 2012). Screening for symptoms 
of psychiatric disorders among primary care patients may be a practical approach for General 
Practitioners as it offers a somewhat objective way of identifying those who might benefit from further 
assessment. 
1.8 Aims and Objectives 
This thesis capitalises on recent developments to study two models of basic psychiatric care frameworks 
co-located in primary care (Puskesmas). With the primary aim of evaluating patient outcomes related 
to the implementation of both frameworks, this thesis adopts a methodical approach which would enable 
the replication of effective programme in other contexts within Indonesia. This thesis hopes to present 
an evaluation of the current situation (pragmatic trial) without introducing additional variables such as 
monitoring and reporting, which might alter clinicians’ attitudes towards their patients. As both 
frameworks co-exist in Yogyakarta, a province within Indonesia, the province was selected to be the 
trial setting. 
In embedding basic psychiatric care into the primary care system, a screening procedure would assist 
in the identification of primary care patients with potential psychiatric disorders. This thesis begins by 
testing the utility of the 12-item General Health Questionnaire (GHQ-12) as a screening tool, 
establishing an appropriate threshold associated with the presence of psychiatric morbidity for the 
Yogyakarta Puskesmas context. A Receiver Operating Curve (ROC) study described in Chapter 2 was 
undertaken to achieve this.   
Alongside the ROC study, a cluster randomised controlled trial evaluated clinical and cost-effectiveness 
of both the adapted WHO mhGAP and the Specialist Framework in Yogyakarta in terms of patient 
outcomes. Chapter 3 of this thesis describes the pilot study and the trial protocol. Clinical effectiveness 
is assessed by looking at patient outcomes at six months after enrolment. Patient outcomes examined 
include mental and social health symptoms, disability rating, and health-related quality of life. Cost-
effectiveness study examines health systems costs associated with patient improvements at six months 
after enrolment. As a pragmatic trial, clinicians’ adherence to the WHO mhGAP Intervention Guide 
was not enforced, in line with current stance of the Ministry of Health. Chapter 4 presents the trial 
results. 
This thesis concludes with a discussion of findings, strengths, and limitations of study approaches, as 
well as potential implications. The WHO increasingly acknowledges the impact of ‘real world’ 
contextual factors on the implementation of evidence-based health interventions in clinical practice 
(Peters et al., 2014). Results of the endeavour detailed in this thesis will not only inform the scale-up of 
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mental health service provisions within Indonesia but also contribute to the limited literature on ‘real 
world’ implementation of evidence-based mental health interventions in clinical practice.  
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2 THE GHQ-12 AS AN EFFECTIVE MENTAL 
HEALTH SCREENING TOOL FOR THE 
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This chapter determines the threshold associated with optimum sensitivity and specificity for the utility 
of the GHQ-12 to establish its potential as a screening tool for psychiatric morbidity among adult 
primary care patients in Yogyakarta. The threshold determined would be used as a screening criterion 
for the cluster randomised controlled trial described in Chapters 3 and 4. 
The prospective Receiver Operating Characteristic study described in this chapter was conducted with 
676 primary care patients. I compared participants’ GHQ-12 scores and psychiatric diagnosis based on 
face-to-face clinical interviews with medical practitioners using the Revised Clinical Interview 
Schedule (CIS-R). Patients were registered with 28 primary care clinics randomly selected for the study. 
From all adult patients attending the clinics, 13.7% agreed to participate (676/ 4944 consecutive patients 
approached), with the median age of 46 years old (range 18 – 82 years), and 67% women. Median 
GHQ-12 score for our primary care sample was 2, interquartile range 4. Mean score was 2.46 
(SD=2.50). The internal consistency of the GHQ-12 was good (Cronbach’s a=0.76). Results from the 
ROC curve indicated that the GHQ-12 is ‘fairly accurate’ when discriminating primary care patients 
with indication of mental disorders from those without. The optimal threshold of the GHQ-12 was either 
1/2 or 2/3 point depending on the intended utility, with a Positive Predictive Value of 0.68 to 0.73 
respectively. 
Results of the study detailed in this chapter led to the conclusion that the Indonesian version of the 
GHQ-12 could be used to screen primary care patients at high risk of mental disorders although with 
significant false positives if reasonable sensitivity is to be achieved. 
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2.1 RATIONALE 
Experts suggested integrating mental health care into primary care, to help bridge Treatment Gap 
(Mendenhall et al., 2014). Embedding a screening procedure into primary care could help early 
identification, intervention, and prevention of common mental disorders, including anxiety and 
depression (Baksheev et al., 2011). For a screening procedure to be effective, a reliable screening 
instrument is necessary, and its optimal threshold needs to be determined. Resources for effective 
intervention must also be in place.  
The General Health Questionnaire (GHQ) is a self-administered screening tool designed to detect 
current state mental disturbances and disorders in the primary care setting (Goldberg and Hillier, 1979). 
The GHQ has been translated into 38 languages since its development, indicating its face validity across 
cultures (Jackson, 2007). While the GHQ was originally developed as a 60-item questionnaire, several 
abridged versions (30-item, 28-item, 20-item, and 12-item) are currently available. The 12-item version 
was adopted as a screening tool in a multi-country World Health Organization (WHO) study of mental 
disorders in the primary care setting, as it was considered the best validated among similar inventories 
(Goldberg et al., 1997, Schmitz et al., 1999b, Üstün and Sartorius, 1995).  
The twelve-item General Health Questionnaire (GHQ-12) is intended to screen for general (non-
psychotic) psychological morbidity among primary care patients (Goldberg et al., 1997). Items on the 
GHQ-12 are rated on a 4-point scale using a time-frame of ‘in the last two weeks’. There are two ways 
of scoring the GHQ-12: the bimodal GHQ scoring method (0-0-1-1) recommended by the test authors 
for use in clinical settings; and the Likert scoring method (0-1-2-3) which is commonly used in research 
settings. 
A review of international validity studies of GHQ-12 conducted 20 years ago, including in low and 
middle-income countries, of GHQ-12, reported that the optimal threshold varied from 1/2 to 6/7, with 
the most common cut-off being 2/3 (Goldberg et al., 1997). Adding a further 17 international studies 
revealed a variation from 0/1 to 5/6 (Goldberg et al., 1998). In later studies, the distribution ranged from 
1/2 to 3/4 (Cano et al., 2001, Caraveo-Anduaga et al., 1998, Schmitz et al., 1999a, Yusoff, 2010). These 
differences may be the result of varying prevalence rates of mental disorders and comorbidity, as well 
as the populations in which the scale was administered and cultural influences (Lewis, 1992).  
The Indonesian Ministry of Health adopted the GHQ-12 for its 2007 Basic Health Research, a nation-
wide survey of the socio-cultural determinants of health (Kemenkes, 2008). As such, an Indonesian 
version has been available for some time. However, its reliability and validity in the primary care setting 
had not been evaluated, and a validated threshold has not been established. A validated, appropriate 
country cut-off is needed to identify patients with potential mental disorders effectively.  
A Study of Two Models of Primary Mental Health Care Provisions in Yogyakarta, Indonesia 
24  Sabrina Gabrielle Anjara – August 2018 
This study aimed to determine appropriate thresholds for optimum sensitivity and specificity of the 
GHQ-12 in adult Indonesian primary care patients. Threshold determined would be a screening criterion 
for the cluster randomised controlled trial described in subsequent chapters. A Receiver Operating 
Characteristic (ROC) study is a valuable method to determine appropriate thresholds. ROC curves have 




A prospective ROC study was conducted to test the screening accuracy of the GHQ-12 and determine 
the point at which the balance between sensitivity and specificity is optimised. The curve is created by 
plotting the true positive rate (sensitivity) against the false positive rate (1-specificity) for each 
discrimination threshold score. The area under a ROC curve represents the probability that a randomly 
chosen subject is correctly rated or ranked with greater suspicion than a non-diseased subject (Hanley 
and McNeil, 1982). The size of the area under the curve is directly proportionate with diagnostic 
accuracy, with the most appropriate threshold value being the closest to the point of perfect 
classification which represents 100% sensitivity and 100% specificity. This threshold can then be 
recommended for screening use in primary care (clinical) settings in Indonesia. 
2.2.2 Participants 
Participants were recruited over a period of two weeks (December 2016) from 28 Puskesmas in 
Yogyakarta, Indonesia, as part of a cluster randomised controlled trial (NCT02700490, 
clinicaltrials.gov). 13.7% (676) agreed to take part out of 4944 consecutive primary care adult attendees. 
Patients self-completed the GHQ-12 before an in-depth psychiatric interview with a General 
Practitioner. 
2.2.3 Measures 
General Health Questionnaire (GHQ-12) 
The primary measure being assessed for its screening accuracy in Indonesian, as translated by the 
Indonesian Ministry of Health and used in the nation-wide Basic Health Research (Kemenkes, 2008) 
was the GHQ-12. As this study took place in a ‘real life’ clinical setting, the GHQ scoring method (0-
0-1-1) was utilised.   
As the aim of this study was to examine the adequacy of the GHQ-12 as a diagnostic tool, lifetime 
diagnoses were not taken into consideration. Instead, current mental health status was evaluated. 
 
Clinical Interview Schedule-Revised (CIS-R) 
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For the evaluation of psychological morbidity, clinicians used the Clinical Interview Schedule-Revised 
(CIS-R) (Lewis and Pelosi, 1990) and any further clinical interview questions (as required), following 
the protocol of similar validity studies in Italy, England, Brazil, and Chile (Goldberg et al., 1998). The 
CIS-R (Lewis and Pelosi, 1990) is a fully structured diagnostic instrument that was developed from an 
existing instrument, the Clinical Interview Schedule (CIS), which was designed for the use of clinically 
experienced interviewers (Blay et al., 1991). The CIS was revised and developed into a fully structured 
interview to increase standardisation and to make it suitable to be used by trained lay interviewers in 
assessing minor psychiatric morbidity in the community, general hospital, occupational and primary 
care research. As the CIS-R specifically diagnoses mood and anxiety disorders, participants with an 
indication of other disorders (psychosis, sleep disorders, dementia) were asked additional questions 
which enabled the interviewers to establish an ICD-10 diagnosis. For our sample, the interview was 
conducted by general practitioners or clinical psychologists employed by each primary care clinic. The 
psychiatric diagnostic criteria of the ICD-10 are widely used in the Indonesian, public healthcare 
services as the Indonesian manual for diagnosing psychiatric disorders (Pedoman Panduan Diagnosa 
Gangguan Jiwa) released in 1993 and used by medical doctors and psychologists, was a translation of 
the ICD-10 released by the WHO in 1992.  
2.2.4 Data Analysis 
The required sample size for a prospective ROC study of a single diagnostic test (Obuchowski, 1998) 
allowing a type I error of 0.05 and a power of 0.80, with the more conservative AUC1 of 0.80, AUC0 
of 0.70, and the allocation ratio of 4 (prevalence of common psychiatric disorders is estimated to be 
20% in the primary care population, thus the prevalence of non-diseased is estimated at 80%) was 370 
subjects (74 clinically confirmed cases and 296 clinically confirmed non-cases). The sample size 
calculation confirmed that the sample size recruited as part of the cluster randomised controlled trial to 
evaluate the clinical and cost effectiveness of primary mental health interventions in Yogyakarta is 
sufficient for this ROC study.  
I used SPSS version 24.0 to calculate descriptive statistics and perform a ROC curve analysis on the 
data, as it is a commonly used method for visualising performance ability and grouping classification 
(Fawcett, 2006). The ROC analysis plots a test’s true positive rate (sensitivity) against its false positive 
rate (1-specificity) (Obuchowski and McClish, 1997). The area under the curve (AUC) ranges from 0.5 
for models with no discrimination ability, to 1 for models with perfect discrimination ability (Miska 
and Jan, 2005). A ROC curve that is near the point of perfect classification (upper left corner of the 
ROC space) is considered superior for detection performance (Metz, 1978).  
In addition, the positive predictive value (PPV) describes the proportion of all positive results that are 
correct; while the negative predictive value (NPV) represents the proportion of all negative results that 
is correct. These predictive values are dependent on the prevalence of mental disorders in the study 
sample (Zweig and Campbell, 1993). 
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Total GHQ-12 scores were utilised as the test variable. The bimodal scoring method (0-0-1-1) was used 
as the study was conducted in a clinical setting. Two-by-two contingency tables were created by cross-
tabulating diagnostic outcomes (the presence or absence of any mental disorders according to ICD-10) 
and the GHQ-12 screening outcomes (positive or negative screening on the GHQ-12). The gold 
standard against which the GHQ-12 was tested was the presence of diagnosis following an in-depth 
psychiatric interview using the CIS-R. 
2.3 RESULTS 
2.3.1 Sample Characteristics 
Participants were aged between 18 and 82 years old (median 46). From 4944 primary care patients 
approached, 676 consented to participate (452 women; 224 men). The mean score for women was 2.60 
(SD=2.55) and for men 2.16 (SD 2.38). The median and interquartile range for women were 2 and 4, 
and for men 2 and 3. The difference in mean scores between women and men was not significant 
(t=2.174, p=0.30). 
The table below presents participants’ demographic characteristics (age, marital status, education level), 
as well as their GHQ-12 scores by gender. 
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Table 2. Total and by gender socio-demographic characteristics and GHQ-12 scores (0-0-1-1 
scoring) 
 Women (N=452)   Men (N=224)   Total (N=676) 
  N %   N %   N % 
Age (11 missing)         
   18-29 117 26.2  47 21.5  164 24.7 
   30-39 62 13.9  24 11.0  86 12.9 
   40-49 118 26.5  28 12.8  146 22.0 
   50-64 119 26.7  81 37.0  200 30.1 
   65+ 30 6.7  39 17.8  69 10.4 
         
Marital Status (2 missing)         
   Unmarried 77 17.1  54 24.1  131 19.4 
   Married 319 71.1  163 72.8  482 71.7 
   Separated/Divorced/Widowed 53 11.8  7 3.1  60 8.9 
         
Education (6 missing)         
   Elementary 94 21.0  33 14.9  127 19.0 
   Middle School 104 23.2  43 19.4  147 21.9 
   High School 157 35.0  97 43.7  254 37.9 
   Diploma 20 4.5  16 7.2  36 5.4 
   University 48 10.7  27 12.2  75 11.2 
   Others 25 5.6  6 2.7  31 4.6 
         
GHQ-12 Score      
Mean (SD) 2.60 (2.55)   2.16 (2.38)   2.46 (2.50) 
Median (IQR) 2.00 (4.00)  2.00 (3.00)  2.00 (4.00) 
 
Almost one in five (19%) had only completed elementary-level education. A further 21% completed 
Junior High School, and 37.9% completed High School. The rest (22.1%) completed undergraduate or 
postgraduate degrees. There is no statistically significant difference in mean and median scores between 
those who received education beyond the High School level, and the rest of the population (t=2.72, 
p=0.07). Fewer than 5% received less than six years of formal education.  
Thirty-two participants (4.7%) were born outside Java and did not belong to the Javanese ethnicity. 
They represented other remote parts of Indonesia including Aceh (Western-most province) and Papua 
(Eastern-most province). In Indonesia, 42% of the population identify as ethnic Javanese.  
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2.3.2 Reliability 
The internal consistency coefficients (Cronbach’s alpha) of the GHQ-12 for bimodal scoring (0-0-1-1) 
was 0.76, indicating satisfactory internal consistency. 
2.3.3 Validity coefficients and area under the ROC curve 
Table 3 shows the prevalence of ICD-10 psychiatric diagnoses and GHQ-12 mean scores for adult 
Indonesian primary care patients.  
For those with a severe depressive episode, the GHQ-12 mean score was 8.40 (SD=3.78), median of 10 
and interquartile range of 7. For those with Comorbid Anxiety and Depression, the GHQ-12 mean score 
was 3.95 (SD=2.46), the median of 3 and Interquartile Range of 3. For those with the general anxiety 
disorder, the GHQ-12 mean score was 4.56 (SD=3.07), the median of 6 and interquartile range of 9. 
Table 3. Total and by gender prevalence of psychiatric diagnoses and mean GHQ-12 scores 
(bimodal scoring) of respondents interviewed with CIS-R and further clinical interviews 
ICD-10 diagnoses 
 Women Men Total  GHQ-12 GHQ-12 
 N (%) N (%) N (%)  M±SD Median (IQR) 
Mild depressive episode  7 (1.0) 29 (4.3) 36 (5.3)  3.42±2.60 2 (3) 
Moderate depressive episode  1 (0.1) 11 (1.6) 12 (1.8)  5.42±2.91 7 (4) 
Severe depressive episode  1 (0.1) 4 (0.6) 5 (0.7)  8.40±3.78 10 (7) 
        
Mixed anxiety and depression  31 (4.6) 71 (10.5) 102 (15.1)  3.95±2.46 3 (3) 
        
General anxiety disorder  7 (1.0) 18 (2.7) 25 (3.7)  4.56±3.07 6 (2) 
Panic disorder  5 (0.7) 15 (2.2) 20 (3.0)  3.55±3.27 5 (6) 
Social phobia  7 (1.0) 13 (1.0) 20 (3.0)  2.50±1.61 2 (1) 
Agoraphobia  1 (0.1) 0 (0.0) 1 (0.1)  2.00±0.00 2 (0) 
Specific isolated phobia  2 (0.3) 6 (0.9) 8 (1.2)  3.25±0.89 3.5 (2) 
Obsessive compulsive disorder  0 (0.0) 3 (0.4) 3 (0.4)  5.67±1.16 5 (0) 
        
Diagnosis of other disorders   15 (2.2) 54 (8.0) 69 (10.2)   3.00±2.58 2 (3) 
 
Mean and median scores for those with a diagnosis (cases) compared to those who do not meet the ICD-
10 diagnostic criteria (non-cases) are shown in Table 4. 
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Table 4. GHQ-12 mean and median scores for non-cases vs cases meeting any ICD-10 diagnostic 
criteria during the sampling period, Bimodal scoring (0-0-1-1) 
 Women  Men  All  
   N    N    N 
Mean (SD)         
   Cases  3.70 (2.66) 235  3.61 (2.64) 89  3.68 (2.65) 324 
   Non-cases 1.40 (1.79) 216  1.21 (1.58) 135  1.33 (1.71) 351 
         
Median (IQR)         
   Cases  3 (3) 235  3 (3) 89  3 (3) 324 
   Non-cases 1 (2) 216  1 (2) 135  1 (2) 351 
         
 
The GHQ-12 mean for cases (48%) was 3.68 (SD=2.65), and the mean for non-cases (52%) was 1.33 
(SD=1.71). The group meeting diagnostic criteria had significantly higher mean scores than those 
without a diagnosis (t=-13.773, df=673, p<0.001).  
The GHQ-12 median for cases (48%) was 3, Interquartile Range of 3, and the median for non-cases 
was 1, Interquartile Range of 2. The group meeting diagnostic criteria had significantly higher median 
scores than those without a diagnosis (Mood’s Median Test c2=111.07, df=1, p<0.001). 
The threshold values, sensitivity, specificity, PPV, NPV, and AUC of the GHQ-12 based on diagnostic 
groups (at two-week prevalence) are summarised in Table 5. 
Table 5. Performance and ROC area of the GHQ-12 (bimodal scoring) 
ICD-10 Diagnoses Threshold SE SP PPV NPV AUC 
Mood Disorders 1/2 0.774 0.433 0.104 0.957 0.702 
 2/3 0.717 0.634 0.143 0.963  
Mixed Anxiety and Depression 1/2 0.902 0.474 0.234 0.965 0.725 
 2/3 0.686 0.659 0.263 0.922  
Anxiety Disorders 1/2 0.805 0.446 0.157 0.947 0.661 
 2/3 0.597 0.624 0.172 0.924  
Any diagnosis 1/2 0.824 0.641 0.679 0.789 0.787 
  2/3 0.599 0.798 0.732 0.683  
 
The ROC analysis indicated that the optimal cut-off point for the identification of any diagnosis was 
1/2. Sensitivity was 82% while specificity was 64%. The AUC of 0.79 indicates that GHQ-12 is ‘fairly 
accurate’. The traditional established point system for the AUC specifies that AUC of at least 0.70 is 
required to ensure fair accuracy (Zweig and Campbell, 1993). The ROC curve for any ICD-10 diagnosis 
is presented in Figure 5.  
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Figure 5. ROC curve of GHQ-12 for ICD-10 psychiatric diagnoses. Bimodal scoring 0-0-1-1. 
2.4 DISCUSSION  
The GHQ-12 was found to have good reliability (inter-item consistency) within the Yogyakarta primary 
care setting. It is also a ‘fairly accurate’ screening tool with predictive power for ICD-10 psychiatric 
diagnosis of nearly 0.8 (AUC=0.78). The recommended optimal threshold differs depending on the 
objectives for using the GHQ-12. For use in Puskesmas, the goal can be to comprehensively screen for 
any ICD-10 psychiatric diagnosis even at the risk of a high false positive rate. As such, the optimal 
threshold for the bimodal scoring is 1/2 points. If the goal is for better discrimination of mood disorders 
and anxiety disorders (Goldberg et al., 1998) it may be more appropriate to adopt the more stringent 
threshold of 2/3 points. 
While for practicality, a more conservative cut-off score will reduce the absolute number of psychiatric 
interviews to be conducted, one must critically form a decision with the awareness that there are people 
who would otherwise be diagnosed, who did not meet the screening criteria (False Negatives). Using a 
cut-off score of 2, the False Negative Rate is 20%, while with a more conservative cut-off score of 3, 
the False Negative Rate is 31%. If the goal of screening for psychiatric disorders in primary care is to 
help bridge Treatment Gap, the recommended threshold is 1/2 points, where a score of 2 or above is 
‘positive’ for at risk of psychiatric disorders. 
The analysis confirms that the Indonesian version of the GHQ-12 can be useful in screening for 
psychiatric morbidity among primary care patients. For clinical services, an optimal threshold score for 
any tool used in screening for mental disorders is necessary to best distinguish at-risk individuals from 
the remaining population (Mann et al., 2005). A screening tool such as the GHQ-12 may have 
considerable utility within primary care in Indonesia, particularly as it may have the potential to increase 
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efficiency within an overburdened healthcare system. It could only be introduced, however, if the 
adequate services to support those screened are in place (Wilson and Jungner, 1968).  
The medians of participants with a psychiatric diagnosis (3) and those without (1), shows that while the 
difference of one or two scores may seem trivial, it was sufficient to highlight potential ‘cases’ from 
other primary care patients. The use of a ‘fairly accurate’ screening tool within a clinical setting would 
facilitate the swift identification of primary care patients at risk of psychiatric morbidity, bolstering the 
confidence of primary care doctors to conduct an in-depth psychiatric interview without fear of making 
a mistake or offending their patients. Those who screened positive should be provided additional 
information regarding common psychiatric disorders (Kelly et al., 2007). Screening, coupled with 
increased mental health literacy could facilitate the early identification and intervention of psychiatric 
disorders, which would help bridge Indonesia’s enormous Treatment Gap.  
While this study’s strength lies in its validation of the utility of the GHQ-12 in Indonesia’s primary care 
setting, this study is not without its limitations. The length of waiting time means more patients who 
agreed to take part in the study left before completing the standardised psychiatric interviews, due to 
other commitments such as work. Women in caregiving roles typically brought their dependent children 
along to the Puskesmas. The manifestations of gender role are reflected in the smaller number of men 
participating in the study (n=224) compared to women (n=452). Women have been shown to be more 
willing to access mental health services than men (Gove, 1984, Mackenzie et al., 2006).  
As this study took place in real life settings, I observed that medical consultations including the 
standardised psychiatric interview took between 20 to 60 minutes longer, depending on the complexity 
and severity of symptoms to be addressed. At some clinics, patients meeting the screening criteria were 
asked to wait for all other patients to have their consultations, drawing sharp criticisms from patients 
who had to wait hours for their consultations. In other clinics, one GP on duty was assigned to handle 
all patients requiring a psychiatric interview, while all other patients had consultations with other GPs 
– a seemingly more realistic pathway. 
While this study confirms the efficacy of the Indonesian version of the GHQ-12 for the Indonesian 
primary care population, it is not necessarily generalisable for whole populations for general screening, 
as opposed to primary care attendees. Further research into the utility of the GHQ-12 to accurately 
screen for mental disorders among the non-primary care population should be attempted. It should be 
noted that although the GHQ-12 identifies at-risk individuals, to establish an ICD-10 diagnosis requires 
a full psychiatric interview with qualified clinicians. 
Introduction of screening for mental disorders could have major implications for services, both in 
primary care, ancillary services to provide effective interventions such as CBT, and secondary care 
psychiatric services. Indonesia’s current mental health system would need to be reviewed to assess in 
what ways it could be strengthened to provide optimal services, given the ongoing systematic roll-out 
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of the adapted WHO mhGAP framework to provide mental health management services in primary care 
clinics across the country. If screening were to be implemented across primary care clinics in Indonesia, 
it is possible its impact would be viewed with concern. Understandably, in clinics with significantly 
fewer resources, the health workforce is limited. Increased consultation time, increased waiting time, 
and possibly increased working hours for clinicians are but some of the issues anticipated, which might 
lead to rejection of the development. 
The benefits of screening for mental disorders in primary care must be weighed against other practical 
considerations. Nonetheless, in Indonesia, where the Treatment Gap for mental disorders is above 95% 
(Kemenkes, 2012), the benefits could potentially outweigh the disruption of implications for service.  
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3 TRIAL PROTOCOL 
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3.1 Study Design 
This study (“the trial”) set out to compare patient outcomes following usual care either by primary care 
doctors additionally trained in the Indonesian-adapted WHO mhGAP framework or clinical 
psychologists in the Specialist Co-location framework through a pragmatic, two-arm cluster 
randomised controlled non-inferiority trial. This study design enabled an examination of patients 
derived from whole populations in a ‘real world’ setting. 
A standard randomised controlled trial (RCT) would require both frameworks of services to be provided 
within each site, i.e. the Puskesmas unit. Within the context of this trial, participants randomised to 
another treatment group would be asked to travel to another location if the current Puskesmas does not 
provide the framework. Having both treatment frameworks within a Puskesmas unit was not desirable 
due to potential contamination between intervention and control participants. Contamination of control 
participants would have two effects: reducing the point estimate of an intervention’s effectiveness and, 
as a result, a higher likelihood of type II error. Considering potential contamination, a pragmatic CRCT 
design was chosen, despite requiring a bigger sample size for the same statistical power and the 
possibility of increased recruitment bias. 
A non-inferiority trial was chosen to test whether either framework is better than the other, for all 
outcomes. This type of trial is frequently used where the use of a superiority trial against a placebo 
control (e.g. no treatment) is considered unethical. 
The primary outcome was the health and social functioning of participants as measured by the Health 
of the Nation Outcome Scale (HoNOS) (Wing et al., 1996) and secondary outcomes were disability as 
measured by WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) (Sousa et al., 2010), quality 
of life as measured by European Quality of Life Scale (EQ-5D-3L) (Oppe et al., 2007), and cost of 
intervention evaluated from a health services perspective, which aimed to determine the clinical 
effectiveness and cost-effectiveness of the adapted WHO mhGAP framework of primary mental health 
care versus a Specialist framework of care at 6-month follow-up. Both are currently operational 
frameworks of primary mental health service provision in several Puskesmas within one province 
(Yogyakarta) in Indonesia. The selection of outcome measures was advised by Dr S. Idaiani from the 
Indonesian Ministry of Health. 
The trial protocol was assessed during a University of Cambridge internal examination on 19th 
November 2015, by Dr Stephen Gillam and Professor Martin Roland.  
The trial involved two phases: a pilot study in June 2016 with the objectives to refine data collection 
procedures and to serve as a practice run for clinicians involved in the trial (Appendix B); as well as a 
substantive trial beginning in December 2016. This chapter describes the methods and outcomes of the 
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pilot study, with a focus on the impact on the recruitment strategies used for the substantive trial. 
Subsequently, this chapter described the methods used for the substantive trial. 
3.2 Pilot Study (June 2016) 
A pilot study is defined by the UK’s National Institute for Health Research (NIHR) as: 
“… a version of the main study that is run in miniature to test whether the components of 
the main study can all work together. It is focused on the processes of the main study, for 
example to ensure recruitment, retention, randomization, treatment, and follow-up 
assessments all run smoothly.” 
The pilot study, therefore, resembled the substantive study in most respects, except for follow-up 
assessments, given the time limitation of the doctoral degree. The recruitment period for the pilot was 
one week, and was designed to assess three questions: 
1. Is it feasible to recruit the number of participants required to meet the planned sample size? 
2. Is the screening and recruitment procedure feasible? 
3. Do clinicians find it difficult to perform the in-depth psychiatric interview required to formalise 
a diagnosis, under time pressure? 
3.2.1 Results of the Pilot Study 
Concerning question 1, the internal pilot proved that recruitment was feasible if conducted over a more 
extended period and that the planned sample size could be achieved in principle. The pilot recruitment 
graph is presented in Appendix C.  
The pilot study was conducted over a period of one week in June 2016. Trained and vetted research 
assistants checked in for duty every morning at 7 am and were asked to take a self-portrait with a specific 
object within the Puskesmas of their duty. Information on the object, e.g. queue number collection 
counter, was provided every morning to ensure compliance. A tally of the number of screenings 
completed was checked against Puskesmas attendance at the end of every day, which enabled the 
calculation of the percentage of adult primary care attendees screened. Research assistants checked out 
from duty by sending a picture of the empty Puskesmas to the PhD Researcher coordinating the study 
on site. All research assistants were given the same base salary (Rp 100,000 ~ £6, per day), but those 
on duty at a Puskesmas more than three hours’ drive from the centre of Yogyakarta were given 
additional transport allowance of a day’s salary. Given the lack of an incentive structure, I observed a 
steady decrease in the percentage of adult attendees screened daily in some Puskesmas, indicating a 
decline in commitment which prompted me to consider an incentive structure for the substantive study. 
Nonetheless, 5341 patients were screened within the recruitment week. 
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The evaluation of question 2 indicated that the provision of one research assistant per clinic to manage 
the screening of all adult primary care attendees raised minor challenges. As the research assistant had 
to conduct recruitment by explaining the trial objectives to those meeting the screening criteria, several 
adult primary care attendees were left unscreened every day. To further complicate matters, older 
patients required help with reading the screening questionnaire which rendered other patients neglected. 
It was also tricky for research assistants to manage four separate documents for each patient: screening 
questionnaire, information sheet, informed consent sheet, and the questionnaire booklet. All this need 
to be compiled with clinician’s assessment following the psychiatric interview. I noticed the potential 
for the mismanagement of paperwork by research assistants. Despite the challenges, the proposed 
procedure proved to be feasible. A focus group with five research assistants and local adviser, Dr 
Bambang Hastha Yoga, discussed potential mitigating strategies for the substantive trial, including 
having a pair of research assistants per Puskesmas, which were eventually implemented in the 
substantive trial.  
The evaluation of question 3 indicated an inconsistency of confidence among clinicians to conduct in-
depth psychiatric interviews during busy clinic hours. The pilot study highlighted that with limited time, 
such as during general practitioner’s consultation, it was difficult for clinicians to ask questions relating 
to symptoms of psychiatric morbidity. Given the interest in also conducting a Receiver Operating Curve 
study on the GHQ-12 (Chapter 2), a gold standard against which the threshold scores could be compared 
to was required. Given the precedent set by similar studies conducted in sub-Saharan Africa, under the 
advice of Professor Martin Prince of King’s College London, I incorporated the Revised Clinical 
Interview Schedule (CIS-R) which is a structured interview guide to assess the symptoms of psychiatric 
disorders efficiently. 
Subtle changes to the substantive study were made, including assigning two research assistants per 
clinic and converting the information sheets, informed consent sheets, questionnaire batteries, and 
structured psychiatric interview guide into booklet form. In addition, I extended the recruitment period 
of the substantive study to two weeks. Doubling the number of research assistants and the length of the 
recruitment period raised logistical and resource challenges, as additional recruitment and training were 
required in addition to extra research expenses.  
3.3 Main Trial Methods 
3.3.1 Ethics and governance 
Ethics approval for the study was granted by the University of Cambridge Psychology Research Ethics 
Committee (reference number PRE.2015.108; Appendix D) and Universitas Gadjah Mada (reference 
number 1237/SD/PL.03.07/IV/2016; Appendix E). Trial insurance further covers investigators and 
research participants (University of Cambridge Trial Insurance reference number 609/M/C/1510; 
Appendix F). Ethics approval from all the clusters was not required as each cluster (Puskesmas) is a 
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state-owned clinic funded and managed by district governments. Permission to conduct research at the 
Province of Yogyakarta including its all five districts was obtained from the Provincial Government 
Office (reference number 070/REG/V/625/5/2016; Appendix G). This trial is registered with 
clinicaltrials.gov on 25 February 2016, NCT02700490. 
3.3.2 Interventions 
3.3.2.1 Experimental Group: Indonesian-adapted WHO mhGAP 
The concept of “Treatment Gap” (TG -- % of those unidentified and untreated who might benefit from 
known treatments) has been identified as a critical issue within global mental health, leading to the 
WHO response that is the Mental Health Gap Action Programme (WHO mhGAP). The training manual 
is available for free download online in various languages, at 
http://www.who.int/mental_health/mhgap/training_manuals/en/. Since 2008, the WHO mhGAP 
programme aims to scale up services for mental, neurological, and substance use disorders especially 
among low and middle-income countries, by providing add-on clinical mental health training to a non-
specialist audience. The intervention guide, first released in 2010, presents integrated management of 
priority conditions including depression, psychosis, bipolar disorder, epilepsy, developmental and 
behavioural disorders in children and adolescents, dementia, disorders due to substance abuse, self-
harm/suicide and other significant emotional or medically unexplained complaints.  
Proposed management of disorders includes psychoeducation, basic and advanced psychosocial 
interventions, and pharmacological therapy. Advanced psychosocial interventions outlined in the WHO 
mhGAP Intervention Guide 1.0 are listed in the WHO website 
(https://www.paho.org/mhgap/en/int_management.html – accessed on 26 October 2018) and include: 
Behavioural Activation, Cognitive Behavioural Therapy, Contingency Management Therapy, Family 
Counselling or Therapy, Interpersonal Psychotherapy, Problem-solving Therapy, Relaxation Training, 
and Social Skills Therapy (Figure 6). 
The WHO mhGAP framework has been translated to Bahasa Indonesia by the Indonesian Ministry of 
Health in 2015, adapted to the country’s context, and systematically introduced throughout the network 
of 10,000 Puskesmas across the country. The implementation of the adapted WHO mhGAP framework 
aims to reduce Treatment Gap through facilitating early identification and providing basic or initial 
intervention in primary care. Since its adaptation and adoption in late 2015, Indonesia’s Directorate of 
Mental Health trained between 10 to 20 pairs of Puskesmas doctors (general practitioners) and 
Puskesmas nurses from each province every month, alternating between 34 provinces. These Puskesmas 
were chosen at random from all available Puskesmas, with the intention of scaling up to all 10,000 
Puskesmas across the country. The training schedule for this trial, detailing the modules taught, is in 
Appendix A. 
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Figure 6. Advanced Psychosocial Interventions recommended in the WHO mhGAP framework 
(source: WHO) 
 
The Ministry of Health designated the adapted WHO mhGAP framework as a scale-up training for 
registered medical practitioners and nurses who already had to complete a set of competencies for a 
comprehensive list of psychiatric conditions prior to gaining a license to practice. The adapted WHO 
mhGAP modules are therefore, in the Indonesian context, akin to the addition of new tools to an already 
comprehensive toolbox of a medical doctor. It should be noted that the set of competencies and 
psychiatric conditions agreed the Indonesian Medical Council and listed in the Indonesian Medical 
Practitioners Competency Standards are specific to the Indonesian context, 
(http://fk.ub.ac.id/profesi/wp-content/uploads/2013/10/Standar-Kompetensi-Dokter-Indonesia_SKDI-
2012-1.pdf) in light of the limited provision of specialist medical care in rural Indonesia, and may not 
be transferable to other countries. WHO mhGAP practitioners typically employ a combination of basic 
psychosocial intervention and pharmacological therapy to manage disorders.  
For the list of Medical Doctor Basic Licensing core competencies in Table 6, there are four levels of 
competency determined: 
1. Level 1: theoretical understanding including biomedical and psychosocial aspects, as well as 
the ability to explain to patients and family members, colleagues, and other professions 
including regarding the principles, indications, and complications which may arise. 
2. Level 2: theoretical and practical understanding, including biomedical and psychosocial 
aspects, with emphases on clinical reasoning and problem solving, including direct observation 
experience of patients. 
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3. Level 3: theoretical and practical understanding, including biomedical and psychosocial 
aspects, with direct practical experience on standardised patients (e.g. through Objective 
Structured Clinical Examinations (OSCE)). 
4. Level 4: independent practice, following thorough theoretical and practical understanding and 
experience, practice under direct supervision, for example through work-based assessments 
(e.g. through mini-CEX). 
1. 4A: core competencies derived upon completing general medical education. 
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Table 6. Medical Doctor Basic Licensing Core Competencies for Psychiatry, Medical 
Practitioners Competency Standards (source: Indonesian Medical Council) 
Number Competency Level of Competency 
ANAMNESIS 
1.  Autoanamnesis with patient 4A 
2.  Alloanamnesis with other family members or significant others 4A 
3.  Information on primary presenting problem 4A 
4.  History of the progress of condition 4A 
5.  Gaining meaningful information regarding early childhood 
development, education, employment, relationship, family life 
4A 
PSYCHIATRIC ASSESSMENT 
6.  Assessment of mental state 4A 
7.  Assessment of consciousness 4A 
8.  Clinical assessment of perception, orientation, and intelligence 4A 
9.  Assessment of orientation 4A 
10.  Clinical assessment of intelligence 4A 
11.  Assessment of form and content of thought 4A 
12.  Assessment of mood and affect 4A 
13.  Assessment of motor function 4A 
14.  Assessment of impulse control 4A 
15.  Assessment of judgment ability 4A 
16.  Assessment of insight 4A 
17.  Assessment of general functioning 4A 
18.  Personality assessment (projective, inventory, etc.) 2 
DIAGNOSIS AND IDENTIFICATION  
19.  Establishing a diagnosis based on multiaxial diagnostic criteria 4A 
20.  Differential diagnosis 4A 
21.  Identifying psychiatric emergency 4A 
22.  Identifying physical, psychological, and social problems 4A 
23.  Considering prognosis 4A 
24.  Determining reason for referral 4A 
ADDITIONAL ASSESSMENT 
25.  Mini Mental State Examination 4A 
26.  Home visit, if required 4A 
27.  Consultative cooperation in a multidisciplinary team 4A 
THERAPY 
28.  Psychopharmacology therapy (antipsychotic, antidepressant, 
anticholinergic, sedative, etc.) 
3 
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29.  Electroconvulsive therapy (ECT) 2 
30.  Supportive psychotherapy (counselling) 3 
31.  Behaviour modification therapy  2 
32.  Cognitive Behaviour Therapy (CBT) 2 
33.  Psychoanalytic psychotherapy  1 
34.  Hypnotherapy and Relaxation therapy 2 
35.  Group Therapy 1 
36.  Family Therapy 2 
 
For the list of psychiatric conditions which are covered in the Medical Practitioners Competency 
Standard (Table 7), there are also four levels of competencies expected: 
1. Level 1: understanding and explaining the clinical presentation of the condition and able to 
utilise the most suitable method to gain further information on the condition, afterwards 
determining the appropriate referral pathway for the patient. Graduates of medical school are 
also able to manage the condition following return from referral. 
2. Level 2: able to form a clinical diagnosis of the condition, and determining the appropriate 
referral pathway for follow-up intervention. Graduates of medical school are also able to 
manage the condition following return from referral.  
3. Level 3: diagnosing, providing initial intervention, and referring. 
3. Level 3A: in non-emergency situations, graduates of medical school are able to form a 
clinical diagnosis and provide initial intervention. Medical school graduates are then able 
to determine the appropriate referral pathway for follow-up intervention. Graduates of 
medical school are also able to manage the condition following return from referral. 
4. Level 3B: in emergency situations, graduates of medical school are able to form a clinical 
diagnosis and provide initial intervention to save patient’s life or prevent further harm on 
the patient. Medical school graduates are then able to determine the appropriate referral 
pathway for follow-up intervention. Graduates of medical school are also able to manage 
the condition following return from referral. 
4. Level 4: diagnosing, managing condition independently, and discharging. 
5. Level 4A: core competencies derived upon graduation from medical school. 
6. Level 4B: proficiencies derived after internship.      
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Table 7. ICD-10 Psychiatric Conditions which are part of Medical Doctors' Basic Licensing Core 
Competencies (source: Indonesian Medical Council) 
Number Conditions Level of Competency 
ORGANIC MENTAL DISORDER 
1.  Delirium not induced by alcohol or other psychoactive substances 3A 
MENTAL AND BEHAVIOURAL DISORDERS FROM SUBSTANCE USE 
2.  Acute intoxication of psychoactive substance 3B 
3.  Addiction/substance dependency 3A 
4.  Delirium induced by alcohol or other psychoactive substances 3A 
PSYCHOSIS 
5.  Schizophrenia 3A 
6.  Delusion 3A 
7.  Psychotic disorder 3A 
8.  Schizoaffective disorder 3A 
9.  Bipolar disorder, manic episode 3A 
10.  Bipolar disorder, depressive episode 3A 
NEUROTIC DISORDERS, STRESS, AND SOMATOFORM DISORDERS 
11.  Cyclothymic disorder 2 
12.  Endogenic depression (single episode or recurrent) 2 
13.  Dysthymic disorder (neurosis depression) 2 
14.  Depressive episode (unclassified) 2 
15.  Baby blues (post-natal depression) 2 
ANXIETY AND PHOBIA  
16.  Agoraphobia with or without panic 2 
17.  Social phobia 2 
18.  Specific phobia 2 
OTHER ANXIETY DISORDERS 
19.  Panic disorder 3A 
20.  General anxiety disorder 3A 
21.  Mixed anxiety and depression 3A 
22.  Obsessive-compulsive disorder 2 
23.  Reaction towards stress and adjustment disorder 2 
24.  Post-traumatic stress disorder 3A 
25.  Dissociative disorder (conversion) 2 
26.  Somatoform disorder 4A 
27.  Trichotillomania 3A 
PERSONALITY DISORDER AND ADULT BEHAVIOURAL DISORDERS 
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28.  Personality disorder 2 
29.  Gender identity disorder 2 
30.  Sexual preference disorder 2 
EMOTIONAL AND BEHAVIOURAL DISORDERS, CHILDHOOD ONSET 
31.  Pervasive developmental disorder 2 
32.  Mental retardation  3A 
33.  Attention deficit disorder, hyperactive disorder (including autism) 2 
34.  Conduct disorder 2 
EATING DISORDERS 
35.  Anorexia nervosa 2 
36.  Bulimia 2 
37.  Pica 2 
TICS 
38.  Tourette’s syndrome 2 
39.  Chronic motor or vocal tics disorder 2 
40.  Transient tics disorder 3A 
EXCRETORY DISORDERS 
41.  Functional encoperasis 2 
42.  Functional enuresis 2 
SPEECH DISORDER 
43.  Uncoordinated speech 2 
SEXUAL DYSFUNCTION DISORDER 
44.  Paraphilia 2 
45.  Sexual desire or arousal disorder 3A 
46.  Female orgasmic disorder or premature ejaculation 3A 
47.  Sexual pain disorder (including vaginismus, dyspareunia) 3A 
SLEEP DISORDERS 
48.  Insomnia 4A 
49.  Hypersomnia 3A 
50.  Sleep-wake cycle disturbance 2 
51.  Nightmares 2 
52.  Sleep walking 2 
In the adapted WHO mhGAP Arm, Puskesmas doctors provided pharmacological therapy and/or 
psychosocial intervention, and/or referred participants to specialist care, as they saw fit. As the trial was 
designed to reflect real-life practice, Puskesmas doctors’ choice of intervention was not recorded, nor 
their utility of the adapted WHO mhGAP modules enforced. 
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3.3.2.2 Experimental Group: Specialist Co-location 
The Specialist framework is the integration of clinical psychologists into the primary care system. It is 
considered an important step towards scaling up mental health services (Hass et al., 2004). There is 
good evidence for the effectiveness of psychotherapy delivered in primary care (Hass et al., 2004) and 
that psychotherapy is as effective as antidepressant medication (Haas, 2004). The co-location of clinical 
psychologists in primary care improves collaboration and potentially reduce the stigma of mental illness 
and barriers to care (Derksen, 2009, Elder and Silvers, 2009, Setiyawati et al., 2014).  
In 2004, the Sleman District Health Office (within Yogyakarta province), in collaboration with the 
Centre for Public Mental Health (Universitas Gadjah Mada), initiated the integration of clinical 
psychologists within primary care (Retnowati, 2011). Following a Bachelor’s Degree in Psychology 
and a Master’s Degree in Clinical Psychology, one is required to obtain professional registration as a 
Clinical Psychologist before seeking employment at a Puskesmas. In 2016, psychologists were 
employed in 43 of 121 Puskesmas in Yogyakarta province, specifically in all Puskesmas within the 
districts of Sleman and Kota. In the Specialist framework, clinical psychologists typically use a 
combination of basic and advanced psychosocial intervention to manage disorders. As the trial was 
designed to reflect real-life practice, Puskesmas psychologists’ choice of intervention for research 
participants was not recorded. 
3.3.3 Clinician training 
Indonesia's Directorate of Mental Health provided health care providers training in the Indonesian-
adapted WHO mhGAP framework. In April 2016 (Appendix A), the week-long training of Puskesmas 
General Practitioners took place in Yogyakarta, the province where the trial took place. A psychiatrist 
from Indonesia’s Directorate of Mental Health who had gone through a WHO mhGAP train-the-trainer 
course conducted the general practitioners’ training. The week-long training covered all WHO mhGAP 
modules, and further incorporated a day of role-playing plus clinical observations in ‘real life’ setting. 
In the Specialist framework, Clinical Psychologists received their mental health assessment and therapy 
training during their two-year Master’s Degree in Clinical Psychology. All psychologists involved in 
the trial had professional registration as a psychologist in Indonesia. Puskesmas psychologists attend 
regular continuing professional development (CPD) training organised by the Centre for Public Mental 
Health, a collaborator of this trial. 
Before the commencement of the Pilot Study, all clinicians involved in the trial attended a one-day 
training session on the questionnaires used and on in-depth psychiatric interviews in non-specialised 
health settings. I conducted the training on the use of questionnaires (WHODAS 2.0, EQ-5D), while a 
renowned local psychiatrist conducted the training on psychiatric interviewing to complete the primary 
outcome measure, HoNOS. The training focused on the standardisation of scoring on primary and 
secondary outcome measures.  
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Before the commencement of the Substantive Study, all clinicians involved in the trial attended a one-
day training session on structured psychiatric interviews in non-specialised health settings (CIS-R). As 
a psychologist trained in Australia and the UK, with several years of clinical experience, I conducted 
the training on the administration of the questions and classification of responses, going through each 
item and facilitating role-play in pairs. Clinicians were also introduced to the research assistants who 
would be based at their clinics. Clinicians were not trained to score or interpret the result of the CIS-R, 
as the utility of the CIS-R in the trial was limited to the standardised way of asking clinical questions, 
analysis of the GHQ-12 as an effective screening tool (Chapter 2), and post-hoc comparisons at the end 
of the trial period. Clinicians did not use the CIS-R score to establish a diagnosis.    
3.3.4 Adherence and fidelity 
As this is a pragmatic trial conducted in ‘real-life’ setting, clinicians were informed that only adherence 
to the interview protocol (baseline and a follow-up at 6-months) would be enforced, while the onus was 
on them to ensure service users’ treatment adherence, as per usual practice. To facilitate buy-in and 
avoid the Hawthorne Effect, the trial did not capture any record of clinicians’ choice of intervention. 
The trial did not evaluate the accuracy of diagnosis, nor the appropriateness of the chosen intervention 
for the diagnosis given. As such, clinicians had the freedom to choose from among their repertoire of 
interventions, which they developed either through their adapted WHO mhGAP training, clinical 
psychology training, or any prior training and development activities, without feeling monitored. 
Fidelity to chosen treatment procedures was not enforced as this study hoped to reflect actual practices 
on the ground, which may be adjusted by clinicians based on service users’ responsiveness to treatment. 
As such, the intention-to-treat (ITT) approach is applied to the design, conduct, and statistical analysis 
of the trial. The ITT approach avoids overoptimistic estimates of the efficacy and feasibility of an 
intervention resulting from the removal of non-compliers from trials or data analysis (Gupta, 2011). 
3.3.5 Setting 
Yogyakarta is a province in Java, the only place in Indonesia where the specialist co-location framework 
is operational at the start of the trial.  It is crucial for any ‘real life’ evaluation to take place in the original 
setting and for any comparison framework to be introduced to a context as similar as possible to the 
original (Hohmann and Shear, 2002). There are five districts in Yogyakarta Province: Kota, Sleman, 
Bantul, Kulon Progo, Gunungkidul, and among them 121 Puskesmas. Sleman district in Yogyakarta 
province also pioneered the specialist primary mental health service model in 2004. Before the start of 
the trial, the Specialist framework was present in only 43 Puskesmas in Kota and Sleman districts. 
The adapted WHO mhGAP has been systematically introduced to Puskesmas within Indonesia since 
2015 but was not yet operational in most Puskesmas. The adapted WHO mhGAP framework was 
introduced to Puskesmas in Yogyakarta in an experimental manner (randomised), enabling a pragmatic 
cluster randomised trial to take place. 
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The trial took place in primary care clinics (Puskesmas) in Yogyakarta province. Stratified random 
sampling was considered the optimum allocation for the estimation of population means when 
considering a multivariate problem. The Puskesmas were assigned to each treatment arm in a 1:1 ratio. 
The number of Puskesmas per district invited to participate in the study was in proportion to each 
district’s population size.  
All Puskesmas in Yogyakarta had received International Organisation for Standardization (ISO) 
Certification, so that data collection points within routine patient flow procedures could be embedded. 
3.3.6 Randomisation and blinding 
Clusters (Puskesmas) were randomised (in a ratio of 1:1) to either treatment arm. Randomisation into 
the adapted WHO mhGAP arm was done by the Ministry of Health, while randomisation into the 
Specialist arm was done by our External Statistical Adviser, Dr Chiara Bonetto. Within the study design, 
the unit of randomisation was the Puskesmas, and the unit of observation and analysis was the service 
user. The cluster model allowed service providers to adhere as a ‘whole service’ to the treatment method 
they were trained to provide. 
The clustered nature of the study allowed patient-participants to be blinded to the treatment allocation. 
Outcome assessments were conducted during home visits, and by a different assessor (trained research 
assistant) blinded to treatment allocation.  
3.3.7 Site recruitment 
Training dates, logistics, and written support from the Ministry of Health, Provincial Health Authority, 
and District Health Authorities facilitated the recruitment of all 14 sites to the trial. For the Specialist 
arm, 14 randomly chosen Puskesmas with existing clinical psychologist co-location were recruited. 
Letters of approval to conduct research by the Ministry of Health and the Provincial Health Authority 
were sent to all 28 Puskesmas, along with an information pack about the trial. A one-day briefing was 
held with Heads of Puskesmas, all clinicians involved, and representatives of District Health Authority, 
hosted and organised by the Provincial Health Authority. Each Puskesmas was assigned a unique cluster 
number. 
All clinicians were current treatment providers in Puskesmas and were employees of the District Health 
Authorities. Therefore, they were not hired specifically for the study, rather the study was integrated 
into their work. Following a discussion with the Head of Medical Services of the Province in 2016, to 
ensure that screening and treatment procedures introduced during the trial continue to be integrated as 
standard operating procedures in each Puskesmas, clinicians were not paid to participate in the trial. 
It was anticipated that clinicians would fear being pitted against each other, as the trial sought to 
compare clinical and cost-effectiveness. Three strategies were used to foster cooperation. Firstly, 
clinicians were introduced to the idea of non-inferiority trial. Secondly, rather than using primary 
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measures such as diagnostic accuracy, discharge rates, and length of treatment, ‘proxy measures’ such 
as symptom reduction at six months, as well as overall health and social functioning (primary outcome 
measure) reduced the spotlight on individual clinicians. Thirdly, conducting joint training sessions 
where clinicians got to know each other and ate together, fostered a collegiate atmosphere and the idea 
that everyone works towards a common goal.    
3.3.8 Patient recruitment 
Participants were adult primary care attendees visiting any of the 28 Puskesmas during the recruitment 
period, and not currently on any psychosocial or pharmacological therapy for mental health issues, who 
met the screening criteria (GHQ-12 score of 2 or above, GHQ scoring method 0-0-1-1) (Goldberg and 
Williams, 2000). Primary care attendees who self-referred to the psychology service were invited to 
participate if they did not have ongoing treatment for mental health issues. Those receiving ongoing 
treatment for mental health issues were excluded from participating in the trial. 
During the recruitment period, all adult primary care patients in participating clusters (estimated at 40 
patients per day) were given the screening questionnaire, the General Health Questionnaire (GHQ-12) 
(Goldberg and Williams, 2000), as well as a demographic questionnaire from the Client Service Receipt 
Inventory (CSRI) by Beecham and Knapp, 2001 (Appendix H). The CSRI is a generic questionnaire 
that records demographics information and health services utility within a specific period (e.g. six 
months) (Beecham and Knapp, 2001). Participants were given the screening questionnaire at the 
registration counter, when they obtained a queue number, to be self-completed while waiting for routine 
blood pressure test.  
Primary care patients were given the screening questionnaire at the registration counter, when they 
obtained a queue number, to be self-completed while waiting for routine blood pressure test. Research 
assistants trained in scoring the GHQ identified patients who met the screening criteria. To ensure 
avoidance of any sense of coercion, participants were asked to provide written informed consent before 
meeting a clinician and were also reassured that declining would not affect usual medical care. 
Participants were invited to ask questions for clarification. Research assistants double-checked potential 
participants’ understanding of the follow-up requirements and their rights to withdraw. Research 
assistants provided a brief overview of the trial and an information sheet (Appendix I). Full consent 
with signature was requested from those who agreed to take part (Appendix J). Participants were then 
given a questionnaire booklet (Appendix K) to complete while waiting to meet either the Puskesmas 
doctor or psychologist, depending on which cluster they were at (Appendix B). The questionnaire 
booklet (Appendix K) contained the self-complete version of the WHO Disability Assessment Schedule 
2.0 (WHODAS 2.0) (Sousa et al., 2010) and the European Quality of Life Scale (EQ-5D-3L) (Oppe et 
al., 2007). Participants were also informed that they were free to withdraw at any time during the study. 
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There were procedures in place to assist illiterate patients, which were not required during the 
recruitment period of this trial. For these patients, consent form would have required the participant’s 
thumbprint and the signature of a witness. Illiterate patients would have been described the research 
aims and procedures as usual, but rather than self-completing the questionnaire booklet (Appendix K), 
a research assistant would interview them, completing the booklet alongside.  
In the WHO mhGAP treatment arm, participants’ medical records and questionnaire booklets were 
passed to the Puskesmas doctor who had received the adapted WHO mhGAP training from the 
Ministry of Health. Standard medical consultations took place, followed by a structured interview 
comprising the CIS-R and HoNOS, located in the second half of the questionnaire booklet (Appendix 
I). Puskesmas doctors would then record participants’ names, the medical record number, and contact 
phone number or home address separately. Plans for medications and/or psychosocial therapy, if 
deemed necessary, were developed together with participants and they were asked to return for further 
therapy sessions.  
In the Specialist arm, participants’ medical records were passed to a general practitioner along with a 
request for a referral to a psychologist. Standard medical consultations for any physical ailments took 
place with general practitioners before participants went to a psychology consultation room for a 
structured interview with the Puskesmas psychologist. The psychologist then completed both the CIS-
R and HoNOS, located in the second half of the questionnaire booklet (Appendix I). Psychologists 
would then record separately participants’ names, the medical record number, and contact phone 
number or home address. If therapy was deemed necessary, participants were asked to return for further 
therapy sessions. 
The questionnaire booklet (Appendix K) incorporated a section where the clinician could indicate 
participant’s diagnosis at the end of the in-depth interview. This diagnosis was not determined by the 
CIS-R score, but rather was based on the clinical judgment of each Puskesmas doctor or clinical 
psychologist. This diagnosis determines whether participants were asked to return for intervention 
sessions.  
3.3.9 Follow-up assessment 
Trained and vetted research assistants blinded to treatment arm allocation conducted follow-up at six 
months. They obtained participants’ contact details from their Puskesmas and contacted participants via 
telephone from the Puskesmas approximately a month to a fortnight before follow-up home visit. 
Participant personal details including phone numbers were not shared with other members of the 
research team and were kept confidential by each field researcher. Participants were re-assessed using 
the full battery of instruments. At this point, no additional/replacement diagnosis was assigned to the 
participants. 
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Prior to the home-visits taking place, all field researchers met the PhD researcher to go through 
mitigation strategies in the event of a crisis (e.g. if a participant becomes distressed or threatening). 
Follow-up interviews were conducted without any other persons present. To ensure safety for both the 
researchers and participants, the room must be unlocked. Field researcher’s vehicle (moped) was 
required to remain parked outside the property of the participant, and the personal properties of field 
researchers must remain with them at all times. They were required to have a mobile phone, fully 
charged, and able to make emergency phone calls if required during the home visit. A representative 
from the Puskesmas must accompany field researchers during the home visit. 
Participants were re-assessed using the full battery of instruments: WHODAS 2.0 (self-report), EQ-5D 
(self-report), CIS-R (during the clinical interview), and HoNOS (post-clinical interview). At this point, 
no additional/replacement diagnosis was assigned to the participants. 
The schedule of enrolment, interventions, and assessments is shown in Table 8, based on the Standard 
Protocol Items: Recommendations for Interventional Trials (SPIRIT) (Chan et al., 2013). 
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Table 8. Modified SPIRIT Checklist  
 STUDY PERIOD 
 Allocation Enrolment Post-enrolment Close-out 
TIMEPOINT** -t1 0 t1 t2 etc. tx 
RANDOMISATION 
of Clusters X      
ENROLMENT:       
Eligibility screen  X     
Informed consent   X     
Baseline Interview  X     
Diagnosis  X     
INTERVENTIONS:       
WHO mhGAP       
Clinical Psychology       
ASSESSMENTS:       
CIS-R  X    X 
HoNOS  X    X 
WHO mhGAP  X    X 
EQ-5D-3L  X    X 




The twelve-item General Health Questionnaire (GHQ-12) was developed to screen for general (non-
psychotic) psychological morbidity among primary care patients (Goldberg & Williams, 1988). Items 
on the GHQ-12 are rated on a 4-point scale using a time-frame of ‘in the last two weeks’. There are two 
ways of scoring the GHQ-12: the bimodal GHQ scoring method (0-0-1-1) recommended by the test 
authors for use in clinical settings; and the Likert scoring method (0-1-2-3) which is commonly used in 
research settings. As this ‘real life’ study took place in a clinical setting, the bimodal scoring method 
was used, and patients with score 2 and above were invited to participate in the study.  
The screening questionnaire incorporates questions on demographic information such as gender, 
education, employment, living arrangement, and chronic illnesses based on the Client Service Receipt 
Inventory (CSRI). The CSRI by Beecham and Knapp (2001) is a generic questionnaire that records 
demographics information and health services utility within a specific period (e.g. 6 months). Data 
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collected from the CSRI indicated the number of outpatient visits to Puskesmas, inpatient stay, and 
visits to the emergency (Beecham and Knapp, 2001). Depression and anxiety have been found to 
increase the risk for hypertension (Meng et al., 2012, Ginty et al., 2013). There is also a strong evidence 
that depression is a risk factor for diabetes mellitus (Clarke and Currie, 2009). The screening 
questionnaire is in Appendix H. 
3.3.10.2 Primary Outcome Measure 
The Health of the Nation Outcome Scale (HoNOS) (Wing et al., 1996) is a 12-item scale to rate mental 
health service users in various aspects of mental and social health, each on a scale of 0-4. The items are: 
Overactive, aggressive, disruptive or agitated behaviour; Non-accidental self-injury; Problem drinking 
or drug-taking; Cognitive problems; Physical illness or disability problems; Problems associated with 
hallucinations and delusions; Problems with depressed mood; Other mental and behavioural problems; 
Problems with relationships; Problems with activities of daily living; Problems with living conditions; 
and Problems with occupation and activities. The ratings were made once all the information became 
available through clinical interview and took less than 5 minutes for the clinician to complete. HoNOS 
Total Score is a sum of individual item scores, with higher scores indicating greater mental or social 
health problems. 
The primary outcomes were changes from baseline to the 6-month follow-up assessment in the health 
and social functioning of participants, as measured by the Health of the Nation Outcome Scale (HoNOS) 
(Wing et al., 1996). 
3.3.10.3 Secondary Outcome Measures 
WHO Disability Assessment Schedule (WHODAS 2.0) is a generic assessment instrument for health 
and disability used across all diseases, including mental, neurological, and addictive disorders. The 
WHODAS 2.0 covers six domains of functioning, including Cognition; Mobility; Self-care; Getting 
along; Life activities; and Participation. This trial used the 36-item, self-administered version, taking 
approximately 20 minutes for self-completion. This trial used the complex scoring method based on 
item response theory, as advised by the WHO. It took the coding for each item separately and then used 
an algorithm to determine the Total score by differentially weighting the items and the levels of severity. 
Total scores are in a metric ranging from 0 (no disability) to 100 (full disability). 
The 3-level European Quality of Life Scale (EQ-5D-3L) is a standardised self-report measure of health-
related quality of life which takes approximately 5 minutes to complete. It comprises five dimensions: 
mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with each dimension 
recording  responses at one of three levels: no problems, some problems, and extreme problems (Lewis 
and Pelosi, 1990). EQ-5D-3L ratings are commonly converted into composite utility scores using 
country-specific value sets, which measure people’s preferences in relation to health and weight each 
of the levels in each EQ-5D-3L dimension accordingly. The single utility scores represent the state of 
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health-related quality of life for a person at any given time. While the Indonesian value set for the 5-
level version of the measure (EQ-5D-5L) has been published in 2016, there is no existing value set for 
EQ-5D-3L.  
Existing Thai and Malaysian value sets were found to be the closest alternative. The Thai value set uses 
the Time Trade-Off (TTO) method to estimate its valuation (Tongsiri and Cairns, 2011), and the 
Malaysian value set combines both the TTO and Visual Analogue Scale using linear additive regression 
(Yusof et al., 2012). Both value sets include the N3 model from the original UK Measure and Valuation 
in Health study. The N3 model adds an interaction variable to capture the effect of any dimension with 
severe health state. 
The Thai value set for the EQ-5D-3L is: 
Thai score = 1 - 0.202 - (0.121*mo) - (0.121*sc) - (0.059*ua) - (0.072*pd) - (0.032*ad) - (0.190*m2) - 
(0.065*p2) - (0.046 * a2) - (0.139 * N3), 
where mo is mobility, sc is self-care, ua is usual activities, pd is pain and discomfort, and ad is anxiety 
and depression. Variable mo is 1 if mobility is level 2, 2 if mobility is level 3, and 0 otherwise; variable 
sc is 1 if self-care is level 2, 2 if self-care is level 3, 0 otherwise; ua is 1 if usual activities is level 2, 2 
if usual activities is level 3, 0 otherwise; pd is 1 if pain and discomfort is 2, 2 if pain and discomfort is 
3, 0 otherwise; ad is 1 if anxiety and depression is 2, 2 if anxiety and depression is 3, 0 otherwise. 
Variable m2 is 1 if mobility is level 3 and 0 otherwise; p2 is 1 if pain and discomfort is level 3 and 0 
otherwise; a2 is 1 if anxiety and depression is level 3 and 0 otherwise and; N3 is 1 if any dimension is 
level 3 and 0 otherwise.  
Where the Malaysian Value set for the EQ=5D-3L is: 
Malaysian score = 1 – (0.067*N2) – (0.116*N3) – (0.084*m1) – (0.191*m2) – (0.097*sc1) – (0.16*sc2) 
– (0.053*ua1) – (0.122*ua2) – (0.054*pd1) – (0,127*pd2) – (0.081*ad1) – (0.086*ad2) 
where mo is mobility, sc is self-care, ua is usual activities, pd is pain and discomfort, and ad is anxiety 
and depression. Variable m1 is 1 if mobility is level 2, and 0 otherwise; m2 is 1 if mobility is level 3, 
and 0 otherwise; sc1 is 1 if self-care is level 2, 0 otherwise; sc2 is 1 if self-care is level 3, 0 otherwise; 
ua1 is 1 if usual activities is level 2, 0 otherwise; ua2 is 1 if usual activities is level 3, 0 otherwise; pd1 
is 1 if pain and discomfort is 2, 0 otherwise; pd2 is 1 if pain and discomfort is 3, 0 otherwise; ad1 is 1 
if anxiety and depression is 2, 0 otherwise; ad2 is 1 if anxiety and depression is 3, 0 otherwise. Variable 
N2 is 1 if any dimension is level 2 and 0 otherwise and; N3 is 1 if any dimension is level 3 and 0 
otherwise.  
Converting EQ-5D-3L scores to both Thai and Malaysian economic values enabled outcome assessors 
to perform some quick comparisons for consistency of reporting. In the economic analyses of QALY, 
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it was determined that the Malaysian value sets would be more appropriate for the Indonesian 
population, given the shared culture, predominant religion, and language of both countries. 
For the evaluation of psychiatric morbidity, the clinician conducted a structured interview using the 
Revised Clinical Interview Schedule (CIS-R) (Lewis and Pelosi, 1990). The CIS-R is a fully structured 
diagnostic instrument that was developed from an existing instrument, the Clinical Interview Schedule 
(CIS), initially designed for the use of clinically experienced interviewers. The CIS was revised and 
developed into a fully structured interview to increase standardisation and to make it suitable to be used 
by trained lay interviewers in assessing minor psychiatric morbidity in the community, general hospital, 
occupational and primary care research. As the CIS-R specifically diagnoses mood and anxiety 
disorders, participants with an indication of other disorders (psychosis, sleep disorders, dementia) were 
asked additional questions which enabled the interviewers (clinicians) to establish an ICD-10 diagnosis. 
For this trial, structured interview using the CIS-R was conducted by general practitioners or clinical 
psychologists in all participating Puskesmas. ICD-10 is widely used in the Indonesian mental health 
services as the national guideline for the diagnosis of psychiatric disorders (Pedoman Panduan Diagnosa 
Gangguan Jiwa) is the translated version of ICD-10.  
Clinician’s own diagnosis of each patient was recorded in participant’s interview booklet. While aided 
by the CIS-R interview questions to make a diagnosis, clinicians formed a diagnosis independently of 
CIS-R score. During the trial, clinicians were not provided the CIS-R diagnosis for their patients, which 
was based on its scoring algorithm. The CIS-R scoring took place during the data analysis. 
The CIS-R (Lewis et al., 1992) was used to assess the presence of symptoms of common mental 
disorders. In the CIS-R, there are 14 different symptom groups which participants were asked to 
consider, regarding the last month prior to the interview, focusing on symptoms experienced within the 
last week. The 14 symptoms enquired after were: (1) Somatic symptoms; (2) Fatigue; (3) Sleep 
problems; (4) Irritability; (5) Physical health worries; (6) Depression; (7) Depressive ideas; (8) Worry; 
(9) Anxiety; (10) Phobias; (11) Panic; (12) Compulsive behaviours; (13) Obsessive thoughts; (14) 
Forgetfulness/concentration problems. Scores on each symptom group ranged from 0 to 4 (and 0 to 5 
for depressive ideas), and Total CIS-R Scores are the sum of each symptom group with higher scores 
indicating higher levels of symptomatology. 
The following were secondary outcomes: 
1. Changes from baseline to the 6-month follow-up assessment in the disability of participants, as 
measured by WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) (Sousa et al., 2010). 
2. Quality-adjusted life year at 6-month follow-up, as computed using the European Quality of 
Life Scale (EQ-5D-3L) (Oppe et al., 2007).  
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Attempts were made to collect reasons for treatment discontinuation and loss to follow-up. 
3.3.11 Translation and Back-translation 
The GHQ-12, HoNOS, WHODAS 2.0, and EQ-5D in Bahasa Indonesia existed prior to the conception 
of this trial. The Bahasa Indonesia version of the GHQ-12, HoNOS, and WHODAS 2.0 were obtained 
from the National Institute of Health Research and Development, Ministry of Health, Indonesia. The 
Bahasa Indonesia version of the EQ-5D was obtained from the Euroqol Group. The CIS-R was 
translated into Bahasa Indonesia by Ms Wulansari Ardianingsih, MPhil (Cantab), MPsi (UIndonesia), 
and back-translated into English by the PhD Researcher. 
3.3.12 Researcher training 
I distributed open recruitment flyers for research assistants, around Universitas Gadjah Mada campus 
and through social media groups. I invited 30% of applicants to an interview and recruited 28 research 
assistants (approximately 10% of all applicants) for the substantive study. Given the tremendous amount 
of interest, research assistants were selected based on a balance of high educational qualification with 
people skills and arithmetic ability, filtering in mainly recent medical graduates and social science 
master degree holders. 
I recruited and trained 28 research assistants for the pilot study, and again for the substantive study, to 
distribute and score the screening questionnaires (GHQ-12) to all adult patients at our research sites. 
Research assistants were introduced to the background and aims of the research project, as well as 
detailed screening procedures. They were given a detailed flowchart of the procedure both hardcopy 
and digitally. They were also informed of the random audits which would be conducted during the 
period of the project. 
For the substantive study, two research assistants were placed on duty per Puskesmas. Each dyad 
consists of a junior doctor and either a medical student or registered nurse. The data collection period 
coincided with the period where recent medical graduates in Yogyakarta and surrounding areas wait for 
news of their residency placements, leaving many free to take part as research assistants for our project. 
3.3.13 Sample size calculation 
First, the sample size for non-inferiority individual randomisation RCT is calculated as a reference, 
using the estimated mean total HoNOS rating as a primary outcome (Wing et al., 1996). The formula 
used is by Zhong, (2009). Assuming statistical significance value (α) of 0.05 and statistical power of 
0.80, the standard deviation of 5.2, and clinical significance threshold (δ0) of 2 (Audin et al., 2001), the 
minimum sample size required for an RCT is 84. The standard deviation of 5.21 and clinical 
significance threshold used is the only available data on HoNOS reported from a sample of patients 
from eight National Health Service outpatient and community psychotherapy services in England. Total 
HoNOS scores range between 0 and 48, and a clinical significance threshold (δ0) of 2 could represent a 
Chapter 3: Trial Protocol 
  Sabrina Gabrielle Anjara – August 2018    55 
plausible and realistic intervention effect. The minimum sample size using these estimates with a 
statistical bilateral significance value (α) of 0.05 and a statistical power of 0.80 is 84.  
A larger sample size was needed to compensate for the clustering effect. For a trial with a fixed number 
of equal sized clusters (k), the required sample size per arm is nc, such that (Hemming et al., 2011): 
nc = !"#[%&'][#&!"']  
where ni is the sample size required under individual randomisation and ρ is the intra-cluster correlation 
coefficient (ICC). The cluster randomisation might result in reduced efficiency and loss of power 
because the within-cluster responses tend to be more similar than those of individuals from different 
clusters (commonalities in the selection, exposure, shared environment, mutual interaction). A larger 
sample size was therefore needed to compensate for this clustering effect. Our approach is simplified 
because it does not consider variations in the number of participants in each cluster. Although this type 
of imbalance in cluster size may reduce the power of the trial, the loss is negligible for studies with 
more than 100 patients per arm (Guittet et al., 2006). Based on the additional assumption of an ICC of 
0.1, the number of patients required would be 189 in each arm. Implementation research studies showed 
that in medical settings ICCs for outcome variables were generally lower than 0.05 (Campbell et al., 
2005). In our trial, I decided to assume a high value for the ICC to consider a possible wide variation 
across different Puskesmas.  
With an attrition rate of approximately 20%, I expected that a sample size of about 227 patients per arm 
(approximately 16 for each Puskesmas) should yield sufficient power. 
Following the completion of baseline recruitment, a more accurate estimate of ICC can be calculated 
using the formula from Dr Yannan Jiang, University of Auckland. The formula (Jiang, 2012) required 
a one-way analysis of variance, where the dependent variable is total HoNOS score, and the grouping 
variable is the cluster (Puskesmas). 
𝐼𝐶𝐶 =
(𝐵𝑒𝑡𝑤𝑒𝑒𝑛	𝐺𝑟𝑜𝑢𝑝𝑠	𝑀𝑒𝑎𝑛𝑠	𝑆𝑞𝑢𝑎𝑟𝑒 −𝑊𝑖𝑡ℎ𝑖𝑛	𝐺𝑟𝑜𝑢𝑝	𝑀𝑒𝑎𝑛𝑠	𝑆𝑞𝑢𝑎𝑟𝑒)
(𝐵𝑒𝑡𝑤𝑒𝑒𝑛	𝐺𝑟𝑜𝑢𝑝𝑠	𝑀𝑒𝑎𝑛𝑠	𝑆𝑞𝑢𝑎𝑟𝑒 + (𝑛𝑢𝑚𝑏𝑒𝑟	𝑜𝑓	𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠	𝑝𝑒𝑟	𝑐𝑙𝑢𝑠𝑡𝑒𝑟 − 1)
 
Given the new ICC derived from the trial dataset, the required sample size to keep a statistical power 
of 0.80 and a statistical bilateral significance value of 0.05 can be re-calculated.  
3.4 Analysis 
3.4.1 Intervention Uptake 
Participant engagement with the treatment process was summarised and reported descriptively. There 
was no consensus regarding the appropriate number of therapy follow-ups (dose). 
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3.4.2 Analysis of primary and clinical outcome measures 
These analyses were carried out using the STATA software package, version 13. Cleaning of outcome 
and baseline data was conducted without the treatment group allocations in view. Summary statistics 
from these preliminary analyses were reviewed to identify data errors.  
Preliminary analyses compared the characteristics of participants with and without complete data at six-
months follow-up, by treatment group. They were carried out for the primary and secondary outcomes. 
This analysis was used to develop an understanding of the missing data mechanism and to determine 
the appropriate methods for dealing with missing outcome data. 
Subsequent analyses took place with the valuable inputs and guidance of Senior Statistician at the 
University of Verona and External Advisor/Trial Manager for the PhD, Dr Chiara Bonetto. The 
substantive study is a pragmatic cluster randomised controlled non-inferiority trial with the aim to assess 
the clinical effectiveness of two frameworks of primary mental health service provision in Puskesmas 
(community health centres) within a province, Yogyakarta. The unit of randomisation was the 
Puskesmas unit, and the unit of observation and analysis was the service users. The objective of 
conducting a non-inferiority trial was to demonstrate that neither the WHO mhGAP framework nor the 
Specialist framework was worse than the other with regards to clinical outcomes such as symptom 
severity and wellbeing. 
Analyses were conducted using an intention-to-treat (ITT) approach. The effect of the type of service 
on HoNOS, EQ-5D and WHODAS 2.0 scores at six months were analysed separately in mixed-effects 
random regression models. Considering the trial design, in which patients (level 1) were nested within 
Puskesmas (level 2) [refer to the CONSORT guidelines for cluster randomised trials], the individual 
Puskesmas were included in the models as a random effect. Each model included treatment allocation 
and the baseline score of the outcome investigated as fixed effects.  
In a secondary analysis, any missing data on follow-up outcomes were estimated using a multiple 
imputation approach by chained equations (MICE), which generated several different plausible imputed 
data sets and combined results from each of them. The predictive mean matching would be used to deal 
with possible non-normality when imputing continuous variables. 
3.4.3 Economic Evaluation 
3.4.3.1 Perspective 
The primary perspective of the economic evaluation was the Health Systems perspective, in line with 
the preference of NICE guidelines (Drummond, 2016) and in line with the effort from national and 
provincial governments to provide universal health coverage to citizens. This study included only the 
use of mental health resources including Puskesmas follow-up services. While data on overnight 
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hospitalisation and visits to outpatient general medical care were captured, they were not included in 
the analysis as they were not related to participants’ mental health.  
At the follow-up, participants were asked to recall their use of health resources during the trial period 
(6 months). Differences in use of services between trial arms were compared and are reported for each 
service as the proportion of the group who had at least one contact. Statistical comparisons were not 
made to avoid problems of multiple testing and to keep the focus of the evaluation on costs and cost-
effectiveness. 
3.4.3.2 Costs 
For each participant, a nationally applicable unit cost was applied to each item of service use reported 
during the trial (at the follow-up interview), to calculate the total cost for the duration of the trial. All 
costs are reported in Rupiah at 2017 prices. Discounting was not relevant as the follow-up did not 
exceed 12 months. Unit costs for primary care outpatient and inpatient services were obtained from a 
provincial cost calculation conducted in 2012 and adjusted for inflation based on national inflation rates 
https://www.statista.com/statistics/320156/inflation-rate-in-indonesia.  
This trial used Yogyakarta health services unit cost valuation from Fidiyawati (2013) which followed 
the methodology recommended by the Directorate of Community Health Service Insurance, Ministry 
of Health 2003. This study of 2012 values (though published in 2013) indicated that the average unit 
cost in Yogyakarta outpatient medical service was Rp 13,961 and inpatient Rp 93,052 (£1 ~ Rp 19000 
in March 2018). Based on these 2012 valuations (Fidiyawati, 2013), the 2016 and 2017 values could be 
calculated by taking into account published inflation rates as displayed in Table 9 (Statista, 2018). 
In the absence of empirical data, the crude unit cost of Clinical Psychology consultation in Puskesmas 
could only be estimated. Psychologists’ monthly pay set by the provincial government (Rp 3,000,000 
effective January 2017) was divided by the average number of psychology consultations per month  
(231 appointments in 2017; annual average of 2772 appointments per psychologist), the unit cost for 
psychology consultation is estimated to be Rp 12, 987. The cost to health services of each psychology 
consultation takes into account the retribution for infrastructure, ancillary workforce, and medical 
record administration, which in Yogyakarta is determined at Rp 2100 (Widodo, 2016). The total cost 
of clinical psychology consultation in 2017 is Rp 15,087 per appointment (Table 9). 
To receive free psychological care, participants required a GP referral. For participants in the Specialist 
Arm, the cost at baseline is a composite of the cost of GP consultation (which includes retribution) and 
the unit cost of psychology consultation (without retribution) which amounts to Rp 30,468. 
Table 9. Unit costs of Puskesmas Mental Health Services, considering published inflation rates 
YEAR INFLATION 
RATE 
WHO mhGAP Consultation COST 
in Rupiah 
Clinical Psychology Consultation 
COST in Rupiah 
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2012 3.98% 13961  
2013 6.41% 14516  
2014 6.40% 15447  
2015 6.36% 16435  
2016 (Baseline) 3.53% 17481 Without retribution: 12987 
2017 (Follow-up) 4.02% 18098 15097 
 
3.4.3.3 Analyses 
The primary economic evaluation explored cost-effectiveness in terms of HoNOS, the primary outcome 
for the trial. A secondary cost-utility analysis explored effectiveness in terms of Quality-Adjusted Life 
Years (QALYs).  
EQ-5D-3L utility scores were used to calculate QALY improvements during the period of the trial (6 








Incremental cost-effectiveness ratios (ICERS), i.e. the additional cost of one intervention compared 
with another divided by the additional effect, were calculated based on parameter estimates from 
random-effects linear regression models that represent costs and both outcomes and take into account 
the clustered structure of these data. While the ICER allows costs and outcomes to be considered 
together in a decision-making context, it is calculated from four sample mean values and is therefore 
subject to statistical uncertainty. The uncertainty of these estimates was explored first, by bootstrapping 
1000 resamples to generate a new distribution of estimates and plotting these onto a cost-effectiveness 
plane for interpretation and then, by constructing cost-effectiveness acceptability curves (CEAC). The 
CEAC is a plot of the probability of the intervention being cost-effective (y-axis) for a range of 
willingness to pay thresholds per unit improvement in outcome (x-axis) (Fenwick et al., 2001). Initially, 
for the cost-utility analysis the WHO recommendation of three times GDP per capita (Rachapelle et al., 
2013, Eichler et al., 2004) or a calculation based on estimates of opportunity costs (Woods et al., 2016) 
were considered to approximate an Indonesian willingness-to-pay threshold, but recent research on the 
Indonesian willingness-to-pay threshold for medical intervention enabled a more exact analysis to be 
conducted (Kristina et al., 2017). 
3.5 Cultural Challenges and Bias 
Prior to the trial, I applied for Leave to Work Away from the University of Cambridge, in light of the 
fieldwork and visiting fellowship to be undertaken in Indonesia. As part of the application, I completed 
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a Risk Assessment document, which helped me highlight several potential issues at the fieldwork 
location. 
While I am an Indonesian, I had not lived in the country for 16 years prior to my first fieldwork visit to 
Yogyakarta. During my first fieldwork, there was a terrorist attack in Jakarta, where several terrorists 
bombed and shot at places and people with foreign attributes, e.g. Starbucks. I established a regular 
reporting schedule with my Supervisor and Adviser in Cambridge, to ensure that safety issues could be 
immediately dealt with, and if required, a return to Cambridge arranged. Having to travel accompanied, 
part of my Risk Assessment compromise, would also limit my independence to travel between each 
fieldwork site, given the distance and remote location of many sites (up to four hours from the centre 
of Yogyakarta).  
I was aware of my negatively perceived identity as a double minority in Indonesia: both in ethnicity 
and religion. As a non-medical doctor, I was also at the lower end of the social power when compared 
to my stakeholders: Muslim, Javanese, older medical doctors working as civil servants. Despite my 
Cambridge affiliation, I did not enjoy the “White Privilege” granted to lighter-skinned researchers when 
working in less developed context, such as the privileges granted to Japanese Dr Nozomi Sakata when 
conducting research in Tanzania (Naveed et al., 2017). Conversely, as a woman ethnic Chinese 
Indonesian researcher who does not wear a hijab, I was vulnerable to discrimination at my fieldwork 
sites. Since I could not show respect by speaking High Javanese, I knew I had to be especially mindful 
of my attire and body language when interacting with stakeholders. Greeting older and important 
stakeholders, I bowed and touched my forehead to the back of their right hand. Towards my research 
assistants, I had to balance authority with Javanese politeness, aware of the secondary status of a woman 
in Javanese culture (Smith-Hefner, 1988). 
I was also aware of the rent-seeking culture of the fieldwork location, which could potentially present 
ethical challenges related to bribery requests, as I represented a foreign university. Prior to each data 
collection period, I would have to renew the provincial and district research licenses in person, as well 
as renew stakeholders’ support for the project. In my role as permission seeker, stakeholders who acted 
as gatekeepers could potentially present challenges. In light of these potential challenges, I developed 
local collaborations and formed a fieldwork advisory team, spearheaded by the previous Dean of 
Universitas Gadjah Mada Faculty of Medicine (Professor Trisnantoro) and the current Director of the 
Centre for Public Mental Health (Dr Setiyawati). Professor Trisnantoro is a respected figure in the 
medical community in Yogyakarta, and on the other hand, all Puskesmas psychologists were required 
to submit biannual reports to Dr Setiyawati. Their presence in the advisory team was deemed helpful 
should issues arise locally during fieldwork. 
As a trained psychologist, there was also a potential that I had implicit bias, favouring the Specialist 
treatment arm over the WHO mhGAP treatment arm. Implicit bias generally tends to favour our own 
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ingroup, and could influence the way I conducted training, negotiation with clinicians, my assessment 
of treatment outcomes, and/or recommendations at the end of the trial. I ensured that all trainings prior 
to the pilot and substantive trials were conducted together for both Puskesmas doctors and 
psychologists. To avoid clinicians feeling as though they were pitted against each other, representatives 
from the Provincial Health Authority opened the training sessions and provided a closing address. While 
I orchestrated the follow-up effort, research assistants who were Javanese collected patient outcomes 
data, introducing themselves in High Javanese as an expression of respect. The Trial Manager (Dr 
Bonetto) was an independent party who conducted the randomisation of clusters, supervised the data 
analysis, and performed the ITT analysis. Being aware of potential biases, and taking the above steps 
as countermeasure, I hope to present an objective evaluation of the two treatment frameworks.   
3.6 Trial administration 
This trial took place under the supervision of an advisory team which comprises of: 
1. Supervisor, Dr Tine Van Bortel (University of Cambridge), 
2. Adviser, Prof Carol Brayne (University of Cambridge), and 
3. Statistical Adviser/Trial Manager, Dr Chiara Bonetto (University of Verona).  
In addition, this trial received ground support from fieldwork advisory team at Universitas Gadjah 
Mada, at which I was appointed Visiting Fellow, including: 
1. External Supervisor, Dr Diana Setiyawati (Centre for Public Mental Health), 
2. External Adviser, Dr Bambang Hastha Yoga (Department of Psychiatry) 
3. External Adviser, Prof Laksono Trisnantoro (Centre for Health Policy), and 
4. External Adviser, Dr Yodi Mahendradhata (Faculty of Medicine). 
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4 TRIAL RESULTS 
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Having established the unanswered questions to be addressed in the roll-out of internationally 
encouraged approaches to primary mental health care (Chapter 1), and having detailed the methodology 
to utilise the unique opportunity to evaluate different approaches in specific areas within Yogyakarta, I 
have four phases from which results were produced. These had the following objectives: 
• Phase 1 (December 2015 – February 2016): Field observations, understanding patient flow 
within research sites and their socio-cultural contexts. These observations form the basis for 
Chapter 3 and are described in the context of Site Recruitment below.  
• Phase 2 (May – June 2016): Pilot study described in Chapter 3. 
• Phase 3 (December 2016): Recruitment period for substantive study. 
• Phase 4 (June – July 2017): Follow-up assessment. 
This chapter begins with details of Phase 1 before focusing on Phases 3 and 4, providing the results of 
the substantive study. The site recruitment, then the clinicians involved are described. Patient 
recruitment is described next with a CONSORT diagram showing the flow of participants through the 
different stages of the trial (Figure 10).  
Participants’ demographic and clinical characteristics with a description of those demographic variables 
related to participants’ outcomes can be found in Table 10. The characteristics of participants who left 
the trial (drop-outs) are afterwards shown (Tables 13-14). 
The clinical effectiveness of the two treatment arms: the adapted WHO mhGAP arm and the Specialist 
Arm are presented subsequently with demographics captured at baseline, before interventions described 
in detail in the previous Chapter (trial protocol). Comparisons of the two treatment arms in both the 
primary outcome (HoNOS) and secondary outcomes (EQ5D and WHODAS 2.0) are also presented. 
The ITT analysis following the research protocol described in Chapter 3 was conducted by Dr Chiara 
Bonetto as Trial Manager, per international recommendations to safeguard the quality of the trial.  
Cost-effectiveness analyses were conducted on the HoNOS, comparing the cost of improvement in each 
“unit” of health. This chapter further describes the analysis of the cost-utility of both treatment arms, 
using the EQ5D data at baseline and follow-up, converted into quality of life utility scores then QALY.  
4.1 Site Recruitment 
The first fieldwork in Yogyakarta, Indonesia, took place between December 2015 and February 2016 
with the main purpose to observe the primary health care system and the provision of mental health 
services within it. I began a one-year appointment as a Visiting Fellow at the Centre for Public Mental 
Health (Universitas Gadjah Mada) in January 2016.  
Key observations of state-run primary care clinics: 
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1. Clinics were open all weekdays and Saturdays in the morning, and a few are also open for some 
hours in the early evening.  
2. All Puskesmas in the province had undergone an ISO accreditation which requires a specific 
patient flow in each Puskesmas. Patients pick-up a queue number upon arrival, either for 
general medical services, dental services, psychology services, or child vaccination services. 
Patients attending general medical services or dental services have their blood pressure 
measured routinely. 
3. Some Puskesmas in Yogyakarta have basic inpatient facilities as well as isolation rooms for the 
containment of suspected cases of infectious diseases. Additionally, some Puskesmas in 
Yogyakarta have their own ambulances, with the licence to operate within the catchment area 
of the Puskesmas.  
4. Medical and dental services are provided free of charge for patients living within the catchment 
area of the Puskesmas. Patients from outside the catchment area, but from within the district, 
pay a nominal consultation fee of Rp. 7000 (~ £0.35) per visit. Patients from outside the district 
pay a higher consultation fee of Rp. 14000 (~ £0.70). 
5. Patients requiring psychology services can either get a referral from general medical services 
(in which case they get a quota of 6 appointments free of charge for the year) or go directly to 
psychology services without referral (in which case the fee differs in different districts). In the 
City District, even patients who attend psychology services without referral can attend free of 
charge if they are from within the district, and a consultation fee of Rp. 14000 (~ £0.70) for 
patients outside the district. In the Sleman District, patients who attend psychology services 
without referral must pay a consultation fee of Rp. 7000 (~ £0.35) per visit if they are from 
within the district, and a higher consultation fee of Rp. 14000 (~ £0.70) for patients outside the 
district. 
6. Most psychologists have three to six appointments per day. Most of their clients are made up 
of those who attend for pre-marital counselling or pre-Hajj pilgrimage briefing, which is 
mandatory for residents of Yogyakarta province.  
7. A new policy was introduced in January 2016 regarding the starting salary of psychologists 
employed in Puskesmas newly set at Rp 3,000,000 (~ £157) per month, including additional 
support funds. For general practitioners, the starting salary is Rp 3,700,000 (~ £197) per month 
including support funds.  
Following randomisation of Puskesmas into both treatment arms, 14 Puskesmas received the adapted 
WHO mhGAP training from the Directorate of Mental Health, and form the WHO mhGAP treatment 
arm. These clinics were sent an information pack concerning the trial, and general practitioners were 
directly recruited during the training. The comparator, the Specialist treatment arm, comprises 14 
Puskesmas which were sent an information pack concerning the trial. Clinical Psychologists were 
recruited into the project before the start of the Pilot Study.  
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4.2 Clinicians’ Characteristics 
Of the 14 general practitioners who took part in the trial, 3 were men while the rest were women. All 
general practitioners had civil servant status and received their licence to practise from the District 
government which manages the health budget for the district, including the management of all state-
owned Puskesmas. All general practitioners were full-time permanent Puskesmas doctors, and not on 
rotation, ensuring they stay within the Puskesmas even after the end of the trial period.  In comparison, 
all 14 psychologists who took part in the trial were women. Each Puskesmas directly employed 
psychologists.  
 
Figure 7. Training of clinicians involved in the trial, December 2016 
4.3 Patient Recruitment 
Trial participants were recruited from among adult primary care attendees at 27 participating Puskesmas 
(all 14 WHO mhGAP arm, and 13 Specialist arm). Recruitment took place between 1-24 December 
2016.  
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Figure 8. Research Assistant reading out the screening questionnaire to a patient 
 
Initially 14 Specialist arm Puskesmas were recruited. Following careful discussion with the supervisory 
team, one Puskesmas in the specialist arm had to be dropped from the trial, losing those potential 
participants. This was because the Head of this Puskesmas prevented any psychiatric interview from 
taking place unless additional monetary benefits for his family were provided which was not part of the 
original agreements and would have threatened the integrity of the research.  
 
Figure 9. Resisting the Request for Bribes. L-R: The Author; Local Adviser, Dr Bambang Hastha 
Yoga; Head of Puskesmas B3 which was eventually dropped from the trial.   
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(n=4944) 
Excluded (n=3460) 
¨   Not meeting inclusion criteria  
 
Analysed in ITT analysis (n=153) 
Lost to follow-up (n=21) 
Discontinued intervention but still 
included in ITT analysis (n=27) 
Recruited to mhGAP arm (n=234) 
¨ Received formal diagnosis from 
Puskesmas doctor (n=174) 
¨ Did not receive a formal diagnosis 
(n=60) 
Lost to follow-up (n=10) 
Discontinued intervention but still 
included in ITT analysis (n=44) 
Recruited to Specialist arm (n=160) 
¨ Received formal diagnosis from 
Puskesmas psychologist (n=151) 
¨ Did not receive a formal diagnosis 
(n=9) 
 







Declined to participate (n=1090)  
Participant Enrolment 
Figure 10. CONSORT 2010 Flow Diagram (Modified) 
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During the recruitment period, 4944 adult primary care patients attended the general medical clinic at 
27 participating Puskesmas (CONSORT Diagram, Figure 10). Following screening (n=1484 met the 
screening criteria) and in-depth psychiatric interview (n=394), 174 WHO mhGAP arm and 151 
Specialist arm participants were given a formal diagnosis and recruited into the trial.  
4.3.1 Revised Sample Size 
The original target sample size was 189 per treatment arm, to account for possible clustering effect and 
an imbalance in the number of participants per cluster. Although this type of imbalance in cluster size 
may reduce the power of the trial, the loss is negligible for studies with more than 100 patients per arm 
(Guittet et al., 2006). Following the completion of the baseline measurements, the required sample size 
was therefore recalculated with the intra-cluster correlation for the primary outcome (HoNOS) derived 
from the baseline dataset.  
Using the formula described in Chapter 3 (Jiang, 2012), I derived an estimate of intra-cluster correlation 
of 0.025 from the baseline dataset. Having determined the sample size required for RCT (84 
participants, see Chapter 3), the required sample size for the trial was re-calculated prior to follow-up. 
Using the formula described in Chapter 3 (Hemming et al., 2011), to keep a statistical power of 0.80 
and a statistical bilateral significance value of 0.05, the number of required participants per treatment 
arm, is estimated to be 96. 
4.3.2 Retention 
While 325 participants in total were given a confirmed or probable diagnosis, and eligible for 
intervention, of these, 295 participants could be approached for re-interview at follow-up. Our retention 
rate is therefore 90.8%. 
There was good follow up with more than three quarters attending one or more sessions delivering 
interventions after baseline (223/295,76%) at a Puskesmas. I further assessed if the likelihood for 
returning for intervention is different among the two treatment arms. The number of participants 
returning for intervention in the WHO mhGAP arm is significantly more than in the Specialist Arm (c2 
= 7.364, p=0.007), 82% (n=126) and 69% (n=97) respectively.  
4.3.3 Participants Lost to Follow-up 
At follow-up, 31 (9.7%) participants dropped out: 21 (12.1%) and 10 (6.8%) in the WHO mhGAP and 
Specialist arms, respectively (Consort Diagram, Figure 10). Of these, 23 (74.2%) were women and 8 
(25.8%) men, of mean age 43.4 (17.5) and median of 46 (30). More than half (n=17, 54.8%) were of 
low education level, compared to 50% and 32% patients followed up from the WHO mhGAP and 
Specialist arms respectively. Considerably more participants lost to follow-up were unemployed at 
baseline (25.8%) compared to 10.3% patients followed-up at both the WHO mhGAP and Specialist 
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arms. There were no notable differences in clinical characteristics at baseline with those who were 
followed-up. 
Several participants lost from the WHO mhGAP arm were staff members of various Puskesmas and 
declined to participate with the follow-up as they feared disclosure to colleagues. Many participants did 
not have a current contact number retained at the Puskesmas. For these, a check at their primary address 
was made. This task was made difficult by the lack of consistency in the recorded address, i.e. at times 
the recorded address detailed the village name, and not a home address. The investigating team had 
some demographic details of the participants, such as gender, age, and birth location. It was discovered 
that some participants had relocated away from their recorded address. As such, it was nearly impossible 
to track their whereabouts. Two participants have moved to West Java and Jakarta respectively and did 
not attend the follow-up sessions. Five participants from a Specialist Arm Puskesmas in Bantul regency 
were also part of a different research project. It was apparent during our follow-up effort that their 
medical records had been removed from the Puskesmas without the knowledge of the research team 
although with the permission of the Head of the Puskesmas. These participants could not be traced. 
4.4 Patient Characteristics 
At baseline, 174 WHO mhGAP arm and 151 Specialist arm participants received a formal diagnosis of 
psychiatric disorders. These were the participants invited to return for intervention and follow-up 
assessment six months after recruitment.  
All participants attended primary care with complaints of a physical ailment, and therefore all 
participants are likely to have mental and physical multimorbidity. In other countries, mental and 
physical multimorbidity was found to be common among older people (van den Brink et al., 2013), and 
conversely, physical ailments are common among psychiatric patients (Lyketsos et al., 2002). The 
WHO mhGAP protocol even stated “Depression commonly occurs alongside other MNS conditions as 
well as physical conditions” (WHO, 2010, WHO, 2016). In the trial, only chronic common conditions, 
diabetes and hypertension, were recorded. 
4.4.1 Demographic Characteristics 
The groups did not differ in many socio-demographic characteristics, except for specialist arm patients, 
who were younger, with a higher educational level and a higher percentage of Indonesian speakers 
(Table 10). 
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Table 10. Socio-demographics of patients assessed at baseline (n=325). 




Test and Significance of 
Difference 
Gender, n (%) 
   Male 








c2=0.34, df=1, p=0.562 
Age 
  mean (SD) 








t=3.35, df=319, p=0.001 
Marital Status, n (%) 
   Unmarried 
   Married 










c2=4.98, df=2, p=0.083 
 
Language, n (%) 
   Indonesian 
   Javanese (fluent in Indonesian) 










c2=9.21, df=2, p=0.010 
 
Educational Level, n (%) 
   Low (Elementary-Middle School) 








c2=11.74, df=1, p=0.001 
Living Condition, n (%) 
   Alone 
   Partner 
   Relatives 












c2=2.43, df=3, p=0.487 
 
Working Status, n (%) 
   Employed 
   Unemployed 










c2=0.45, df=2, p=0.800 
 
 
4.4.2 Clinical Characteristics 
No differences were observed in service utilisation in the six months before baseline assessment, with 
the only exception being outpatient contacts more frequently in the WHO mhGAP arm (Table 11). A 
sizeable proportion of participants from both treatment arms were diagnosed with Mixed Anxiety and 
Depression, 25.4% and 37.2% in the WHO mhGAP and Specialist arms respectively.  
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Table 11. Service utilisation in the six months before baseline assessment and CIS-R diagnosis at 
baseline (n=325). 




Test and Significance of 
Difference 
Hospital Admissions, n (%) 
   No 








c2=2.75, df=1, p=0.097 
Outpatient Contacts, n (%) 
   No 








c2=3.98, df=1, p=0.046 
Puskesmas Contacts, n (%) 
   No 








c2=0.85, df=1, p=0.355 
Diagnosis at Baseline, n (%) 
   No Disorder per CIS-R 
   Mild or Moderate Depressive Episode 
   Panic Disorder 
   Obsessive Compulsive Disorder 
   Social Phobia 
   Agora Phobia 
   Specific (Isolated) Phobia 
   Generalized Anxiety Disorder 
   Mixed Anxiety Depression 


























Participants’ diagnosis at baseline described here are purely based on the algorithm of the CIS-R, rather 
than the listed diagnosis of each clinician who interviewed the participants. Reporting participants’ 
diagnosis based on the CIS-R here is intended purely to improve objectivity when comparing baseline 
with outcomes at 6-month follow-up. As the scoring was conducted post-hoc, clinicians were not 
provided these diagnoses, based on scoring the CIS-R interview, during the trial period. It is noted that 
some of the diagnoses computed by the algorithm are beyond the scope of the WHO mhGAP 
framework, but are within the Medical Doctors Competency Standard list of conditions which medical 
graduates must be familiar with and able to provide initial intervention for, before obtaining a practice 
license.  
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Table 12 captures a comparison of participants’ means of dependent variables at baseline and follow-
up, as well as a test of significant difference. All total scores (dependent variables) were treated as 
continuous variables, and a paired samples T-test was performed for each baseline and follow-up pair 
of scores.  
Table 12. Means of Dependent Variables at Baseline and 6-months Follow-up for participants 





Test and Significance of Difference 
CIS-R Total Score 
 Overall (n=294) 
 WHO mhGAP (n=153) 










t=9.63, df=293, p=0.000 
t=5.09, df=152, p=0.000 
t=9.62, df=140, p=0.000 
HoNOS Total Score 
 Overall (n=287) 
 WHO mhGAP (n=150) 










t=6.10, df=286, p=0.000 
t=2.66, df=149, p=0.009 
t=6.26, df=136, p=0.000 
WHODAS 2.0 
 Overall (n=294) 
 WHO mhGAP (n=153) 










t=11.56, df=293, p=0.000 
t=8.41,   df=152, p=0.000 
t=7.98,   df=140, p=0.000 
EQ-5D Malaysian Value 
 Overall (n=295) 
 WHO mhGAP (n=153) 










t=-11.01, df=294, p=0.000 
t=-9.32, df=152, p=0.000 
t=-6.31, df=140, p=0.000 
 
A statistically significant reduction in mental and social health problems at follow-up was found, as 
indicated by the HoNOS Total Score, for both treatment arms and overall (Table 12). Internal 
Consistency of the HoNOS is good, Cronbach’s alpha 0.77 at baseline and 0.81 at follow-up. 
Internal Consistency of the EQ-5D-3L is poor at baseline, Cronbach’s alpha 0.56, but good at follow-
up, Cronbach’s alpha 0.73. I found a significant increase in health-related quality of life as measured 
by the EQ-5D-3L utility index (Malaysian value set, Table 12).  
Next, between-Puskesmas differences were analysed. Appendix L compares participants’ means, 
standard deviations, median, as well as the range of scores in all dependent variables at baseline and 
follow-up, arranged by Puskesmas. One-way Analyses of Variance were conducted on the absolute 
change in clinical interview ratings as well as primary and secondary outcome measures (Appendix L). 
Absolute change is defined as participant score at follow up deducted by the score at baseline. For 
absolute change in Clinical Interview Ratings, there are significant differences between Puskesmas F 
(26) = 3.31, p<0.001. The data also show statistically significant differences between Puskesmas in 
health and social functioning as measured by the HoNOS, F (26) = 2.76, p<0.001. Statistically 
significant differences between Puskesmas in the reduction of disability as measured by WHODAS 2.0 
was also found, F (26) = 2.42, p<0.001). In measuring inter-Puskesmas differences in improving Quality 
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of Life, the Malaysian utility index shows the differences are not statistically significant, F (26) = 0.917, 
p=0.585. 
Gender differences were statistically significant on the absolute change in disability ratings as measured 
by the WHODAS 2.0, t (291) = -2.083, p<0.05, as well as the Quality of Life utility index as measured 
by the Malaysian utility index, t (292) = 2.057, p<0.05. Women were found to show a greater reduction 
in disability and a larger improvement in Quality of Life utility index. They also showed a greater 
reduction in clinical symptoms and health and social functioning although these differences were not 
statistically significant.  
Marital status was only statistically significant on the absolute change in health and social functioning 
as measured by the HoNOS, F (2) = 3.615, p<0.05, with those who are separated, divorced or widowed 
showing a greater improvement in health and social functioning during the trial period. They also 
showed a greater reduction in clinical symptoms and disability ratings, as well as greater improvement 
in Quality of Life utility index although these differences are not statistically significant.  
Education was only statistically significant on the absolute change in disability ratings as measured by 
the WHODAS 2.0, t (291) = 2.188, p<0.05, with those educated at the High School level or above 
showing a greater reduction in disability ratings. There were no significant or meaningful differences 
in other outcome variables. Employment status, on the other hand, were found to not have any 
significant influence on any of the outcome variables. 
While those living with parents or relatives show greater improvements across all outcome variables, 
these differences did not reach significance.   
Those with diabetes were found to have a statistically significantly greater improvement in clinical 
symptoms as measured by the CIS-R than those without, t (292) = 2.174, p<0.05. They were also found 
to have greater improvements in health and social functioning as well as Quality of Life utility indices, 
but less in disability ratings, compared to those without diabetes. These differences, however, are not 
statistically significant.   
In comparison, those with chronic high blood pressure at baseline were found to have statistically 
significantly lower improvements in health and social functioning as measured by the HoNOS, t (285) 
= -2.170, p<0.05, and lower reduction in disability ratings as measured by the WHODAS, t (291) = -
3.073, p<0.05. They also have less reduction in clinical symptoms compared to those without high 
blood pressure, although this difference is not statistically significant. Those with chronic high blood 
pressure at baseline were found to have a statistically significantly higher systolic blood pressure at the 
recruitment interview, t (257) = -11.336, p<0.001. The data did not show significant differences in 
diastolic blood pressure. 
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Diagnosis at baseline was found to be statistically significant in influencing improvements in clinical 
symptoms as measured by the CIS-R, F (4) = 12.094, p<0.001, as well as increases in health and social 
functioning as measured by the HoNOS, F (4) = 4.019, p<0.05. Those diagnosed with comorbid Anxiety 
and Depression were found to have the greatest average reductions in clinical symptoms. These 
participants, along with those diagnosed with other mood disorders at baseline were found to have the 
greatest average improvements in health and social functioning.  
4.4.3 Drop-outs 
During the trial period, 31 (9.5%) participants recruited at baseline declined to participate further in the 
trial or were unreachable due to having moved to a different province. Of these, 21 (67.7%) belonged 
to the WHO mhGAP arm and 10 (32.3%) belonged to the Specialist arm. Most drop-outs were female 
(n=23, 74.4%). More than half (n=17, 54.8%) were married, and about half (n=15, 48.4%) were living 
with their partners. More than half (n=17, 54.8%) were educated below High School (low education), 
a greater percentage than those who completed the trial.  
The following table indicates the frequency of drop-outs by Puskesmas. The table below indicates that 
on top of the expected rate of drop-outs in individual Puskesmas. It is alarming that almost half (n=8, 
42.1%) of 19 patients recruited at Puskesmas Ngaglik II dropped out of the trial. All five drop-outs from 
Puskesmas Wates could not be contacted as the Puskesmas lost their medical record files.    
In comparison, the MANAS Trial which evaluated mental health interventions by lay counsellors in 
primary care, in India, had an attrition rate of 12-15% in the two treatment arms (Patel et al., 2010). 
Table 13. The distribution of drop-outs by Puskesmas (N=31)     
 Recruited Drop-Outs Percent of 
Recruited 
Percent of All 
Drop-Outs 
Treatment Arm 
NGAGLIK II 19 8 42.1 25.8 WHO mhGAP 
UMBULHARJO I 14 3 21.4 9.7 WHO mhGAP 
KOTA GEDE I 16 3 18.8 9.7 WHO mhGAP 
JETIS II 17 1 5.9 3.2 WHO mhGAP 
SRANDAKAN 10 1 10.0 3.2 WHO mhGAP 
WATES 23 5 21.7 16.1 WHO mhGAP 
MINGGIR 9 1 11.1 3.2 Specialist 
MLATI II 11 1 9.1 3.2 Specialist 
BERBAH 11 3 27.3 9.7 Specialist 
KALASAN 18 3 16.7 9.7 Specialist 
DANUREJAN I 16 1 6.3 3.2 Specialist 
JETIS 20 1 5.0 3.2 Specialist 
 
The table below details the diagnoses which drop-outs received at baseline. This distribution is not 
markedly different from those who completed the trial. Those who dropped out were found not to have 
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any significant distinguishing demographic characteristics when compared to the rest of the group. 
There was no significant correlation between dropping out and any demographic variables.  
Table 14. CIS-R Diagnosis Received by drop-out participants at Baseline (N=31)  
 Frequency Percent 
Mild or Moderate Depressive Episode 6 19.4 
Panic Disorder 2 6.5 
Social Phobia 1 3.2 
Generalised Anxiety Disorder 5 16.1 
Mixed Anxiety And Depression 10 32.3 
Other Disorder  7 22.6 
 
There was a significant small correlation between dropping out and disability at baseline as measured 
by WHODAS 2.0 (Spearman’s Rho = 0.21, p<0.001) and between dropping out and quality of life 
utility score as measured by the EQ5D (Spearman’s Rho = -0.19, p<0.001). The difference in mean 
disability score among drop-outs, 35.63 (SD= 17.10) and trial completer, 23.62 (SD=16.32) was 
statistically significant, t (323) = -3.879, p<0.001. Those who dropped-out scored significantly higher 
in disability ratings at baseline compared to participants who completed the trial. The difference in 
quality of life (Malaysian) utility score among drop-outs, 0.70 (SD= 0.13) and trial completer, 0.79 
(SD=0.13) was statistically significant, t (323) = 3.366, p<0.05. Those who dropped out had a 
significantly lower quality of life utility scores at baseline compared to participants who completed the 
trial.   
4.5 Trial Outcomes 
4.5.1 Primary Outcome (HoNOS) 
Both groups experienced a similar improvement in the health and social functioning (HoNOS total 
score) at the 6-month follow-up: the regression coefficient of Specialist vs Enhanced Usual Care was -
0.55 (95%CI -1.69 to 0.58) with p=0.341 (Table 15). The bootstrap procedure gave 95%CI -1.46 to 
0.35 with p=0.232. The re-analysis by using one-sided 97.5%CI showed that for Beta≤0 p=0.829. 
Multiple imputation analysis (31 observations imputed at follow-up) confirmed the result: the 
regression coefficient of Specialist vs WHO mhGAP was -0.55 (95%CI -1.67 to 0.56) with p=0.333. 
 
Table 15. Means (SDs) and mixed-effects random regression coefficients of Specialist vs WHO 
mhGAP (95% CI) for primary (HoNOS) and secondary outcomes (EQ-5D and WHODAS 2.0) of 





WHO mhGAP arm 
 
Specialist arm 
Regression coefficient# of 
Specialist vs WHO 
mhGAP (95% CI) 
 
p-value 
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0.29 (-4.38 to 4.96) 
 
0.903 
# Random effects linear regression models with Puskesmas as a random effect and the corresponding baseline score and the treatment 
assignment as fixed effects 
Multiple Imputation with 20 replications: 
HoNOS (31 imputed observations at follow-up) Beta=-0.55, 95%CI (-1.67 to 0.56), p=0.333 
EQ-5D (30 imputed observations at follow-up) Beta=-0.01, 95%CI (-0.02 to 0.01), p=0.187 
WHODAS (31 imputed observations at follow-up) Beta=-0.02, 95%CI (-4.33 to 4.30), p=0.994 
 
4.5.2 Secondary Outcomes  
4.5.2.1 EQ-5D-3L 
A similar improvement was estimated in both groups for the quality of life (EQ-5D Utility Scored using 
the Malaysian Algorithm: the regression coefficient of Specialist vs WHO mhGAP was -0.01 (95%CI 
-0.02 to 0.01) with p=0.296 (Table 15). The bootstrap procedure gave 95%CI -0.02 to 0.01 with 
p=0.312. The re-analysis by using one-sided 97.5%CI showed that for Beta≤0 p=0.852. Multiple 
imputation analysis (30 observations imputed at follow-up) confirmed the result: the regression 
coefficient of Specialist vs WHO mhGAP was -0.01 (95%CI -0.02 to 0.01) with p=0.187. 
Table 16 indicates the numbers and proportions of trial participants reporting levels within each of the 
dimensions. A comparison of the proportions at baseline and follow-up, as well as an assessment of the 
change in the proportion of participants reporting problems, indicate a general improvement in health-
related quality of life.  
 
 
Table 16. Numbers and proportions of participants reporting levels within EQ-5D-3L dimensions 
at Baseline and Follow-up 
EQ-5D Level 
Mobility Self-Care Usual Activities Pain/Discomfort Anxiety/Depression 






















2 64 32 15 10 88 21 192 95 179 117 
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% Change in 
Number -10.5% -1.8% -15.2% -33.8% -25.5% 
Rank in Terms 
Of % Changes 4 5 3 1 2 
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4.5.2.2 WHODAS 2.0 
A similar amelioration was estimated in both groups for disability (WHODAS 2.0 total score) at follow-
up: the regression coefficient of Specialist vs WHO mhGAP was 0.29 (95%CI -4.38 to 4.96) with 
p=0.903 (Table 15). The bootstrap procedure gave 95%CI -2.52 to 3.10 with p=0.840. The re-analysis 
by using one-sided 97.5%CI showed that for Beta>0, p=0.548. Multiple imputation analysis (31 
observations imputed at follow-up) confirmed the result: the regression coefficient of Specialist vs 
WHO mhGAP was -0.02 (95%CI -4.33 to 4.30) with p=0.994. 
Table 17. Means of WHODAS 2.0 Domain Scores at Baseline and 6-months Follow-up for 





Test and Significance of Difference 
Domain 1: Cognition 
 Overall  
 WHO mhGAP  










t=11.10, df=293, p=0.000 
t=7.91, df=152, p=0.000 
t=7.83, df=140, p=0.000 
Domain 2: Mobility 
 Overall  











t=9.63 df=293, p=0.000 
t=7.92, df=152, p=0.000 
t=5.62, df=140, p=0.000 
Domain 3: Self-care 
 Overall  











t=6.68, df=293, p=0.000 
t=5.35, df=152, p=0.000 
t=4.03, df=140, p=0.000 
Domain 4: Getting Along 
 Overall  











t=7.68, df=293, p=0.000 
t=5.07, df=152, p=0.000 
t=5.90, df=140, p=0.000 
Domain 5: Activities  
 Overall  
 WHO mhGAP  
 Specialist  
 
Domain 5b: Work  
 Overall (n=173) 
 WHO mhGAP (n=84) 




















t=7.17, df=293, p=0.000 
t=5.08, df=152, p=0.000 
t=5.10, df=140, p=0.000 
 
 
t=5.58, df=172, p=0.000 
t=4.44, df=83, p=0.000 
t=3.43, df=88, p=0.000 
Domain 6: Participation 
 Overall  











t=11.07, df=293, p=0.000 
t=7.81, df=152, p=0.000 
t=7.87, df=140, p=0.000 
 
A significant reduction in all domains of disability as measured by the WHODAS 2.0 domain scores 
was found, for both treatment arms and overall (Table 17). Similarly, a significant reduction in disability 
at follow-up as measured by the overall WHODAS 2.0 score was found, for both treatment arms and 
overall (Table 15). The WHODAS 2.0 was found to have excellent Internal Consistency, Cronbach’s 
alpha 0.90 at Baseline and 0.91 at Follow-up. 
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WHODAS 2.0 is additionally supplemented with three questions pertaining the number of days in the 
last 30 days where problems were present (Table 18). 
Table 18. Number of days affected by disability in the last 30 days as per WHODAS 2.0 





















































































4.6 Recovery and Remission 
Among participants followed up from the WHO mhGAP arm (n=173) and the Specialist arm (n=151), 
a large proportion of participants were no longer meeting any diagnostic criteria according to CIS-R, 
and were considered in remission (n=152 and n=134 respectively).  
The groups did not differ in many socio-demographic characteristics (Table 19), except that participants 
in the WHO mhGAP arm were older than those in the Specialist arm. Participants in the Specialist arm 
also tend to be more educated. 
Looking at the response to treatment among participants who had one or more intervention sessions, 
there was greater improvement in health and social functioning among the Specialist arm participants 
(mean reduction in HoNOS score of 2.86, SD 5.40) compared to WHO mhGAP arm participants (mean 
reduction in HoNOS score of 1.11, SD 5.82). This difference is statistically significant (t=2.26, df=214, 
p=0.025). 
In terms of disability, there was a greater overall improvement among the WHO mhGAP arm (mean 
reduction in WHODAS 2.0 score of 12.23, SD 18.46) compared to the Specialist arm (reduction of 
9.84, SD 15.11). This difference is not statistically significant. 
Table 19.  Socio-demographics of patients in remission (n=286). 
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Test and Significant 
Difference 
Gender, n (%) 
   Male 



















t=2.98, df=282, p=0.003 
Marital Status, n (%) 
   Unmarried 
   Married 










c2=5.21, df=2, p=0.074 
 
Language, n (%) 
   Indonesian 
   Javanese (fluent in Indonesian) 










c2=6.65, df=2, p=0.036 
 
Educational Level, n (%) 
   Low (Elementary-Middle School) 








c2=10.23, df=1, p=0.001 
Living Condition, n (%) 
   Alone 
   Partner 
   Relatives 












c2=3.13, df=3, p=0.371 
 
Working Status, n (%) 
   Employed 
   Unemployed 










c2=0.752, df=2, p=0.687 
 
 
4.7 Subgroup Analysis 
The data show that 223 of 294 participants (75.9%) followed-up attended one or more sessions at a 
Puskesmas for the delivery of interventions. Those who did not take up the intervention on offer were 
found to be significantly younger than those who attended intervention (Table 20). For the subgroup 
analysis, participants who did not attend any intervention session during the trial period became part of 
the non-intervention group. Non-intervention group here differs from the traditional ‘control’ for cluster 
RCT defined as participants recruited in ‘control’ clusters. The non-intervention group includes 
participants recruited into the trial who met all the screening and diagnosis criteria for inclusion but did 
not receive any treatment for the duration of the trial. For the following analyses, participants were 
divided into three groups: 
1. Non-intervention (n=71) 
2. WHO mhGAP arm (n=126) 
3. Specialist arm (n=97) 
Table 20. Socio-demographics of participants for subgroup analysis (n=294). 
 Treatment Groups Non-Intervention 
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Gender, n (%) 
   Male 























F=6.54, df=2, p=0.002 
Marital Status, n (%) 
   Unmarried 
   Married 













c2=12.21, df=4, p=0.016 
Language, n (%) 
   Indonesian 
   Javanese (fluent in Indonesian) 













c2=9.88, df=4, p=0.043 
Educational Level, n (%) 
   Low (Elementary-Middle School) 










c2=10.28, df=2, p=0.006 
Living Condition, n (%) 
   Alone 
   Partner 
   Relatives 
















c2=8.49, df=6, p=0.204 
Working Status, n (%) 
   Employed 
   Unemployed 













c2=1.238, df=4, p=0.872 
 
The groups differ in several socio-demographic characteristics. The non-intervention group had 
significantly more participants who were younger, unmarried and primarily Indonesian speakers (Table 
20). The WHO mhGAP group had more participants with lower educational qualification. 
Resource use during the six months’ period of the trial is reported by group in Table 21. Reasons for 
hospital inpatient service varied and mostly involved admission to the general ward. Hospital and 
Puskesmas outpatient service also varied, and no one type of service was predominant. There were no 
admissions to Accident and Emergency reported by any participant. Attendance at intervention sessions 
was on average once a month for both treatment groups. 
Table 21. Resource use by group during the trial period. 
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   mean (sd) 
   median 
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Intervention Session (attendance) 
   n (%) of users 
   mean (sd) 
   median 














Across all groups, participants show significant collective improvements in their HoNOS and 
WHODAS 2.0 scores, as well as their health-related quality of life index scores (Table 22). 
Table 22. Means of Outcome Variables at Baseline and 6-months for participants included in the 
Economic Analyses (n=294) 




Test and Significance of Difference 
HoNOS Total Score 
 Non-intervention (n=71) 
 WHO mhGAP (n=126) 










t=3.98,   df=70,  p=0.000 
t=2.11,  df=122, p=0.037 
t=5.11,   df=92,  p=0.000 
WHODAS 2.0 
 Non-intervention (n=71) 
 WHO mhGAP (n=126) 










t=6.18, df=70, p=0.000 
t=7.40, df=124, p=0.000 
t=6.41, df=96, p=0.000 
EQ-5D  
 Non-intervention (n=71) 
 WHO mhGAP (n=126) 










t=-5.41, df=70, p=0.000 
t=-8.54, df=125, p=0.000 
t=-4.89, df=96, p=0.000 
 
While all groups reported significant differences between baseline and follow-up scores (Table 22), 
there are no significant differences between the three groups in any of the outcome variables at six 
months after baseline. The non-intervention group recovered as well as the treatment groups. 
The table below shows participants’ report of the number of days affected by disability in the last 30 
days prior to baseline and follow-up assessments, as measured by the WHODAS 2.0. 
Table 23. Number of days affected by disability in the last 30 days as per WHODAS 2.0 
 WHO mhGAP arm Specialist arm Non-Intervention Group 
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Most of the 294 participants (73.1%, 215) followed-up reported the same or a reduction of the number 
of days affected by difficulty in the 30 days prior to follow-up compared to baseline. This included 50 
of the Non-intervention Group (70.4%), 102 of the WHO mhGAP arm (81.0%), and 63 of the Specialist 
arm (64.9%). The rest reported an increase in the number of days affected by difficulty. 
Most of the 294 participants (88.8%, 261) followed-up reported the same or a reduction in the number 
of days unable to carry out activities in the 30 days prior to follow-up compared to baseline. This 
included 63 of the Non-intervention Group (88.7%), 108 of the WHO mhGAP arm (85.7%), and 90 of 
the Specialist arm (92.8%). The rest reported an increase in the number of days they were unable to 
carry out activities. 
Most of the 294 participants (75.8%, 223) followed-up reported the same or a reduction of the number 
of days they had to reduce activities in the 30 days prior to follow-up compared to baseline. This 
included 57 of the Non-intervention Group (80.2%), 97 of the WHO mhGAP arm (77.0%), and 69 of 
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4.8 Economic Analysis 
4.8.1 Perspective 
As described in the trial protocol (Chapter 3), the economic evaluation took a health systems perspective 
and included the use of all health resources including Puskesmas follow-up services, overnight 
hospitalisation, and visits to hospital emergency. Our participants did not report any visits to hospital 
emergency during the trial period. Due to the relatively easy access to specialist physicians, Indonesians 
seldom visit hospital emergency except for acute and severe situations, like traffic accidents.  
4.8.2 Participants 
The figure below describes the flow of participants from recruitment at baseline to follow-up and 
subsequent economic analyses. 
 
Figure 11. Modified CONSORT diagram for economic analyses 
*     data from Fidiyawati (2013) adjusted to 2017 rate  
**   crude estimate based on the mandated monthly income of clinical psychologists divided by aggregate number of appointments 
*** HoNOS data at follow-up was only available for 140 Specialist Arm participants despite 141 participants completing the trial  
 
4.8.3 Resource Use 
For all trial participants, service use was recorded using a modified version of the Client Service Receipt 
Inventory. At the follow-up, participants were asked to recall their utility of health resources during the 
trial period (6 months). Table 24 below shows the use of inpatient services (number of overnight stays), 
outpatient medical care (number of appointments), as well as mental health intervention sessions at a 
Puskesmas (number of appointments). A greater proportion of participants returned for intervention 
sessions at the WHO mhGAP arm (82.4%) compared to the Specialist Arm (68.8%). The trial was 
Primary Care Patients eligible to 
participate (n=1484). 
Declined to participate (n=1090)
Participants recruited to WHO 
mhGAP arm and received formal 
diagnosis (n=174)
Estimated treatment cost per 
session is Rp  18.098*
Participants completed trial and 
included in ITT economic 
analyses (n=153)
Participants lost to follow-up 
(n=21)
Participants recruited to 
Specialist arm and received 
formal diagnosis (n=151)
Estimated treatment cost per 
session is Rp 15,097**
Participants complete trial and 
included in ITT economic 
analyses (n=140)***
Participants lost to follow-up 
(n=10)
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unable to capture the cost of prescribed medication during the trial, as records on prescriptions filled 
within each Puskesmas were inconsistent between Puskesmas. All Puskesmas allowed patients to fill 
prescriptions from private doctors at the Puskesmas. Some Puskesmas record this within patients’ 
medical records, while others do not. As such, it would be difficult to calculate an accurate aggregate 
cost of mental health care alone. 
Table 24. Average resource use by each Treatment Arm during the trial period (6 months). 




Inpatient (number of nights) 
   n (%) of users 
   mean (sd) 









Outpatient (number of appointments) 
   n (%) of users 
   mean (sd) 









Intervention Session (number of appointments) 
   n (%) of users 
   mean (sd) 










4.8.4 Costs and Outcomes 
Based on the 2014 report (most recent publicly available), the ratio of Puskesmas doctor to catchment 
area residents in Yogyakarta is 1:5999 (Kisworini, 2015). The same report indicates that in 2014, each 
Puskesmas doctor had on average 10220 consultations. District Governments own all Puskesmas 
buildings, and there is no rental to be paid on the land and building for each Puskesmas. Residents of 
each Puskesmas’ catchment area receive free healthcare from a Puskesmas.  
The table below details average costs over six months and outcomes for all participants who completed 
the trial. Average HoNOS scores at baseline was significantly higher among the Specialist arm 
participants (mean of 6.25, SD=5.57) compared to WHO mhGAP arm (mean of 4.76, SD=4.72), 
adjusted mean difference of -1.49. There was little difference in utility scores between trial arms and 
across follow-up, which resulted in small differences in QALYs between trial arms (Table 25).  
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Table 25. Mean Outcomes per Participant over the trial period (6 months) 
 
 
WHO mhGAP arm (I) 
N=153 




Adjusted mean difference (I-C) 
Mean (SD) Mean (SD) estimate 95% CI p-value 
Costs       
Intervention 17481 30468 -12987    
MH Treatment 81145 (61377) 60388 (53253) 20807 20397 7163 to 33632 0.004 
Total Cost 98626 (61377) 90856 (53253) 7770 7410 -5823 to 20645 0.2 
HoNOS Total        
Baseline 4.76 (4.72) 6.25 (5.57) -1.49 -1.41 -0.26 to 2.55 0.04 
6-months 3.48 (4.39) 3.44 (4.59) 0.04 -0.1 -1.3 to 1.1 0.9 
Utility scores       
Baseline 0.78 (0.14) 0.80 (0.13)     
6-months 0.83 (0.11) 0.83 (0.11)     
QALYs       
6-months 0.4015 (0.060) 0.4082 (0.059) -0.0067 -0.0067 -0.02 to 0.007 0.6 
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4.8.5 Cost-Effectiveness Analysis using HoNOS 
For the primary cost-effectiveness analysis using HoNOS scores, the lower costs and better outcomes 
in the Specialist framework generate an ICER of Rp 4,843 per unit improvement in HoNOS score, 
which suggest that the Specialist framework that the Specialist framework may be better able to improve 
health and social functioning for the same cost as the WHO mhGAP framework 
Figure 12 shows the scatterplot of bootstrapped mean differences in costs and HoNOS outcome. The 
majority of the scatter points indicate that the Specialist framework is more effective than WHO 
mhGAP framework (to the right of the y-axis) and lie in the northeast quadrant (78%) where the 
Specialist framework is more effective but more costly, and the southeast quadrant (9%) where the 
Specialist framework is more effective and less costly. The remaining scatter points show poorer 
outcomes for the Specialist framework compared to the WHO mhGAP framework and fall in the 











Figure 12. Bootstrapped mean differences in costs and HoNOS scores of WHO mhGAP arm 
compared with Specialist arm at 6-month follow-up 
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The CEAC for the primary analysis suggests that the probability of the Specialist framework being cost-
effective compared to the WHO mhGAP framework ranges from just under 10% at a zero willingness 
to pay for a unit of improvement in HoNOS score to over 80% at a Rp 1,000,000 willingness to pay 
threshold (Figure 13). The point at which the Specialist care has a higher probability of being cost-
effective compared to the WHO mhGAP arm (i.e. probability >50%) is at a willingness to pay level of 












Figure 13. Cost-effectiveness acceptability curve showing the probability that Specialist 
framework is cost-effective compared to WHO mhGAP for different values of willingness to pay 
thresholds using the HoNOS score at 6-month follow-up 
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4.8.6 Cost-Utility Analysis  
For the secondary cost-utility analysis, the lower costs and marginally better outcomes in the Specialist 
framework generate an ICER of - Rp 11,105,970 per QALY which suggest that the Specialist 
framework dominates the intervention at the 6-month follow-up point.  
Figure 14 shows the scatterplot of bootstrapped mean differences in costs and QALYs. The majority of 
the scatter points indicate that Specialist framework is more effective than WHO mhGAP framework 
(to the right of the y-axis) and lie in the northeast quadrant (78%) where the Specialist framework is 
more effective but more costly, and the southeast quadrant (7%) where the Specialist framework is more 
effective and less costly. The remaining scatter points show poorer outcomes for Specialist framework 
compared to WHO mhGAP framework and fall in the northwest (14%; less effective, more costly) and 











Figure 14. Bootstrapped mean differences in costs and QALYs of WHO mhGAP arm compared 
with Specialist arm at 6-month follow-up  
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The CEAC for the cost-utility analysis suggests that the probability of the Specialist framework being 
cost-effective compared to WHO mhGAP framework is at 50% at the Indonesian willingness to pay for 











Figure 15. Cost-effectiveness acceptability curve showing the probability that Specialist 
framework is cost-effective compared to WHO mhGAP for different values of willingness to pay 
thresholds using QALYs at 6-month follow-up  
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5 DISCUSSION AND CONCLUSIONS 
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In this real-life study comparing different delivery options for primary mental health care in a lower 
middle-income country (Indonesia), several expected and unexpected outcomes were discovered. 
5.1 Principal Outcomes  
The GHQ-12 was established as a ‘fairly accurate’ screening tool for psychiatric morbidity among 
primary care patients. Using the GHQ scoring method of 0-0-1-1, Chapter 2 concluded with the 
following recommended threshold scores. For use in the clinical setting, a threshold of 1/2 is 
recommended, where a total score of 2 or above signify a likelihood of psychiatric morbidity. In a 
research setting, a higher threshold of 2/3 is recommended, where a total score of 3 or above merit 
inclusion into a clinical sample. 
The cluster randomised controlled trial described in Chapter 3 explored two core aims: 
1. the clinical effectiveness of the adapted WHO mhGAP approach of primary mental health care 
versus a Specialist model (co-location of clinical psychologists in primary care) at six months 
2. the cost-effectiveness of the adapted WHO mhGAP approach of primary mental health care 
versus a Specialist model (co-location of clinical psychologists in primary care) at six months. 
The WHO mhGAP arm was proven to be statistically not inferior to the Specialist arm in reducing 
symptoms of social and physical impairment, reducing disability, and improving health-related quality 
of life at six months. In both treatment arms, large proportions of participants went into remission. The 
WHO mhGAP arm had a higher percentage of patients returning for intervention than the Specialist 
arm. Patients reporting a diagnosis of hypertension at baseline screening, were found to have 
significantly less improvements compared to those who did not. 
The primary cost-effectiveness analysis, comparing outcomes concerning HoNOS scores suggested that 
the Specialist arm may be cost-effective compared to WHO mhGAP arm at 6-months, despite the 
employment of clinical psychologists costing the health system additional spending. Secondary cost-
effectiveness analysis using QALYs indicate the 50% probability of the Specialist arm being more cost-
effective than the adapted WHO mhGAP at the Indonesian willingness to pay for medical interventions 
of Rp 11,000,000 per QALY. 
Data gathered could be used to explore the acceptability of the adapted WHO mhGAP approach versus 
a Specialist co-location model in primary care.  
5.2 Strengths and Weaknesses 
The trial was the first study of its kind in Indonesia, where despite the Specialist framework having 
existed for over 10 years, there was no empirical study which examined its clinical effectiveness and 
cost-effectiveness. The systematic introduction of the adapted WHO mhGAP framework into the 
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country’s primary care system allowed a pragmatic cluster randomised controlled trial to examine the 
impact of both frameworks in the Indonesian context. It also provided the rare opportunity to conduct 
a statistically robust trial in a ‘real-life’ setting. The trial recruited to target and retention in the six 
months was high (90.4%). 
As this is a pragmatic trial, efforts were made to reflect the ‘real life’ conditions as far as possible. 
Reflecting the lack of Ministry of Health monitoring of the use of the WHO mhGAP Intervention Guide 
among those who received the training, this trial chose to not enforce the adherence of the WHO 
mhGAP treatment arm to the Intervention Guide. As such, this trial did not control what the clinicians 
used from their adapted WHO mhGAP training, which has been regarded by the Ministry of Health as 
an add-on to Puskesmas doctors’ competency standards. The ITT approach was used in the design, 
conduct, and analysis of the trial, reducing the potential for an overly optimistic estimate of the efficacy 
of both frameworks.  
While it is beneficial to reflect on-the-ground lack of monitoring as is, it could also be considered a 
weakness, as there is no way of ensuring if the adapted WHO mhGAP training received by Puskesmas 
doctors had any contribution to the treatment outcomes of their patients. Future studies should attempt 
to incorporate this assessment. A third treatment arm comprising Puskesmas doctors who did not attend 
the adapted WHO mhGAP training could have been considered as a third arm in the trial. 
While a clinical trial typically requires enormous budgets and a large manpower base, following the 
timeline of the Indonesian Ministry of Health and collaborating with Health Authorities at district and 
provincial levels, and matched-funded collaborators enabled significant reductions of resources 
required. The adapted WHO mhGAP “standardised” training was conducted by a dedicated team from 
the Ministry of Health, which was an advantage in terms of external validity, in that training was not 
restricted to only those who participated in the trial, highlighting the pragmatic nature of the study. 
Conducting a pragmatic trial without the backing of a large research grant from one principal funder 
was challenging, and it is no wonder that few people have attempted this. This trial proved that it can 
be feasible and that the payoff is enormous. However, the length of the recruitment period and the 
overall size of the trial was a function of funding constraints. Moreover, delays with the start of the trial 
and the time restriction of a PhD degree allowed only a six-month follow-up and nothing further.  
The trial methodology established a systematic procedure for the identification of primary care patients 
with psychiatric morbidity. The trial also achieved its primary objectives of evaluating the clinical and 
cost-effectiveness of the adapted WHO mhGAP and Specialist frameworks.  
This trial reflects what happens outside laboratory conditions, when general practitioners employed in 
state-run primary care clinics were provided an additional framework of care to treat their patients, 
compared to clinical psychologists treating patients as per routine. The trial could not impose any 
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control of what kind of intervention each clinician provided participants with but was more concerned 
instead with the impact of clinicians’ academic and add-on training backgrounds on job performance, 
i.e. patient outcomes.  
While the pragmatic nature is an advantage, the size of recruitment and delivery of intervention do have 
disadvantages. As with many mental health trials, there will always be concerns about the potential bias 
in the response of those patients who agreed to participate in research. The nature of the recruitment 
process which we agreed on with the health services did mean it was impossible to estimate the 
demographic profiles of those who refused to participate.  
The recruitment procedure, unfortunately, created a long waiting time in clinics for those who agreed 
to participate. As such, there were inevitably dropouts even before the recruitment interview took place.  
A significant issue with the economic evaluation pertains to the reliance on patient recall and report of 
health services utilisation, which for many reasons may be under- or over-reported. Moreover, the lack 
of Indonesian utility indices for EQ-5D-3L resulted in a reliance on Thai and Malaysian indices. Both 
Malaysia and Thailand are Indonesia’s geographical neighbours with similar cultural practices. 
However, the Thai and Malaysian indices were rather different, causing uncertainties about which 
indices should be adopted for this trial’s analyses. Eventually, the Malaysian utility index was chosen 
over the Thai due to higher proximity in culture and religion to Indonesia.  
The development of mapping algorithms enables researchers to translate information gained from 
preference-based measurements into health state utility weights for use in economic evaluations. 
Although NICE recommends the use of mapped health state utility estimates when directly collected 
data are not available, the validity of these mapping methods has not been fully addressed. It has been 
argued that current methods for mapping are not known to be conceptually robust (Round and Hawton, 
2017) and carries a “significant risk that may be harmful to population health” (McCabe et al., 2013). 
It is therefore important to consider the results of the mapped cost-utility analysis with greater 
uncertainty, especially when making country-wide decisions.  
The cost-utility analysis used a willingness-to-pay (WTP) threshold of Rp 11,000,000.00 for medical 
intervention in the country (Kristina et al., 2017), which was determined using a pay-for-service 
perspective, i.e. when patients must pay for interventions out of pocket. There is a lack of established 
Indonesian WTP threshold for medical interventions from the health systems perspective. What 
individuals are willing to pay out of pocket is likely to differ from a structural, top-down perspective of 
the country’s universal health coverage system. As this study aims to assist the Indonesian Ministry of 
Health in the scale-up of the most appropriate primary mental health service framework, the lack of 
established WTP threshold from the health systems perspective is significant. 
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Findings support existing literature in that he primary outcome, HoNOS, was able to detect change in 
the community for those with common mental disorders (Rees et al., 2004) and those with higher 
HoNOS scores at the diagnosis (Parabiaghi et al., 2005), such as in the average mean scores of our 
Specialist arm participants at baseline. 
The culture of rent-seeking and bribery (or even discrimination) embedded within the primary care 
system resulted in inconsistent buy-in among gatekeepers (Heads of Puskesmas). One Head of 
Puskesmas (Cluster B3), sought support (bribes) for his son’s high school tuition fees, rejected 
screening for the first few days of recruitment, and placed the clinical psychologist on leave for the 
remaining duration of recruitment. As a result, cluster B3 was dropped out of the trial. Other researchers 
willing to offer bribes were able to bypass established regulations. While during this trial my research 
assistants and I were not allowed to view medical record files without supervision, let alone take them 
out of the Puskesmas, some researchers agreeing to bribe received special privileges. For example, in 
one WHO mhGAP cluster (Puskesmas), a different research project could ‘borrow’ medical record files 
and took them out of the premises of the Puskesmas. As a result, we were unable to follow-up with 
most participants from this cluster, as their medical record files went missing. The Puskesmas official 
did not have any information on who “borrowed” the files and therefore could not retrieve them. 
5.3 Possible Mechanisms and Explanations of Findings 
As hypothesised, the adapted WHO mhGAP framework was found to be not inferior to the Specialist 
model. This result should be viewed keeping in mind that most participants had mild to moderate 
severity of disorders. Relatively brief psychosocial therapy was perhaps sufficient, where a more 
elaborate intervention plan might be required for severe disorders. The Specialist arm started out with 
higher ratings of morbidity (more severe cases) but could reduce the severity ratings to levels similar to 
those of the WHO mhGAP arm. 
The percentage of participants returning to intervention by Clinical Psychologists were markedly lower 
than the WHO mhGAP arm. It is possible that participants did not return for intervention due to stigma, 
or the belief that it does not work, or other reasons. In-depth qualitative research needs to shed light on 
this.  
A sizeable minority of participants from the Specialist arm who screened positive for psychiatric 
morbidity declined the offer of a free intake interview and, if applicable, intervention. It was possible 
that they did not fully understand the work of psychologists. Two patients from a particular cluster, 
representing 5% of patients who declined the offer of an interview/intervention, explicitly requested for 
a free intake interview and intervention to be provided by a clinical psychologist from private practice 
instead, expressing concerns regarding the competence of Puskesmas psychologist.  
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The low return rate would not be a surprise to clinicians involved. Psychologists I spoke to during one 
of the trainings for the trial procedures mentioned that, in general, few patients returned for intervention. 
There is potentially a limited understanding among patients of psychologists that intervention takes a 
few sessions and must be completed. The low return rate for intervention could indicate the belief 
among patients that one session with a psychologist could already cure them of their symptoms. This 
could be due to psychologists not telling their patients explicitly their treatment plans, which would 
require several sessions.  While the idea of a ‘one-session fix’ could be attributed to the lack of 
communication regarding treatment plans with patients, there are indications that psychologists seldom 
develop treatment plans. The big perceived knowledge gap between service providers and services users 
might also contribute to the lack of psychoeducation, or at least an explanation of the current prognosis 
and what could be done to improve the situation. On the other hand, there are indications that patients 
talk among themselves about the perceived effectiveness of an intervention, and where the experience 
was perceived to be negative, word will spread regarding the perceived incompetence of a clinician in 
the community. 
Unlike their medical counterpart, clinical psychology training in Indonesia might lack consistency 
specifically in the training of clinical interventions. Based on my observation in January 2016, the 
training of clinical psychologists in Indonesia is such that theories of aetiology and presentation of 
symptoms were prioritised over the development of practical skills through observations and clinical 
placements, as well as the practice of standardised therapeutic approaches and formulating a treatment 
plan. Master of Clinical Psychology theses at the largest state university in Yogyakarta are generally a 
thorough case study of a patient, rather than an evaluation of a therapeutic intervention characteristic of 
a Western programme, built upon an apprenticeship with intensive supervisions.  
There might be a general lack of knowledge among clinicians that home visit, while time-consuming, 
attract additional funding for the Puskesmas (i.e. paid for by the country’s universal health coverage). 
The inertia caused by busy clinic hours might have resulted in a lack of follow-up even for patients who 
required intervention. Unlike medical practitioners who had to pass a rotation in A&E, are familiar with 
ward rounds and follow-up care, and are facing oversubscribed clinic hours every day, psychologists 
did not work under time pressure. Participants in the Specialist treatment arm had a much higher rating 
of symptom intensity as measured by the CIS-R, but at the end of the trial period had this rating lowered 
to levels similar to those in the WHO mhGAP treatment arm.  
The Javanese ethos “alon alon asal kelakon” – translated as “slowly, slowly, so long as it gets done one 
day” – seems to remain pervasive despite the demands of modernisation. As this may influence the rate 
of participants’ return to Puskesmas for intervention, a trial period of only six months is in hindsight 
too short for Yogyakarta. A more extended trial period is likely to increase the return rate, although the 
number of participants lost to follow-up could increase.  
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Participants who did not attend any intervention still remitted and had positive clinical outcomes. They 
recovered just as well as participants who attended intervention sessions in either treatment arms. There 
are several hypotheses regarding this phenomenon: 
1. that the clinical instruments used in this trial lack criterion validity; 
2. that positive outcomes were due to other variables, and not either framework of care; 
3. the episodic manifestation of mood disorders is such that symptoms – while debilitating when 
they occur – may come and go and the absence of effective intervention may result in a more 
severe relapse; 
4. the very nature of psychiatric morbidity cannot yet be assessed through physiological tests, and 
reliance on patients’ self-reporting carry its own intrinsic biases; 
5. regression fallacy, where remission or the perceived clinical effectiveness of both frameworks 
were merely a regression to the mean.  
When instruments used to assess outcomes lack criterion validity, any effects of the frameworks in 
question may not be reflected in these outcomes. While possible, it is unlikely that several standardised 
instruments on health and social impairment, disability, and health-related quality of life all lack 
criterion validity. Other hypotheses are therefore more likely.   
An awareness of psychiatric morbidity established during recruitment might be sufficient to encourage 
positive changes in lifestyle or strengthening of social support among participants. These variables 
outside the remit of the trial may contribute to overall good clinical outcomes. In a tightly-knit Javanese 
community, social support was adequately available. The living arrangement where three generations 
cohabit under one roof is still prevalent in Java. It is common for parents to work while the children are 
looked after by grandparents at home. Homes in Yogyakarta are also likely to have been passed down 
through generations, and as such neighbours are very closely-knit.  
Overall positive clinical outcomes among participants could also be attributed to the episodic 
manifestation of mood disorders, where “improvements” were potentially captured during the 
progression of the illness, not recovery, and without any guarantee that relapse would not occur. While 
depression is a highly recurrent condition, the relapse is usually due to several risk factors, including 
genetics, gender, and psychosocial functioning, including prior history (Burcusa and Iacono, 2007). The 
stress generation hypothesis proposed that recurrent depressives generate stressful conditions for 
themselves, and are prone to relapse (Harkness et al., 1999). For others, coping with the single 
precipitating event would enable them to recover. The lack of long-term follow-up made it impossible 
to test this hypothesis.  
Next, the reliance on participants’ self-reporting of their symptoms carries its own intrinsic biases. A 
cultural bias could be true especially in the Javanese community, where suffering is considered part and 
parcel of life – humans having sinned against God - and that one must not complain about hardships – 
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the cultural concept of acceptance or “nrimo” (Subandi et al., 2014). The shame of being weak could 
prevent participants from disclosing any undesirable physical and mental states, especially as follow-
up interviews were conducted at home. Despite ensuring that each follow-up interview took place in 
private, the presence of family members within the home could present undue stress causing “faking-
good”.    
Given that patients who did not attend any intervention sessions were found to improve, it is possible 
that initial elevated measurements of symptom frequency and severity could be due to natural random 
variation in the presence of these symptoms at any given time. Given that the baseline interview took 
place while patients were at a Puskesmas for a physical ailment, it is also possible that elevated 
symptoms like the “white coat effect” happened. Patients may have felt inclined to inflate their 
experience of symptoms to legitimise their presence at the Puskesmas. Improvements across both 
treatment arms, as well as those who did not attend any intervention, could be attributed to coincidental 
improvements rather than a treatment effect.  
Additionally, there might be spillover effects in the health-related quality of life of residents of specific 
geographical areas. Considering participants were recruited from specific Puskesmas, it was possible 
that they shared experiences and strategies for improvement with each other, thereby collectively 
reducing symptoms and improving wellbeing. Spillover effects might explain the general improvements 
experienced by all participants, including those who did not attend intervention sessions. 
Links between physical and mental health have long been established (Clarke and Currie, 2009). 
Participants with comorbid hypertension at baseline were found to have significantly less improvements 
than those who did not. A critical review of the literature found two types of link between depression 
and hypertension, the first being related to amine depletion induced by medication, and the second 
pertaining to the consequences of hypertensive illness (Huapaya and Ananth, 1980).  
A significant proportion of participants were categorised as having mixed anxiety and depression, as 
per their CSI-R score (25% in the WHO mhGAP arm, and 37% in the Specialist arm) at baseline. This 
finding is in line with a study conducted among general practice patients in Australia, which found 25% 
point prevalence rate of comorbid depression and anxiety, and where general practitioners are deemed 
well placed to identify and manage these illnesses (Tiller, 2013). The same study found that there is 
often a treatment gap, where around 40% of people with current disorders did not seek treatment, and 
from those who did, only 45% had access to effective treatment. In the Indonesian context, where 
specialist care is often inaccessible, the primary care is expected to deal with the comorbidity. Tiller 
(2013) also noted that while there are effective treatments for either depression or anxiety, there is a 
paucity of data about the treatment for comorbid anxiety and depression, and thus the two are still 
treated separately. The two disorders share many common symptoms (including somatic complaints) 
and similar risk factors which are likely to include the interactions between environmental and genetic 
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factors, and cognitive behavioural therapy has been proposed as an effective treatment (Pollack, 2005). 
There is abundant evidence for abnormalities of the norepinephrine and serotonin neurotransmitter 
systems in both depression and anxiety disorders (Ressler and Nemeroff, 2000) and more recently the 
role of gamma aminobutyric acid (GABA) in both disorders (Kalueff and Nutt, 2007). The significant 
of proportion of participants with mixed anxiety and depression is therefore not a surprise.    
Regarding cost-effectiveness, the Specialist Arm had on average lower costs for intervention because 
of two possible reasons. Firstly, the average hourly cost of Clinical Psychologists in Puskesmas is lower 
than that of General Practitioners. Secondly, there are fewer follow-up appointments made with a 
Puskesmas psychologist (97 recorded sessions) compared to Puskesmas doctors (126 recorded 
sessions). Despite the higher initial cost, i.e. to receive free psychology consultations, a patient needs 
first to be referred by a General Practitioner, overall aggregate of treatment cost (initial interview and 
intervention combined) was slightly lower than the WHO mhGAP arm. Coupled with more substantial 
improvements in health outcomes, the Specialist Arm was the more cost-effective option. For the health 
system, however, the employment of Clinical Psychologists require additional spend on staff.  
While the Specialist arm Puskesmas had more patients who screened positive for psychiatric morbidity, 
many more patients declined participation in the trial, compared to patients in the WHO mhGAP arm. 
Primary care patients’ general preference for GP over Clinical Psychologists might indicate that there 
is possibly still fear of the unknown or even stigma of mental illness. Coupled with the fear of high 
intervention costs once the research project ends, patients might be reluctant to explore their mental 
health in a clinical setting.   
5.4 Comparison with Existing Literature 
While the first WHO mhGAP Intervention Guide was used by over 80 countries and translated into 
more than 20 languages, few research studies had directly addressed the utility of the mhGAP 
framework in LMICs, highlighting the pressing need for evidence (Dua et al., 2016). A recent 
systematic review of the WHO mhGAP evidence from LMICs found 13 studies describing the training 
of health workers using the WHO mhGAP Intervention Guide (Appendix J) but only nine studies 
describing the clinical implementation of the WHO mhGAP framework in LMICs (Keynejad et al., 
2018):  
1. In Ethiopia, a survey of experiences, strengths, and challenges of integrating mental health in 
primary health centres was conducted (Ayano et al., 2017).  
2. Charlotte Hanlon and team (2016) proposed a randomised, controlled, non-inferiority trial 
based on task-sharing model also in Ethiopia, where health centre nurses and health officers 
were trained to deliver mental health care for people with severe mental disorders, based on the 
WHO mhGAP framework (Hanlon et al., 2016).  
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3. In Haiti, a retrospective chart review of outpatient assessments using the WHO mhGAP 
framework was conducted (Grelotti et al., 2015).  
4. A mixed methods study of acceptability and patient satisfaction of mental health care plan 
designed by staff trained using the WHO mhGAP framework was conducted in Nepal but did 
not examine clinical outcomes (Jordans et al., 2016).  
5. A study in Afghanistan examined the functionality and acceptability of a WHO mhGAP 
mobile application used by primary health centre clinicians but did not consider patient 
outcomes (Khoja et al., 2016).  
6. Several studies in Kenya, including an evaluation of a WHO mhGAP mobile application for 
depression screening and a longitudinal non-randomised interventional study of adult patients 
seeking care for depression from rural public healthcare workers or traditional health 
practitioners trained in WHO mhGAP framework were conducted (Musyimi et al., 2017a, 
Musyimi et al., 2018, Musyimi et al., 2017b). Over three months, patients who sought care from 
traditional health workers were found to have significant reductions in depression symptoms as 
measured by the Beck Depression Inventory.  
7. In Zambia, an RCT of WHO mhGAP framework intervention for alcohol problems with an 8-
week follow-up was conducted at a hospital in Lusaka (Sheikh et al., 2017). The intervention 
group was found to have a significantly longer abstinence period.      
Studies by Musyimin et al (2017a) in Kenya and Sheikh et al (2017) in Zambia were the only two 
existing literature reporting patient outcomes for interventions conducted with the WHO mhGAP 
framework. Studies proposed by Hanlon et al (2016) to take place in Ethiopia and conducted by Sheikh 
et al (2017) in Zambia were the only two existing literature reporting a robust experimental design. The 
trial reported in this thesis is hitherto the only completed evaluation of an adapted WHO mhGAP 
framework looking at patient outcomes with robust experimental design taking place in ‘real life’ 
primary care setting. 
On the other hand, literature evaluating the effectiveness of collaborative colocation of psychologists 
in primary care is even more limited, despite the abundance of articles extolling the virtues of a 
collaborative care model. Looking at the colocation of psychologists in primary care, a report shows 
between 14% (South Dakota) to 50% (Rhode Island) general practitioners sharing practice with a 
psychologist in American states (Miller et al., 2014). The same report stated a positive correlation 
between the state supply of psychologists and the percentage of colocation (Pearson’s r = 0.58). A meta-
analysis has shown that integrated care model improves patient outcomes, although it is unclear whether 
colocation is either necessary or sufficient for improving outcomes (Kwan and Nease, 2013). The trial 
reported in this thesis is therefore the only completed evaluation of ‘real life’ colocation framework in 
Indonesia, and among the first worldwide, looking at patient outcomes, with robust experimental 
design.  
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The trial found that there are significantly more participants returning for intervention in the WHO 
mhGAP arm compared to the Specialist arm. It is possible that there is a stronger stigma associated with 
a mental health consultation with a psychologist than the generic nature of GP consultations. Stigma 
has been found to be a barrier to help-seeking (Clement et al., 2015) resulting in low demands for mental 
health services. Seeking help from a Clinical Psychologist requires recognition of one’s mental health 
needs. In comparison, seeking mental health assistance from a GP, especially one that the patient 
already holds a queue number for, may be deemed more palatable. Separating mental health care from 
physical health care can entrench isolation and encourage stigma towards those affected (Link and 
Phelan, 2006, Schulze and Angermeyer, 2003). The provision of mental health care by primary care 
doctors addresses this isolation and stigma issue to a large extent.  
The study finding is a stark contrast with a previous study of patient preferences for mental health 
service providers conducted in England alongside an effectiveness trial (Ward et al., 2000). The English 
study found that when given a choice, primary care patients who met the criteria for depression preferred 
non-directive counselling or cognitive behaviour therapy with a psychologist instead of general 
practitioner care. Primary care patients were also reluctant to risk being randomly allocated to the 
general practitioner care. On the other hand, a different study conducted in the primary care setting in 
India found that patients reported similar levels of trust and perceived experience of quality from both 
physician and non-physician clinicians (Rao et al., 2013). Similar to the current study, patients were 
given the option to choose the type of service provider. It should be noted that the study in India 
examined patients who received care for their physical ailments instead of mental health care, although 
this was the only other related research available. More in-depth, context-specific and cross-contextual 
research should be undertaken to understand these differences fully. 
5.5 Implications 
This trial shows that screening could quickly identify those with an indication of psychiatric morbidity 
in busy primary care clinics. The GHQ-12 has been established as a satisfactory tool for screening 
psychiatric morbidity in the Yogyakarta Puskesmas setting. The screening procedure has been tested 
during the pilot and substantive phases of the trial and could be further refined for adoption in 
Indonesian primary care clinics.  
A functional screening procedure is perhaps the quickest way to identify primary care patients at risk 
of psychiatric disorders. Primary care clinicians may lack confidence in asking questions pertaining to 
mental health, as described in Chapter 2. Given busy primary care settings and the limitations of time 
which could be spared for probing patients who might not otherwise express their symptoms verbally, 
I believe that screening helps strengthen the primary mental health care system. A ‘fairly accurate’ 
screening tool like the GHQ-12 in the Indonesian primary care context has an acceptable balance of 
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sensitivity and specificity, which means primary care clinicians could ask follow-up questions with 
considerably greater confidence.     
At the outset of the trial, there were concerns that the trial aimed to compare the competency of general 
practitioners in mental health care management against clinical psychologists. Both professions were 
reluctant to participate, fearing their work contracts could be terminated if their performance was 
considered sub-par. Mitigation strategies described in Chapter 3 were found to be successful in dealing 
with clinicians’ reluctance. Despite initial concerns that non-specialist may do poorly compared to 
specialists, both frameworks were found to work equally well in improving patient outcomes. This trial 
shows that mild to moderate mental health issues could be handled in primary care, echoing previous 
international research (van Ginneken et al., 2011, Caulfield et al., 2018).  
While the adaptation of the WHO mhGAP in Indonesia highlighted the government commitment to 
mental health care, without a monitoring system to ensure accountability, treatment adherence is 
unknown, and efficacy not guaranteed. Without a monitoring system in place, perhaps the health system 
should focus on introducing a screening procedure to assist with the identification of psychiatric 
morbidity. Moreover, post-hoc analysis of participants’ symptoms at baseline, using the CIS-R 
algorithm to map symptoms to ICD-10 diagnoses found that the majority of participants had symptoms 
of disorders beyond the scope of the WHO mhGAP protocol. Adherence to the mhGAP protocol means 
three quarters of current WHO mhGAP arm participants would be dropped out of the trial. Given the 
remaining stigma surrounding psychology consultations, if adherence to the mhGAP protocol is the 
approach taken in real-life practice, Treatment Gap would remain enormous. 
Arguably, all Indonesian medical graduates would have competency in diagnosing and (at least) initial 
intervention of all ICD-10 psychiatric diagnoses commonly found in primary care. Puskesmas doctors, 
should therefore be able to recognise and manage these disorders in the first instance, or have a 
procedure for referral otherwise. This leads to questions regarding the utility of the adapted WHO 
mhGAP framework in the Indonesian context. As the implementation cost is enormous, the Indonesian 
Ministry of Health should wisely reconsider the nation-wide scale-up and resist international pressure 
to take action. The WHO mhGAP framework, despite its adaptation, is a costly exercise which may not 
be the answer the country was hoping for. A primary focus on screening and early identification, 
followed by initial intervention by publicly trusted Puskesmas doctors, relying on their existing medical 
competencies, is a less costly and feasible alternative. A second focus on strengthening the referral 
system for moderate to severe cases, may help reduce the mental health Treatment Gap.  
There is a significant need for all clinicians to discuss treatment plans with patients and for patients to 
be actively involved in its development. All clinicians must inform their patients the of predicted 
number of sessions, what kind of intervention it would be, what are the key indicators of remission, and 
a discharge process at the end. Forming a therapeutic alliance with patients is a key determinant of 
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treatment efficacy for psychiatric disorders. While building trust is a challenging exercise, once the 
therapeutic alliance is established, treatment adherence could significantly improve.   
The reluctance of patients to return for intervention or follow-up interview suggests that in the 
Yogyakarta context, home visit was preferable and should be considered more frequently to improve 
adherence and fidelity, despite loopholes such as the presence of family members in the vicinity. The 
health system has additional provision for home visits under the universal health coverage, which 
supports the proposition of increasing the frequency of home visits. Puskesmas receives additional 
reimbursements from the state insurance system for home visits. While home visits require significantly 
more time investment, the outcomes may be favourable. 
A recent systematic review of the WHO mhGAP evidence from LMICs (Keynejad et al., 2018), 
highlighted the pressing need for an understanding of contextual challenges in the field, detailed 
protocols, qualitative studies, as well as randomised controlled trials – all of which have been offered 
by this trial and studies conducted alongside, for the Indonesian context.  
This trial therefore provides potential learning points for other countries, which may not be considered 
Low or Middle-Income, but have similarly limited resources for mental health services due to an 
imbalance of supply and demand, such as the UK and Singapore. Stigma towards mental health issues, 
and by proxy, stigma towards consultations with mental health specialists, is not limited to LMICs. 
Migrant populations might carry the stigma and lack of psychoeducation with them. In an increasingly 
globalised world, societies are becoming multi-cultural, and as a result, mental health systems must be 
prepared to catch those who would otherwise fall through the cracks due to fear of stigma of seeing a 
mental health specialist, or lack understanding of mental health altogether. 
In contexts where the waiting time to see a specialist could result in further detriment to the patient, 
providing mental health services for mild to moderate conditions within primary care is a clinically 
effective temporary solution, until the number of specialists reach acceptable levels.  
While there are clear arguments for the integration of mental health into primary care, Saraceno et al. 
(2007) noted the three key barriers to the integration of mental health into primary care. Firstly, the 
overburdened primary care means that general practitioners may not have the time to provide adequate 
mental health care. Secondly, primary care physicians do not receive regular supervision and support 
for mental health care, which may result in inappropriate treatment. Lastly, essential psychotropic 
medication may not be available. It has been argued that the role of mental health specialists, including 
psychiatrists, psychologists, and mental health nurses, among others, should transform from service 
provision to training and supervision (Saraceno et al., 2007).  
Provincial and district governments which in Indonesia are responsible for the management of primary 
care clinics are increasingly interested in implementing the Specialist Co-location model too. Recently, 
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the governor of Jakarta stated his wish to provide psychology services in the capital province’s primary 
care clinics (Purba, 2017). This requires enormous resources which require additional safeguarding of 
budgets to prevent corruption, followed by a sharp increase in the number of qualified clinical 
psychologists interested in primary care work. As the ultimate consumers and beneficiaries, patients’ 
preferences should be considered not only in the development of an effective approach but also when 
deciding to scale-up the programme across the country. 
Given our findings, the systematic roll-out of the WHO mhGAP framework across all Indonesian state-
owned primary care signals the government’s commitment to improving the mental health system. As 
Saraceno and colleagues (2007) argued, specialist mental health workforce in low-resource settings 
should consider training and supervision roles instead, perhaps limiting direct clinical work to severe 
and persistent cases; whereas task-shifting and sharing, and investing in the community and primary 
care might be preferable and beneficial. 
5.6 Suggestions for Further Research 
In detailing the strengths and weaknesses of the trial, information gaps specifically on the relevance of 
the adapted WHO mhGAP training for Puskesmas doctors, its subsequent utility in clinical practice, 
and the impact of adherence to the framework in terms of the accuracy of diagnosis and improved 
treatment outcomes remain unaddressed. Future evaluations in the Indonesian context might benefit 
from addressing these gaps.   
Future research should adopt a third treatment arm: Puskesmas doctors who had not been trained in the 
adapted WHO mhGAP. Future research should also explore the accuracy of Puskesmas doctors’ 
diagnosis of common mental disorders, compared to a gold standard such as the CIS-R, or the 
Comprehensive Psychopathological Rating Scale (CPRS).  
Although the trial design was relevant to the potential implementation of a screening procedure within 
primary care setting in Indonesia, and develop a primary mental health system which combines the 
benefits of both the adapted WHO mhGAP and Specialist Co-location frameworks, high-quality health 
services and delivery research is required to explore how best to combine available resources and 
package an implementable procedure.  
Geo-cultural context, specifically as the trial took place in rural Java, would have undoubtedly 
influenced the outcomes of the current trial. While this increases the generalisability of the trial in the 
Indonesian context, with the majority of Indonesians being ethnic Javanese and living in Java, a large 
proportion of the population who live outside Java were underrepresented.  These are arguably the 
people who needed the adapted WHO mhGAP framework the most, as there are far too few mental 
health specialists (psychiatrists or clinical psychologists) living outside Java. Additionally, the power 
dynamics between clinicians and patients, and especially when the patients also become ‘the 
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researched’ remain understudied, especially in Indonesia’s primary care context. Replicating this trial 
in other provinces within Indonesia, with more substantial research funding and longer duration of 
recruitment might be beneficial for future country-level decision-making. Future trials should also 
consider social support and social connectivity as a moderating effect influencing patient outcomes.   
Additionally, substantial qualitative work should be carried out alongside and as part of future work in 
order to fully understand preferences, attitudes, socio-cultural and other contextual factors and issues at 
play. Patient preferences are often disregarded within clinical settings (Allison and Sudore, 2013). 
Despite this, they are increasingly regarded as key to ensure the development of a mental health system 
that patients feel comfortable to access and do actually access. An often-neglected perspective, the 
people coming to the service should be consulted when planning a scale-up of existing services, as 
ultimately, it is they who will either benefit or not from the service. Unlike market research prior to the 
roll-out of consumer products, the scale-up of healthcare interventions still tends to be decided top-
down, without considering patients’ preferences.  
5.7 Fieldwork Learning Points 
There were several important lessons I gathered from the various fieldwork periods in Indonesia. Most 
important of all is to maintain records of communications with policymakers so that when inevitable 
staff turnover occurred, I could continue moving forward. During the trial, the Chief Executive of the 
Provincial Health Authority was reshuffled to a new position, and the post of Chief Executive was 
vacant for six months. Additionally, the Head of Medical Services at the Provincial Health Authority 
was also reshuffled to become the Director of a psychiatric hospital, just after the pilot study. 
During the trial, a few stakeholders including a local collaborator, a Head of Puskesmas, and 
administrators of several Puskesmas requested financial contributions which were not previously 
communicated, some of which were beyond the official financial guidelines of Puskesmas fees. It seems 
the local culture did not frown upon such requests, which was a surprise. While I agreed to pay data 
collection fees according to local guidelines, with the receipt provided, I declined to make any financial 
contributions to individuals. As a result, our baseline recruitment at one Puskesmas had to be cut short.  
I also learned to be proactive and prepared for concise impromptu speeches, for longer seminars, and 
for any visual aids required during the period of the trial. Stakeholders are usually extremely busy and 
are working on multiple projects, so being clear, concise, and memorable was my adopted strategy.  
Finally, I learned that working in real-life settings is very different from working in a lab, in that I have 
very little control over the context of the trial. Prescribed time frames were, in fact, a guide rather than 
definite and cultural differences in work ethics could result in misunderstandings. It was imperative to 
try to remain a motivated realist during the trial. 
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5.8 Recommendations 
Given the capability of the primary care system to manage mild to moderate cases, perhaps existing 
specialist resources could be rearranged into a hub-and-spoke model. This would reduce healthcare 
spending associated with employing a clinical psychologist for every clinic, ensure the efficiency of 
their working time, and improve accountability. From a health systems perspective, the hub-and-spoke 
model would simplify the delivery of interventions and reduce the requirement of specialist workforce, 
while improving the utility of Clinical Psychologists’ working hours. Clinical psychologists working in 
a hub could further specialise in key intervention technique and hone their expertise with a subset of 
clients (e.g. children, geriatric population, juvenile offenders) based on their diagnoses and needs. 
Upskills training such as the Dialectical Behavioural Therapy for Borderline Personality Disorder, and 
Trauma-Focused CBT for children and adults who had been abused, and Functional Family Therapy 
for juvenile delinquents are copyrighted training programmes with established efficacy and 
accompanying high price tags. Nation-wide training costs could be reduced by sending one clinical 
psychologist per hub to attend these expensive certifications, while requiring a mandatory work 
commitment (bond) commensurate to the cost of the training.  
 
Figure 16. Clinical Psychology Hub in a Hub and Spoke Model 
 
The suggested model facilitates stepped-care arrangements where patients are offered a low-intensity 
intervention in the first instance, at Puskesmas level, with a smaller proportion going on to higher-
intensity options at the Clinical Psychology hubs. Those failing to benefit from low-intensity 
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A collegiate working environment would be beneficial for the morale of clinical psychologists, improve 
creativity in managing cases through discussions, and increase accountability through supervisions. 
Regular audits could be performed, which would ensure the timeliness of assessment from the date of 
referral, appropriate management of conditions, as well as appropriate discharge procedures.  
There are currently no existing psychosocial therapy guidelines for psychiatric disorders in Indonesia, 
like the NICE guidelines in the UK. There is merit in producing evidence-based ‘good clinical practice’ 
guidelines to inform clinicians of the appropriate management strategy for psychiatric disorders, given 
the obvious limitations of the WHO mhGAP manual. It would be even more impactful if the guidelines 
could be supplemented with empirical evidence from Indonesia. Such guidelines could also assist 
clinicians in informing their patients of their customised treatment plan, including any step-up care 
arrangement should they not respond to low-intensity treatment.  
Halting current nation-wide implementation of the WHO mhGAP framework is recommended, in light 
of the limitations of the manual in providing relevant new competencies for primary care doctors. If the 
week-long training only served to improve primary care doctors’ confidence in diagnosing mental 
disorders among their patients, less costly alternatives should be explored, and perhaps included in the 
continuing medical education framework for a maximum reach. 
There is merit, however, in keeping the delivery of mental health services in primary care. When 
referrals are made to a secondary mental health service, no appointment is ever made for up to 90% of 
referrals made (Callahan et al., 2002, Katon, 1995, Kessler and Stafford, 2008). Integrating depression 
and hypertension treatment has been found to be effective in improving patient outcomes (Bogner and 
de Vries, 2008), and despite their limitations, both frameworks tested in the trial would make this 
feasible.  
5.9 Conclusion 
This thesis achieved its primary aims. The primary care mental health services as part of the Indonesian-
adapted WHO mhGAP or the Specialist Co-location framework were found to be equally effective in 
improving patients’ clinical outcomes. Given that both frameworks yielded positive patient outcomes, 
there is no immediate need to increase the absolute number of specialist mental health professionals in 
community psychiatry (i.e. replicate the specialist framework outside Yogyakarta). The colocation of 
Clinical Psychologists in primary care requires a larger health budget (manpower costs), which may be 
a worthwhile investment as the Specialist framework was found to be cost-effective compared to the 
adapted WHO mhGAP framework.  
As most psychologists and psychiatrists in Indonesia reside in large cities, the current systematic roll-
out of the adapted WHO mhGAP framework might address the need to strengthen non-stigmatising 
mental health care within community contexts, reflecting the preferences of primary care patients. 
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Indonesian primary care doctors should be equipped to deal with the range of mental disorders 
presenting in primary care, even without the additional adapted mhGAP training, and therefore further 
research confirming this should be conducted. Meanwhile, the nation-wide implementation of the 
adapted mhGAP framework should be halted before the merits of the training are made certain. Various 
models of integrated care, which optimises the availability of manpower and cost of hiring manpower 
against community demands, should be tested in Indonesia before a new nation-wide policy is decided.   
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APPENDIX A: ADAPTED WHO MHGAP TRAINING 
SCHEDULE IN YOGYAKARTA 
JADWAL PELATIHAN PENINGKATAN KETERAMPILAN KESWA BAGI PETUGAS 
KESEHATAN DI PUSKESMAS  (DOKTER UMUM)  
Training timetable for Add-on Competency Training in Mental Health for Health Workers in 
Puskesmas (General Practitioners) 
 
HARI  (DAY) I  Senin (Monday), 11 April 2016 
11.00 – 12.00 WIB Registrasi  dan Makan Siang (Registration and Lunch) 
12.00 – 12.30 WIB  Pembukaan (Opening Address) 
   Laporan Ketua Panitia (Report from Head of Programme) 
   Sambutan Direktur P2MKJN (Welcome from Director of Mental Health) 
12.30 – 13.15 WIB  Situasi Terkini Kesehatan Jiwa dan Kebijakan Nasional Kesehatan Jiwa 
2015-2019 (Latest Situation on Mental Health and National Mental Health 
Policies 2015-2019) 
13.15 – 14.15 WIB ISHOMA (Rest, Prayer, Meal) 
14.15 – 14.45 WIB Pre Test  
15.45 – 16.15 WIB         BLC (Background and Learning Content) 
16.15 – 17.00 WIB Deteksi Dini Masalah Kesehatan Jiwa (Early Detection of MH Problems) 
17.00 – 17.15 WIB Break Shalat Ashar + Coffee Break 
17.15 – 18.00 WIB Wawancara Psikiatri (Psychiatric Interviewing) 
 
HARI  (DAY) II   Selasa (Tuesday), 12 April  2016 
07.30 – 07.45 WIB Refleksi (Reflection)  
07.45 – 09.30 WIB Gangguan Depresi (Depression) 
09.30 – 09.45 WIB Coffee Break 
09.45 – 12.00 WIB         Gangguan Depresi (Depression) 
12.00 – 13.00 WIB ISHOMA (Rest, Prayer, Meal) 
13.00 - 14.30 WIB   Gangguan Ansietas (Anxiety) 
14.30 – 14.45 WIB Coffee Break 
14.45 – 16.15 WIB Gangguan Ansietas (Anxiety) 
16.15 – 16.30 WIB Break Shalat Ashar (Break and Afternoon Prayer) 
16.30 – 17.30 WIB Gangguan Perkembangan dan Perilaku pada Anak (Child and adolescent 
mental and behavioural disorders) 
 
HARI  (DAY) III   Rabu (Wednesday), 13 April 2016 
07.30 – 07.45  WIB Refleksi (Reflection) 
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07.45 – 09.15  WIB Gangguan Psikotik (Psychoses) 
09.15 – 09.30 WIB Coffee Break 
09.30 – 12.00 WIB Gangguan Psikotik (Psychoses) 
12.00 – 13.00 WIB         ISHOMA (Rest, Prayer, Meal) 
13.00 – 14.30 WIB Gangguan Demensia pada Lansia (Dementia) 
14.30 – 14.45 WIB         Coffee Break 
14.45 – 16.15 WIB Gangguan Demensia pada Lansia (Dementia) 
 
HARI   (DAY) IV   Kamis (Thursday), 14 April 2016 
07.30 – 07.45 WIB Refleksi (Reflection)   
07.45 – 10.00 WIB Kegawatdaruratan Psikiatrik (Psychiatric Emergency) 
10.00 – 10.15 WIB  Coffee Break 
10.15 – 12.00 WIB         Kegawatdaruratan Psikiatrik (Psychiatric Emergency) 
12.00 – 13.00 WIB ISHOMA (Rest, Prayer, Meal) 
13.00 -  15.00 WIB Pelaksanaan Sistem Rujukan (Referral System) 
15.00 – 15.15 WIB Coffee Break 
15.15 – 16.30 WIB Pencatatan dan Pelaporan (Recording and Reporting) 
16.30 – 17.00 WIB Penjelasan Praktek Lapangan (Field Practice Briefing)  
17.00 – 17.30 WIB Rencana Tindak Lanjut (RTL) (Management Plan) 
 
HARI  (DAY) V  Jumat (Friday), 15 April 2016 
07.00 – 07.15 WIB Refleksi (Reflection) 
07.15 – 07.45 WIB Menuju tempat praktek lapangan (Head to Field Practice) 
07.45 – 08.00 WIB Persiapan praktik lapangan (Field Practice Preparation) 
08.00 – 11.00 WIB Praktik Lapangan (Field Practice) 
11.00 – 11.30 WIB  Kembali ke tempat pelatihan 
11.30 – 13.00 WIB ISHOMA (Rest, Prayer, Meal) 
13.00 – 14.00 WIB Diskusi Kelompok Hasil PKL (Group Discussion of Field Practice Results) 
14.00 – 14.15 WIB  Coffee Break 
14.15 – 15.45 WIB  Presentasi Hasil Diskusi Kelompok dan Diskusi Pleno (Group Presentation) 
15.45 – 16.15 WIB Post Test 
16.15 – 16.30 WIB Simpulan dan Penutupan (Conclusion and Closing Remarks) 
16.30 – 17.30 WIB Penyelesaian administrasi (Administrative Matters) 
 
JADWAL PELATIHAN PENINGKATAN KETERAMPILAN KESWA BAGI PETUGAS 
KESEHATAN DI PUSKESMAS (PERAWAT) 
Training timetable for Add-on Competency Training in Mental Health for Health Workers in 
Puskesmas (Nurses) 
HARI  (DAY) I  Senin (Monday), 11 April 2016 
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11.00 – 12.00 WIB Registrasi  dan Makan Siang (Registration and Lunch) 
12.00 – 12.30 WIB  Pembukaan (Opening Address) 
   Laporan Ketua Panitia (Report from Head of Programme) 
   Sambutan Direktur P2MKJN (Welcome from Director of Mental Health) 
12.30 – 13.15 WIB  Situasi Terkini Kesehatan Jiwa dan Kebijakan Nasional Kesehatan Jiwa 
2015-2019 (Latest Situation on Mental Health and National Mental Health 
Policies 2015-2019) 
13.15 – 14.15 WIB ISHOMA (Rest, Prayer, Meal) 
14.15 – 14.45 WIB Pre Test 
15.45 – 16.15 WIB         BLC (Background and Learning Content) 
16.15 – 17.00 WIB Deteksi Dini Masalah Kesehatan Jiwa (Early Detection of MH Problems) 
17.00 – 17.15 WIB Break Shalat Ashar + Coffee Break  
17.15 – 18.00 WIB Komunikasi dalam Pelayanan Keperawatan Jiwa (Communication in Mental 
Health Nursing) 
 
HARI  (DAY) II   Selasa (Tuesday), 12 April 2016 
07.30 – 07.45 WIB Refleksi (Reflection)   
07.45 – 09.30 WIB Komunikasi dalam Pelayanan Keperawatan Jiwa (Communication in Mental 
Health Nursing) 
09.30 – 09.45 WIB Coffee Break 
09.45 – 12.00 WIB         Asuhan Keperawatan Gangguan Depresi (Nursing Care for Depression) 
12.00 – 13.00 WIB ISHOMA (Rest, Prayer, Meal)        
13.00 - 14.30 WIB   Asuhan Keperawatan Gangguan Depresi (Nursing Care for Depression) 
14.30 – 14.45 WIB Coffee Break 
14.45 – 16.15 WIB  Asuhan Keperawatan Gangguan Ansietas (Nursing Care for Anxiety) 
16.15 – 16.30 WIB Break Shalat Ashar  
16.30 – 17.30  WIB Asuhan  Keperawatan Gangguan  Ansietas (Nursing Care for Anxiety) 
 
HARI  (DAY) III   Rabu (Wednesday), 13 April  2016 
07.30 – 07.45  WIB Refleksi (Reflection) 
07.45 – 09.15  WIB Asuhan Keperawatan Gangguan Psikotik (Nursing Care for Psychoses) 
09.15 – 09.30 WIB Coffee Break 
09.30 – 12.00 WIB Asuhan Keperawatan Gangguan  Psikotik (Nursing Care for Psychoses) 
Efek Samping Antipsikotik dan Obat Psikiatrik Lainnya (Side effects of antipsychotics and other 
psychiatric medications) 
12.00 – 13.00 WIB         ISHOMA (Rest, Prayer, Meal) 
13.00 – 14.30 WIB        Asuhan Keperawatan pada Gangguan  Perkembangan & Gangguan Perilaku 
Pada Anak (Nursing care for Child and adolescent mental and behavioural disorders)  
14.30 – 14.45 WIB         Coffee Break 
14.45 – 15.45 WIB Asuhan Keperawatan Gangguan Psikotik (Nursing Care for Psychoses) 
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15.45 – 17.00  WIB Asuhan Keperawatan pada Gangguan Demensia pada Lansia (Nursing care for 
Dementia) 
                 
HARI   (DAY) IV   Kamis (Thursday), 14 April 2016 
07.30 – 07.45 WIB Refleksi (Reflection) 
07.45 – 10.00 WIB Kegawatdaruratan Psikiatrik (Psychiatric Emergency) 
10.00 – 10.15 WIB  Coffee Break 
10.15 – 12.00 WIB         Kegawatdaruratan Psikiatrik (Psychiatric Emergency) 
12.00 – 13.00 WIB ISHOMA (Rest, Prayer, Meal) 
13.00 -  15.00 WIB Pelaksanaan Sistem Rujukan (Referral System) 
15.00 – 15.15 WIB Coffee Break 
15.15 – 16.30 WIB Pencatatan dan Pelaporan (Recording and Reporting) 
16.30 – 17.00 WIB Penjelasan Praktek Lapangan (Field Practice Briefing)  
17.00 – 17.30 WIB Rencana Tindak Lanjut (RTL) (Management Plan) 
 
HARI  (DAY) V  Jumat (Friday), 15 April 2016 
07.00 – 07.15 WIB Refleksi (Reflection) 
07.15 – 07.45 WIB Menuju tempat praktek lapangan (Head to Field Practice) 
07.45 – 08.00 WIB Persiapan praktik lapangan (Field Practice Preparation) 
08.00 – 11.00 WIB Praktik Lapangan (Field Practice) 
11.00 – 11.30 WIB  Kembali ke tempat pelatihan 
11.30 – 13.00 WIB ISHOMA (Rest, Prayer, Meal) 
13.00 – 14.00 WIB Diskusi Kelompok Hasil PKL (Group Discussion of Field Practice Results) 
14.00 – 14.15 WIB  Coffee Break 
14.15 – 15.45 WIB  Presentasi Hasil Diskusi Kelompok dan Diskusi Pleno (Group Presentation) 
15.45 – 16.15 WIB Post Test 
16.15 – 16.30 WIB Simpulan dan Penutupan (Conclusion and Closing Remarks) 
16.30 – 17.30 WIB Penyelesaian administrasi (Administrative Matters) 
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APPENDIX B: RANDOMISED CLUSTERS AND 
CLINICIANS INVOLVED IN THE TRIAL 
No. WHO mhGAP Cluster District General Practitioner Mobile Phone Number 
1 SEYEGAN Sleman dr. Dharmawan Lingga A 0818 721 336 
2 NGEMPLAK I Sleman dr. Nurul Agus D 0853 9732 4393 
3 NGAGLIK II Sleman dr. Adriana 0856 4363 6660 
4 UMBUL HARJO I Kota dr. Alissyah 0853 6991 8700 
5 KOTA GEDE I Kota dr. Liza D. Anjumi 0818 508 638 
6 GONDOMANAN Kota dr. Deo Hadi Nanda 0818 0405 0278 
7 RONGKOP Gunung Kidul dr. M. Muslih 0813 2929 3838 
8 KARANGMOJO II Gunung Kidul dr. Nuri Cahyawati 0877 3823 7937 
9 JETIS II Bantul dr. Yulia Dewi Irawati 0812 1550 0707 
10 SEDAYU II Bantul dr. Sri Rahayu 0812 2699 811 
11 SRANDAKAN Bantul dr. Fifi Sumarwati 0812 2595 9400 
12 TEMON I Kulon Progo dr. Fitri Nurkhamidah 0815 7854 8608 
13 WATES Kulon Progo dr. Dian Monika Sharie 0813 2847 1675 
14 KALIBAWANG Kulon Progo dr. Ria Fitriana S.  0857 2929 2575 
No. Specialist Cluster District Clinical Psychologist Mobile Phone Number 
1 MOYUDAN Sleman Nyimas Rafika 0812 2710 1182 
2 MINGGIR Sleman Fahrunnisa 0856 4330 0651 
3 GODEAN II Sleman Ratih Ary Nurani 0857 1179 9904 
4 GAMPING I Sleman Setyoningrum 0815 7917 590 
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5 MLATI II Sleman Berta Devi Aryani 0877 3939 2818 / 0856 286 3101 
6 DEPOK II Sleman Elly Ervinawati 0813 2283 2077 
7 BERBAH Sleman Liawati 0811 266 319 / 0818 0431 4900 
8 KALASAN Sleman Herlin Utari 0815 6843 3282 
9 SLEMAN Sleman Titik Adianingsih 0813 2822 9998 
10 KOTA GEDE II Kota Firra Berlinawati 0818 0434 2407 
11 DANUREJAN I Kota Sarita M & Mega D 0819 1552 4913 
12 DANUREJAN II Kota Salwa Usrati 0818 0362 1172 
13 NGAMPILAN Kota Eka Maulidya Bastra 0815 2424 9938 
14 JETIS Kota Ermin Emillia 0818 0269 2949 
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APPENDIX C: PILOT RECRUITMENT GRAPH 
During the pilot recruitment period, 2-9% of daily adult attendees from 27 Puskesmas agreed to 
additional psychiatric interviewing. At the end of the recruitment week (5 days), 178 patients agreed to 















07 June 2016 08 June 2016 09 June 2016 10 June 2016 11 June 2016
Pilot Recruitment between 7 - 11 June 2016
WHO mhGAP Specialist
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APPENDIX D: UNIVERSITY OF CAMBRIDGE ETHICS 
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APPENDIX F: UNIVERSITY OF CAMBRIDGE TRIAL 
INSURANCE 
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APPENDIX G: YOGYAKARTA PROVINCE APPROVAL 
TO CONDUCT RESEARCH 
 
opealor2@yahoo.com
PEMERINTAH DAERAH DAERAH ISTIMEWA YOGYAKARTA
SEKRETARIAT DAERAH
Kompleks Kepatihan, Danurejan, Telepon (0274) s6281 1 - s6281A'(Hunting)
YOGYAKARTA 55213
Membaca Surat : KEPALA GMPHranssal : 26 MEI 2016






Mengingat : 1. Peraturan Pemerintah Nomor 41 Tahun 2006, tentang Perizinan bagi Perguruan Tinggi Asing, Lembaga penelitian dan
Pengembangan Asing, Badan Usaha Asing dan Orang Asing dalam melakukan Kegitan Penelitian dan Pengembangan di
lndonesia;
2. Peraturan Menteri Dalam Negeri Nomor 20 Tahun 2011, tentang Pedoman Penelitian dan Pengembangan di Lingkungan
Kementrian Dalam Negeri dan Pemerintah Daerah;
3' Peraturan Gubemur Daerah lstimewa Yogyakarta Nomor 37 Tahun 2008, tentang Rincian Tugas dan Fungsi Satuan Organisasi di
Lingkungan Sekretariat Daerah dan Sekretariat Dewan Perwakilan Rakyat Daerah.
4. Peraturan Gubemur Daerah lstimewa Yogyakarta Nomor 18 Tahun 2009 tentang Pedoman Pelayanan Perizinan, Rekomendasi
Pelaksanaan Survei, Penelitian, Pendataan, Pengembangan, Pengkajian, dan'Studi La5langan di Daerah lstimewa yogyakarta.
DIIJINKAN untuk melakukan kegiatan survei/penelitian/pendataan/pengembangan/pengkajian/studi lapangan kepada:Nama : SABRINA GABRIELLE ANJARA
AIAMAT :FAKULTAS PSIKOLOG!, CENTER FOR PUBLIC MENTAL HEALTH, UNIVERSITAS
MADA
JUdUI :EVALUASI EFEKTIVITAS KLTNIS DAN BIAYA PELAYANAN KESEHATAN JIWA
PUSKESMAS DI YOGYAKARTA, INDONESIA
Lokasi : DINAS KESEHATAN DIY
waktu :27 MEl2016 s/o 27 AGUSTUS 2016
Dengan Ketentuan
1. Menyerahkan surat keterangan/ijin survei/penelitian/pendataan/pengembangan/pengkajian/studi lapangan *) dari pemerintah Daerah Dly
kepada Bupati/Walikota melalui institusi yang berwenang mengeluarkan ijin dinnksud;
2' Menyerahkan soft copy hasil penelitiannya baik kepada Gubemur Daerah lstimewa Yogyakarta melalui Biro Administrasi pembangunan Setda
DIY dalam compact disk (CD) maupun mengunggah (upload) melalui website adbang jogjaprov.go.id dan menunjukkan cetakan asli yang sudah
disahkan dan dibubuhi cap institusi;





Asisten Perekonomian dan Pembangunan
ub.
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S1	 Dapat	berkonsentrasi	pada	apa	pun	yang	Anda	kerjakan?	 LEBIH	 BIASA	 KURANG	 SANGAT	KURANG	
S2	 Sulit	tidur	karena	khawatir?	 TIDAK	 TIDAK	LEBIH	 LEBIH	DARI	BIASA	 SANGAT	LEBIH	
S3	 Merasa	berperan	dalam	berbagai	hal	yang	bermanfaat?	 LEBIH	 BIASA	 KURANG	 SANGAT	KURANG	
S4	 Merasa	mampu	untuk	membuat	suatu	keputusan?	 LEBIH	 BIASA	 KURANG	 SANGAT	KURANG	
S5	 Merasa	terus	menerus	di	bawah	tekanan?	 TIDAK	 BIASA	 LEBIH	DARI	BIASA	 SANGAT	LEBIH	
S6	 Merasa	tidak	sanggup	mengatasi	kesulitan	–kesulitan	Anda?	 TIDAK	 BIASA	 LEBH	DARI	BIASA	 SANGAT	LEBIH	
S7	 Dapat	menikmati	aktivitas	kegiatan	sehari-hari?	 LEBIH	 BIASA	 KURANG	 SANGAT	KURANG	
S8	 Mampu	menanggung	masalah-masalah	Anda?	 LEBIH	 BIASA	 KURANG	 SANGAT	KURANG	
S9	 Merasa	tidak	bahagia	dan	tertekan?	 TIDAK	 TIDAK	LEBIH	 LEBIH	DARI	BIASA	 SANGAT	LEBIH	
S10	Kehilangan	kepercayaan	diri?	 TIDAK	 TIDAK	LEBIH	 LEBIH	DARI	BIASA	 SANGAT	LEBIH	
S11	Berpikir	bahwa	diri	Anda	tidak	berguna?	 TIDAK	 TIDAK	LEBIH	 LEBIH	DARI	BIASA	 SANGAT	LEBIH	
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Judul	 penelitian:	 Evaluasi	 efektivitas	 pelayanan	 kesehatan	 di	 Puskesmas	 DI	 Yogyakarta,	
Indonesia	
	
Jika	 Anda	 berusia	 di	 atas	 18	 tahun	 dan	 saat	 ini	 berobat	 di	 puskesmas,	 Anda	 diundang	 untuk	






dapat	 membantu	 para	 pembuat	 kebijakan	 di	 Kementerian	 Kesehatan	 dalam	 membuat	
peraturan	-	peraturan	kesehatan.	
• Jika	 Anda	memutuskan	 untuk	 ikut	 serta,	 Anda	 akan	 diminta	 untuk	menandatangani	 lembar	







§ Informasi	 pribadi	 yang	 bisa	 dilacak	 kembali	 kepada	 Anda	 tidak	 akan	 diketahui	 orang	 lain	
selain	petugas	kesehatan	Anda	dan	Tim	Peneliti.		











Jika	 Anda	memerlukan	 perhatian	medis	 segera	 oleh	 karena	 pertanyaan	 –	 pertanyaan	 di	 kuesioner	
atau	selama	wawancara,	tolong	informasikan	petugas	kesehatan	yang	akan	merujuk	Anda	ke	rumah	
sakit	terdekat.	Terima	kasih	untuk	perhatian	dan	kesediaan	Anda.	
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INFORMATION SHEET FOR PARTICIPANTS 
 
University of Cambridge Research Ethics Committee Ref: PRE.2015.108 
Universitas Gadjah Mada Research Ethics Committee Ref: 1237/SD/PL.03/07/IV/2016 
 
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
 
Evaluating the clinical and cost-effectiveness of two primary mental health service frameworks 
in Yogyakarta, Indonesia 
 
If you are between 18 and 64 years old and receiving treatment in a primary care facility (puskesmas), you are 
invited to take part in this doctoral research project. Please take time to read the following information 
carefully to understand why the research is being done and what your participation will involve. You can 
discuss it with others if you wish.  Ask us if there is anything that is not clear or if you would like more 
information. 
 
§ You will participate in a pioneering study looking at the clinical and cost-effectiveness of two different 
mental health service frameworks in a primary care setting. The study will shed some light on the value 
of primary mental health service in Indonesia: information which is not readily available. The study is 
expected to help policy makers in producing future regulations beneficial for people with psychiatric 
disorders. 
§ If you do decide to take part, you will be given this information sheet to keep and be asked to sign a 
consent form. Following that, you will be given a survey that takes approximately 30 minutes to 
complete. 
§ After the survey, you will meet a health worker who will ask you further questions about your 
experiences.You may find some of the questions sensitive. It is okay if you do not want to answer some 
questions. 
§ You will be asked by the service provider to provide your name, identity card number, and any other 
information that can let your service provider follow-up on your experiences 6 months and 12 months 
from now.  
§ Identifying information is kept only by your service providers. The researchers will not be able to identify 
you as a respondent.  
§ The consent form with your signature on it will not be stored together with the survey or the service 
provider’s record. 
§ This study will hopefully enable us to compare two mental health service frameworks. You are welcome 
to request for a copy of the final report (due out in September 2018) by contacting the researcher at 
sga29@medschl.cam.ac.uk  
 
It is up to you to decide whether to take part or not.  If you decide to take part you are still free to 
withdraw at any time and without giving a reason. 
 
If this study has harmed you in any way you can contact University of Cambridge using the details 




+44 7475 494866 
 
Tine Van Bortel 
tv250@medschl.cam.ac.uk  
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APPENDIX J: CONSENT FORM 
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CONSENT FORM FOR PARTICIPANTS IN RESEARCH STUDIES 
 
Please complete this form after you have read the Information Sheet 
and/or listened to an explanation about the research. 
 
Title of Study:  Evaluating the clinical and cost-effectiveness of two primary mental health 
service frameworks in Yogyakarta, Indonesia 
 
University of Cambridge Research Ethics Committee Ref: PRE.2015.108 
Universitas Gadjah Mada Research Ethics Committee Ref: 1237/SD/PL.03/07/IV/2016 
 
Thank you for considering taking part in this research. The person organising the research must 
explain the project to you before you agree to take part.  If you have any questions arising from the 
Information Sheet or explanation already given to you, please ask the service provider before you 





• I understand that if I decide at any time during the research that I no longer wish 
to participate in this project, I can notify the researchers involved and withdraw 
from it immediately without giving any reason.  
 
• I consent to the processing of my personal information for the purposes 
explained to me.  I understand that such information will be handled in 







agree that the research project named above has been explained to me to my satisfaction and I 
agree to take part in the study. I have read both the notes written above and the Information Sheet 
about the project, and understand what the research study involves. 
 




Service Provider’s Statement: 
 
I __________________________________________ 
Confirm that I have carefully explained the nature, demands and any foreseeable risks (where 
applicable) of the proposed research to the participant. 




Please tick or initial 
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World Health Organization Disability Assessment Schedule 2.0 
36-item version, self-administered 
Patient Name: _______________________ Age: ______         Sex:   Male   Female       Date:_____________ 
This questionnaire asks about difficulties due to health/mental health conditions.  Health conditions include diseases or illnesses, 
other health problems that may be short or long lasting, injuries, mental or emotional problems, and problems with alcohol or 
drugs. Think back over the past 30 days and answer these questions thinking about how much difficulty you had doing the following 
activities. For each question, please circle only one response.   
 Clinician Use Only 






























In the last 30 days, how much difficulty did you have in: 
Understanding and communicating 
D1.1 Concentrating on doing something for ten minutes? 












D1.2 Remembering to do important things? None Mild Moderate Severe Extreme or  cannot do 
 
D1.3 Analyzing and finding solutions to problems in day-to-day life? 
None Mild Moderate Severe Extreme or  cannot do 
 
D1.4 Learning a new task, for example, learning how to get to a new place? 
None Mild Moderate Severe Extreme or  cannot do 
 
D1.5 Generally understanding what people say? None Mild Moderate Severe Extreme or  cannot do 
 
D1.6 Starting and maintaining a conversation? None Mild Moderate Severe Extreme or  cannot do 
 
Getting around  












D2.2 Standing up from sitting down? None Mild Moderate Severe Extreme or  cannot do 
 
D2.3 Moving around inside your home? None Mild Moderate Severe Extreme or  cannot do 
 
D2.4 Getting out of your home? None Mild Moderate Severe Extreme or  cannot do 
 
D2.5 Walking a long distance, such as a kilometer (or equivalent)? 
None Mild Moderate Severe Extreme or  cannot do 
 
Self-care  












D3.2 Getting dressed? None Mild Moderate Severe Extreme or  cannot do 
 
D3.3 Eating? None Mild Moderate Severe Extreme or  cannot do 
 
D3.4 Staying by yourself for a few days? None Mild Moderate Severe Extreme or  cannot do 
 
Getting along with people  












D4.2 Maintaining a friendship? None Mild Moderate Severe Extreme or  cannot do 
 
D4.3 Getting along with people who are close to you? 
None Mild Moderate Severe Extreme or  cannot do 
 
D4.4 Making new friends? None Mild Moderate Severe Extreme or  cannot do 
 
D4.5 Sexual activities? None Mild Moderate Severe Extreme or  cannot do 
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In the last 30 days, how much difficulty did you have in: 
Life activities—Household 












D5.2 Doing most important household tasks well? None Mild Moderate Severe Extreme or  cannot do 
 
D5.3 Getting all of the household work done that you needed to do? 
None Mild Moderate Severe Extreme or  cannot do 
 
D5.4 Getting your household work done as quickly as needed? 
None Mild Moderate Severe Extreme or  cannot do 
 
Life activities—School/Work  
If you work (paid, non-paid, self-employed) or go to school, complete questions D5.5–D5.8, below. 
Otherwise, skip to D6.1.  
Because of your health condition, in the past 30 days, how much difficulty did you have in: 












D5.6 Doing your most important work/school tasks well? 
None Mild Moderate Severe Extreme or  cannot do 
 
D5.7 Getting all of the work done that you need to do? 
None Mild Moderate Severe Extreme or  cannot do 
 
D5.8 Getting your work done as quickly as needed? None Mild Moderate Severe Extreme or  cannot do 
 
Participation in society   
In the past 30 days: 
D6.1 
How much of a problem did you have in joining 
in community activities (for example, festivities, 
religious, or other activities) in the same way as 
anyone else can? 

























How much of a problem did you have living 
with dignity because of the attitudes and 
actions of others? 
None Mild Moderate Severe Extreme or  cannot do 
 
D6.4 How much time did you spend on your health condition or its consequences? 
None Some Moderate A Lot Extreme or  cannot do 
 
D6.5 How much have you been emotionally affected by your health condition? 
None Mild Moderate Severe Extreme or  cannot do 
 
D6.6 How much has your health been a drain on the financial resources of you or your family? 
None Mild Moderate Severe Extreme or  cannot do 
 
D6.7 How much of a problem did your family have because of your health problems? 
None Mild Moderate Severe Extreme or  cannot do 
 
D6.8 How much of a problem did you have in doing things by yourself for relaxation or pleasure? 
None Mild Moderate Severe Extreme or  cannot do 
 









© World Health Organization, 2012. All rights reserved. Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0), World Health 
Organization, 2010, Geneva. 
 
The World Health Organization has granted the Publisher permission for the reproduction of this instrument. This material can be reproduced without permission by 
clinicians for use with their own patients. Any other use, including electronic use, requires written permission from WHO. 
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World Health Organization Disability Assessment Schedule 2.0 
36-item version, self-administered 
 
The adult self-administered version of the World Health Organization Disability Assessment Schedule 2.0 
(WHODAS 2.0) is a 36-item measure that assesses disability in adults age 18 years and older. It assesses disability 
across six domains, including understanding and communicating, getting around, self-care, getting along with 
people, life activities (i.e., household, work, and/or school activities), and participation in society. If the adult 
individual is of impaired capacity and unable to complete the form (e.g., a patient with dementia), a 
knowledgeable informant may complete the proxy-administered version of the measure, which is available at 
www.psychiatry.org/dsm5. Each item on the self-administered version of the WHODAS 2.0 asks the individual to 
rate how much difficulty he or she has had in specific areas of functioning during the past 30 days. 
 
WHODAS 2.0 Scoring Instructions Provided by World Health Organization 
WHODAS 2.0 Summary Scores: There are two basic options for computing the summary scores for the WHODAS 
2.0 36-item full version. 
Simple: The scores assigned to each of the items—“none” (1), “mild” (2), “moderate” (3), “severe” (4), 
and “extreme” (5)—are summed. This method is referred to as simple scoring because the scores from each of 
the items are simply added up without recoding or collapsing of response categories; thus, there is no weighting 
of individual items. This approach is practical to use as a hand-scoring approach, and may be the method of choice 
in busy clinical settings or in paper-and-pencil interview situations. As a result, the simple sum of the scores of the 
items across all domains constitutes a statistic that is sufficient to describe the degree of functional limitations. 
 Complex: The more complex method of scoring is called “item-response-theory” (IRT)–based scoring. It 
takes into account multiple levels of difficulty for each WHODAS 2.0 item. It takes the coding for each item 
response as “none,” “mild,” “moderate,” “severe,” and “extreme” separately, and then uses a computer to 
determine the summary score by differentially weighting the items and the levels of severity. The computer 
program is available from the WHO Web site. The scoring has three steps: 
 
• Step 1—Summing of recoded item scores within each domain. 
• Step 2—Summing of all six domain scores. 
• Step 3—Converting the summary score into a metric ranging from 0 to 100  
(where 0 = no disability; 100 = full disability). 
 
WHODAS 2.0 Domain Scores: WHODAS 2.0 produces domain-specific scores for six different functioning domains: 
cognition, mobility, self-care, getting along, life activities (household and work/school) and participation.  
 
WHODAS 2.0 Population Norms: For the population norms for IRT-based scoring of the WHODAS 2.0 and for the 
population distribution of IRT-based scores for WHODAS 2.0, please see  
http://www.who.int/classifications/icf/Pop_norms_distrib_IRT_scores.pdf 
 
Additional Scoring and Interpretation Guidance for DSM-5 Users 
The clinician is asked to review the individual’s response on each item on the measure during the clinical interview 
and to indicate the self-reported score for each item in the section provided for “Clinician Use Only.” However, if 
the clinician determines that the score on an item should be different based on the clinical interview and other 
information available, he or she may indicate a corrected score in the raw item score box. Based on findings from 
the DSM-5 Field Trials in adult patient samples across six sites in the United States and one in Canada, DSM-5 
recommends calculation and use of average scores for each domain and for general disability. The average scores 
are comparable to the WHODAS 5-point scale, which allows the clinician to think of the individual’s disability in 
terms of none (1), mild (2), moderate (3), severe (4), or extreme (5). The average domain and general disability 
scores were found to be reliable, easy to use, and clinically useful to the clinicians in the DSM-5 Field Trials. The 
average domain score is calculated by dividing the raw domain score by the number of items in the domain (e.g., 
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if all the items within the “understanding and communicating” domain are rated as being moderate then the 
average domain score would be 18/6 = 3, indicating moderate disability). The average general disability score is 
calculated by dividing the raw overall score by number of items in the measure (i.e., 36). The individual should be 
encouraged to complete all of the items on the WHODAS 2.0. If no response is given on 10 or more items of the 
measure (i.e., more than 25% of the 36 total items), calculation of the simple and average general disability scores 
may not be helpful. If 10 or more of the total items on the measure are missing but the items for some of the 
domains are 75%–100% complete, the simple or average domain scores may be used for those domains. 
 
Frequency of Use 
To track change in the individual’s level of disability over time, the measure may be completed at regular intervals 
as clinically indicated, depending on the stability of the individual’s symptoms and treatment status. Consistently 
high scores on a particular domain may indicate significant and problematic areas for the individual that might 
warrant further assessment and intervention. 
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Health of the Nation Outcome Scales (HoNOS) 
 
HoNOS rating guidelines 
 Rate items in order from 1 to 12. 
 Use all available information in making your rating. 
 Do not include information already rated in an earlier item. 
 Consider both the degree of distress the problem causes and the effect 
it has on behaviour 
 Rate the most severe problem that occurred in the period rated. 
 The rating period is generally the preceding two weeks, except at 
discharge from inpatient care, when it is the previous three days. 
 Each item is rated on a five-point item of severity (0 to 4) as follows: 
0 No problem. 
1 Minor problem requiring no formal action. 
2 Mild problem.  
3 Problem of moderate severity. 
4 Severe to very severe problem. 
9 Not known or not applicable. 
 As far as possible, the use of rating point 9 should be avoided, because 
missing data make scores less comparable over time or between 
settings.   
 Specific information on how to rate each point on each item is provided 
in the Glossary. 
 
 
Eagar, K. Buckingham, B. Coombs, T. Trauer T, Graham, C. Eagar, L. and Callay, T 
(2000) Victorian outcome measurement strategy resource manual. Victorian 
Department of Human Services. 
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1 Overactive, aggressive, disruptive or agitated behaviour 
 
Include such behaviour due to any cause, eg, drugs, alcohol, dementia, psychosis, 
depression, etc. 
Do not include bizarre behaviour, rated at Scale 6. 
0 No problems of this kind during the period rated. 
1 Irritability, quarrels, restlessness etc.  Not requiring action. 
2 Includes aggressive gestures, pushing or pestering others; threats or verbal 
aggression; lesser damage to property (eg, broken cup or window); marked over-
activity or agitation. 
3 Physically aggressive to others or animals (short of rating 4); threatening manner; 
more serious over-activity or destruction of property. 
4 At least one serious physical attack on others or on animals; destruction of property 
(e.g., fire-setting); serious intimidation or obscene behaviour. 
 
2 Non-accidental self-injury 
 
Do not include accidental self-injury (due eg, to dementia or severe learning disability); 
the cognitive problem is rated at Scale 4 and the injury at Scale 5. 
Do not include illness or injury as a direct consequence of drug or alcohol use rated at 
Scale 3, (e.g. cirrhosis of the liver or injury resulting from drunk driving are rated at 
Scale 5). 
0 No problem of this kind during the period rated. 
1 Fleeting thoughts about ending it all, but little risk during the period rated; no self-
harm. 
2 Mild risk during period; includes non-hazardous self-harm eg, wrist–scratching. 
3 Moderate to serious risk of deliberate self-harm during the period rated; includes 
preparatory acts eg, collecting tablets. 
4 Serious suicidal attempt or serious deliberate self-injury during the period rated. 
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3 Problem drinking or drug-taking 
 
Do not include aggressive or destructive behaviour due to alcohol or drug use, rated at 
Scale 1. 
Do not include physical illness or disability due to alcohol or drug use, rated at Scale 5. 
0 No problem of this kind during the period rated. 
1 Some over-indulgence, but within social norm. 
2 Loss of control of drinking or drug-taking; but not seriously addicted. 
3 Marked craving or dependence on alcohol or drugs with frequent loss of control, risk 
taking under the influence, etc. 
4 Incapacitated by alcohol or drug problems. 
 
4 Cognitive problems 
 
Include problems of memory, orientation and understanding associated with any 
disorder: learning disability, dementia, schizophrenia, etc. 
Do not include temporary problems (e.g. hangovers) resulting from drug or alcohol use, 
rated at Scale 3. 
0 No problem of this kind during the period rated. 
1 Minor problems with memory or understanding e.g. forgets names occasionally. 
2 Mild but definite problems, e.g. has lost way in a familiar place or failed to recognise 
a familiar person; sometimes mixed up about simple decisions. 
3 Marked disorientation in time, place or person, bewildered by everyday events; 
speech is sometimes incoherent, mental slowing. 
4 Severe disorientation, e.g. unable to recognise relatives, at risk of accidents, speech 
incomprehensible, clouding or stupor. 
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5 Physical illness or disability problems 
 
Include illness or disability from any cause that limits or prevents movement, or impairs 
sight or hearing, or otherwise interferes with personal functioning. 
Include side-effects from medication; effects of drug/alcohol use; physical disabilities 
resulting from accidents or self-harm associated with cognitive problems, drunk driving 
etc. 
Do not include mental or behavioural problems rated at Scale 4. 
0 No physical health problem during the period rated. 
1 Minor health problem during the period (eg, cold, non-serious fall, etc). 
2 Physical health problem imposes mild restriction on mobility and activity. 
3 Moderate degree of restriction on activity due to physical health problem. 
4 Severe or complete incapacity due to physical health problem. 
 
6 Problems associated with hallucinations and delusions 
 
Include hallucinations and delusions irrespective of diagnosis. 
Include odd and bizarre behaviour associated with hallucinations or delusions. 
Do not include aggressive, destructive or overactive behaviours attributed to 
hallucinations or delusions, rated at Scale 1. 
0 No evidence of hallucinations or delusions during the period rated. 
1 Somewhat odd or eccentric beliefs not in keeping with cultural norms. 
2 Delusions or hallucinations (eg, voices, visions) are present, but there is little 
distress to patient or manifestation in bizarre behaviour, that is, moderately severe 
clinical problem. 
3 Marked preoccupation with delusions or hallucinations, causing much distress 
and/or manifested in obviously bizarre behaviour, that is, moderately severe clinical 
problem. 
4 Mental state and behaviour is seriously and adversely affected by delusions or 
hallucinations, with severe impact on patient. 
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7 Problems with depressed mood 
 
Do not include over-activity or agitation, rated at Scale 1. 
Do not include suicidal ideation or attempts, rated at Scale 2. 
Do not include delusions or hallucinations, rated at Scale 6. 
0 No problems associated with depressed mood during the period rated. 
1 Gloomy; or minor changes in mood. 
2 Mild but definite depression and distress: eg, feelings of guilt; loss of self-esteem. 
3 Depression with inappropriate self-blame, preoccupied with feelings of guilt. 
4 Severe or very severe depression, with guilt or self-accusation. 
 
8 Other mental and behavioural problems 
 
Rate only the most severe clinical problem not considered at items 6 and 7 as follows: 
specify the type of problem by entering the appropriate letter: A phobic: B anxiety; 
C obsessive-compulsive; D stress; E dissociative; F somatoform; G eating; H sleep; 
I sexual; J other, specify. 
0 No evidence of any of these problems during period rated. 
1 Minor non-clinical problems. 
2 A problem is clinically present at a mild level, eg, patient/client has a degree of 
control. 
3 Occasional severe attack or distress, with loss of control eg, has to avoid anxiety 
provoking situations altogether, call in a neighbour to help, etc., that is, a 
moderately severe level of problem. 
4 Severe problem dominates most activities. 
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9 Problems with relationships 
 
Rate the patient’s most severe problem associated with active or passive withdrawal 
from social relationships, and/or non-supportive, destructive or self-damaging 
relationships. 
0 No significant problems during the period. 
1 Minor non-clinical problems. 
2 Definite problems in making or sustaining supportive relationships: patient 
complains and/or problems are evident to others. 
3 Persisting major problems due to active or passive withdrawal from social 
relationships, and/or to relationships that provide little or no comfort or support. 
4 Severe and distressing social isolation due to inability to communicate socially 
and/or withdrawal from social relationships. 
 
10 Problems with activities of daily living 
 
Rate the overall level of functioning in activities of daily living (ADL): eg, problems with 
basic activities of self-care such as eating, washing, dressing, toilet; also complex skills 
such as budgeting, organising where to live, occupation and recreation, mobility and use 
of transport, shopping, self-development, etc. 
Include any lack of motivation for using self-help opportunities, since this contributes to 
a lower overall level of functioning. 
Do not include lack of opportunities for exercising intact abilities and skills, rated at Scale 
11 and Scale 12. 
0 No problems during period rated; good ability to function in all areas. 
1 Minor problems only eg, untidy, disorganised. 
2 Self-care adequate, but major lack of performance of one or more complex skills 
(see above). 
3 Major problems in one or more areas of self-care (eating, washing, dressing, toilet) 
as well as major inability to perform several complex skills. 
4 Severe disability or incapacity in all or nearly all areas of self-care and complex 
skills. 
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11 Problems with living conditions 
 
Rate the overall severity of problems with the quality of living conditions and daily 
domestic routine. 
Are the basic necessities met (heat, light, hygiene)?  If so, is there help to cope with 
disabilities and a choice of opportunities to use skills and develop new ones? 
Do not rate the level of functional disability itself, rated at Scale 10. 
NB: Rate patient’s usual accommodation.  If in acute ward, rate the home 
accommodation.  If information not obtainable, rate 9. 
0 Accommodation and living conditions are acceptable; helpful in keeping any 
disability rated at Scale 10 to the lowest level possible, and supportive of self-help. 
1 Accommodation is reasonably acceptable although there are minor or transient 
problems (eg, not ideal location, not preferred option, doesn’t like food, etc). 
2 Significant problems with one or more aspects of the accommodation and/or regime 
(eg, restricted choice; staff or household have little understanding of how to limit 
disability, or how to help develop new or intact skills). 
3 Distressing multiple problems with accommodation (eg, some basic necessities 
absent); housing environment has minimal or no facilities to improve patient’s 
independence. 
4 Accommodation is unacceptable (eg, lack of basic necessities, patient is at risk of 
eviction, or ‘roofless’, or living conditions are otherwise intolerable making patient’s 
problems worse). 
 
12 Problems with occupation and activities 
 
Rate the overall level of problems with quality of day–time environment.  Is there help to 
cope with disabilities, and opportunities for maintaining or improving occupational and 
recreational skills and activities?  Consider factors such as stigma, lack of qualified staff, 
access to supportive facilities, eg, staffing and equipment of day centres, workshops, 
social clubs, etc. 
Do not rate the level of functional disability itself, rated at Scale 10. 
NB: Rate the patient’s usual situation.  If in acute ward, rate activities during period 
before admission.  If information not available, rate 9. 
0 Patient’s day–time environment is acceptable; helpful in keeping any disability rated 
at Scale 10 to the lowest level possible, and supportive of self-help. 
1 Minor or temporary problems, eg, late pension cheques, reasonable facilities 
available but not always at desired times etc. 
2 Limited choice of activities, eg, there is a lack of reasonable tolerance (eg, unfairly 
refused entry to public library or baths etc.); or handicapped by lack of a permanent 
address; or insufficient carer or professional support; or helpful day setting available 
but for very limited hours. 
3 Marked deficiency in skilled services available to help minimise level of existing 
disability; no opportunities to use intact skills or add new ones; unskilled care 
difficult to access. 
4 Lack of any opportunity for daytime activities makes patient’s problem worse. 
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section B
A Somatic symptoms
A1 Have you had any sort of ache or pain in the past month?
Yes ............................. 1   A3
No ............................... 2   A2
A2 During the past month have you been troubled by any sort
of discomfort, for example, headache or indigestion?
Yes ............................. 1   A3
No ............................... 2   Go to
A3 Was this ache or pain/discomfort brought on or made worse
because you were feeling low, anxious or stressed?
Yes ............................. 1 A4
If informant has more than
one pain/discomfort, refer No ............................... 2 Go to
to ANY of them Section B
A4 In the past seven days, including last (DAY OF WEEK), on how
many days have you noticed the ache or pain/discomfort?
4 days or more ............ 1
A5
1 to 3 days .................. 2
None ........................... 3 A9
A5 In total, did the ache or pain/discomfort last for more than 3 hours
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A6 In the past week, has the ache or pain/discomfort been
very unpleasant ............................. 1
Running
prompt a little unpleasant .......................... 2
or not unpleasant?.............................. 3
A7 Has the ache or pain/discomfort bothered you when you were
doing something interesting in the past week?
Yes ................................................................... 1
No/has not done anything interesting .............. 2
A8 How long have you been feeling this
ache or pain/discomfort as you have just described?
less than 2 weeks.............................................. 1
Show card 2 2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
A9 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at A4, A5, A6 and A7.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on check card,
enter score then go to
section B
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B Fatigue
B1 Have you noticed that you've been getting tired
in the past month?
Yes ............................. 1 B3
No ............................... 2 B2
B2 During the past month, have you felt you've been
lacking in energy?
Yes ............................. 1 B3
No ............................... 2 Go to
section C
B3 Do you know why you have been feeling tired/lacking in energy?
Yes ............................. 1 (a)
No ............................... 2 B4
(a) What is the main reason? Can you choose from this card?
Problems with sleep ......................................... 1
Show card 3
Medication ....................................................... 2
Code one Physical illness ................................................. 3    B4
only
Working too hard (inc. housework, looking
                              after baby) .......................... 4
Stress, worry or other psychological reason .... 5
Physical exercise .............................................. 6    Go to
Other ................................................................ 7    B4
B4 In the past seven days, including last (DAY OF WEEK)
on how many days have you felt tired/lacking in energy?
4 days or more ............ 1
B5
1 to 3 days .................. 2
None ........................... 3 B10
B5 Have you felt tired/lacking in energy for more
than 3 hours in total on any day in the past week?
Yes ............................. 1




Chapter 7: Appendices 
  Sabrina Gabrielle Anjara – August 2018    173 
 
  
13 1361 A 2/93 LC V5
B6 Have you felt so tired/lacking in energy that
you've had to push yourself to get things done
during the past week?
Yes, on at least one occasion ........................... 1
No ............................... 2
B7 Have you felt tired/lacking in energy when doing
things that you enjoy during the past week?
                           Yes, at least once .................. 1 B9
No ............................... 2
Spontaneous Does not enjoy anything .................................. 3
B8 Have you in the past week felt tired/lacking in energy
when doing things that you used to enjoy?
Yes ............................. 1
No ............................... 2
B9 How long have you been feeling tired/lacking in energy
in the way you have just described?
less than 2 weeks.............................................. 1
Show card 2 2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
B10 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at B4, B5, B6, B7 and B8.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on check card,
enter score then go to
section C
B8
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C Concentration and forgetfulness
C1 In the past month, have you had any problems
in concentrating on what you are doing?
Yes, problems concentrating ......... 1
No .................................................. 2
C2 Have you noticed any problems with forgetting things




Informant has problems concentrating or
   forgets things (coded 1 at C1 or C2) ................................ 1 C4
Others .................................................................................. 2 Go to
section D
C4 Since last (DAY OF WEEK), on how many days have
you noticed problems with your concentration/memory?
4 days or more ............ 1
C5
1 to 3 days .................. 2
None ........................... 3 C9
C5 Informants who had concentration problems
DNA: others (coded 2 at C1) ............... 1  C7
In the past week could you concentrate on a TV programme,
read a newspaper article or talk to someone without your mind
wandering?
Yes .......................................................... 2
No/not always ......................................... 1
C6 In the past week, have these problems with your concentration
actually stopped you from getting on with things
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C7 Informants who had memory problems
DNA: others (coded 2 at C2) ...... 1   C8
(Earlier you said you have been forgetting things.)
Have you forgotten anything important
in the past seven days?
Yes ............................. 1
No ............................... 2
C8 How long have you been having the problems with
your concentration/memory as you have described?
Less than 2 weeks ............................................ 1
2 weeks but less than 6 monthss ...................... 2
Show card 2 6 months but less than1 year ............................ 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
C9 Interviewer check:
 Sum codes which you have ringed in the
 shaded boxes at C4, C5, C6 and C7.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on check card,
enter score then go to
section D
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D Sleep problems
D1 In the past month, have you been having problems
with trying to get to sleep or with getting back
to sleep if you woke up or were woken up?
Yes ............................. 1 D3
No ............................... 2 D2
D2 Has sleeping more than you usually do been a problem
for you in the past month?
Yes ............................. 1 D3
No ............................... 2 Go to
section E
D3 On how many of the past seven nights did you
have problems with your sleep?
4 nights or more ......... 1
D4
1 to 3 nights ................ 2
None ........................... 3 D11
D4 Do you know why you are having problems with
your sleep?
Yes ............................. 1 (a)
No ............................... 2 D5
(a) Can you look at this card and tell me the main
reason for these problems?
Noise ................................................................ 1
Show card 4




Needing to go to the toilet ................................ 5
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D5 Informants who had problems trying to get (back) to sleep
DNA : others (coded 2 at D1) ..... 1 D8
Thinking about the night you had the least sleep in the
past week, how long did you spend trying to get to
sleep? (If you woke up or were woken up I want
you to allow a quarter of an hour to get back to sleep).
Less than 1/4 hr ............................. 3 Go to D11
and code ‘0’
At least 1/4 hr but less than 1 hr ... 1
D7
At least 1 hr but less than 3 hrs ..... 2
3 hrs or more ................................. 2 D6
D6 In the past week, on how many nights did you spend
3 or more hours trying to get to sleep?
4 nights or more ......... 1
1 to 3 nights ................ 2
None ........................... 3
D7 Do you wake more than two hours earlier than
you need to and then find you can't get back to sleep?
Yes ............................. 1
No ............................... 2
D8 Informants who slept more than usual
Thinking about the night you slept the longest in the past week,
how much longer did you sleep compared with how long you
normally sleep for?
Less than 1/4 hr ............................. 3 Go to D11
and code ‘0’
At least 1/4 hr but less than 1 hr ... 1
D10
At least 1 hr but less than 3 hrs ..... 2
3 hrs or more ................................. 2 D9
D9 In the past week, on how many nights did you sleep for more
than 3 hours longer than you usually do?
4 nights or more ......... 1
1 to 3 nights ................ 2
None ........................... 3
Only include time
spent trying to get
to sleep.
D10
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D10 How long have you had these problems with your
sleep as you have described?
less than 2 weeks.............................................. 1
Show card 2
2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
D11 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at D3, D5, D6, D8 and D9.
Ring ‘0’ if sum of codes is zero .. 0
(or if coded 3 at D5 or D8)
or Insert score
on Check card,
enter score then go to
section E
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E Irritability
E1 Many people become irritable or short tempered at times,
though they may not show it.
Have you felt irritable or short tempered with those
around you in the past month?
Yes/no more than usual ....... 1 E3
No ........................................ 2 E2
E2 During the past month did you get short tempered or angry
over things which now seem trivial when you look back
on them?
Yes ............................. 1 E3
No ............................... 2 Go to
section F
E3 Since last (DAY OF WEEK), on how many days have
you felt irritable or short tempered/angry?
4 days or more ............ 1
E4
1 to 3 days .................. 2
None ........................... 3 E11
E4 What sort of things made you irritable or short tempered/angry
in the past week?
E5 In total, have you felt irritable or short tempered/angry for
more than one hour (on any day in the past week)?
Yes ............................. 1
No ............................... 2
E6 During the past week, have you felt so
irritable or short tempered/angry that
you have wanted to shout at someone,




A Study of Two Models of Primary Mental Health Care Provisions in Yogyakarta, Indonesia 
180  Sabrina Gabrielle Anjara – August 2018 
 
  
20 1361 A 2/93 LC V5
E7 In the past seven days, have you had arguments, rows
or quarrels or lost your temper with anyone?
Yes ............................. 1 (a)
No ............................... 2 E10
(a) Did this happen once or more than once
(in the past week)?
Once ........................... 1 E8
More than once........... 2 E9
E8 Do you think this was justified?
Yes, justified .............. 2
E10
No, not justified.......... 1
E9 Do you think this was justified on every occasion?
Yes ................................................................... 2
E10
No, at least one was unjustified ....................... 1
E10 How long have you been feeling irritable or
short tempered/angry as you have described ?
less than 2 weeks.............................................. 1
Show card 2
two weeks but less than 6 months .................... 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
E11 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at E3, E5, E6, E8 and E9.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on Check card,
enter score then go to
section F
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F Worry about physical health
F1 Many people get concerned about their physical
health. In the past month, have you been at all
worried about your physical health?
Include women who Yes, worried ............... 1 F3
are worried about their
pregnancy No/concerned ............. 2 F2
F2 Informants who have no problems with physical health
DNA :has a physical health problem
shown at 11a page 6 ..................................... 1 Go to
section G
During the past month, did you find yourself worrying
that you might have a serious physical illness?
Yes ............................. 1 F3
No ............................... 2 Go to
section G
F3 Thinking about the past seven days, including last (DAY OF WEEK),
on how many days have you found yourself worrying about
your physical health/that you might have a serious physical illness?
4 days or more ............ 1
F4
1 to 3 days .................. 2
None ........................... 3 F8
F4 In your opinion, have you been worrying too much in
view of your actual health?
Yes ............................. 1
No ............................... 2
F5 In the past week, has this worrying been
very unpleasant ............................. 1
Running
prompt a little unpleasant .......................... 2
or not unpleasant?.............................. 3
*
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F6 In the past week, have you been able to take your mind off
your health worries  at least once, by doing something else?
Yes ............................. 2
No, could not be distracted once ...................... 1
F7 How long have you been worrying about  your physical
health in the way you have described?
less than 2 weeks.............................................. 1
Show card 2
2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
F8 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at F3, F4, F5 and F6.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on Check card,
enter score then go to
section G
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G Depression
G1 Almost everyone becomes sad, miserable or depressed
at times.
Have you had a spell of feeling sad, miserable or depressed
in the past month?
Yes ............................. 1
No ............................... 2
G2 During the past month, have you been able to enjoy
or take an interest in things as much as you usually do?
Yes ................................................ 1
No/no enjoyment or interest .......... 2
G3 Interviewer check:
Code Informant felt sad, miserable or depressed
first    (coded 1 at G1) ....................................................... 1 G4
that
applies Informant unable to enjoy or take an interest
   (coded 2 at G2) ....................................................... 2 G5
Others ........................................................................ 3 Go to
G4 In the past week have you had a spell of feeling
sad, miserable or depressed?
Yes ............................. 1
No ............................... 2
G5 Informants who were unable to enjoy or take
an interest in things
DNA: coded 1 at G2 ....................................... 1 See G6
In the past week  have you been able to enjoy
or take an interest in things as much as usual?
Yes ................................................ 2
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G7 Have you felt
sad, miserable or depressed/unable to enjoy or take an
interest in things for more than 3 hours in total
(on any day in the past week)?
Yes ............................. 1
No ............................... 2
G8 (a)  What sorts of things made you feel
sad, miserable or depressed/unable to enjoy or take
an interest in things in the past week? Can you choose
from this card?
Ring code(s) in column (a). Code all Code one
that apply only
Members of the family .............................. 01 01
Relationship with spouse/partner .............. 02 02
Relationships with friends ......................... 03 03
Show card 5 Housing ..................................................... 04 04
Money/bills ................................................ 05 05
Own physical health (inc. pregnancy) ....... 06 06
Own mental health .................................... 07 07
Work or lack of work (inc. student) .......... 08 08
Legal difficulties ....................................... 09 09
Political issues/the news ............................ 10 10
Other .......................................................... 11 11
Don't know/no main thing ......................... 99 99
(b) DNA : Only one item coded at (a) .................................... 1 G9
What was the main thing?
Ring code in column (b)
G6 Informants who felt sad, miserable or depressed or unable to
enjoy or take an interest in things in the past week
(coded 1 at G4 or G5)
DNA: others ................................. 1 Go to G11
Since last (DAY OF WEEK) on how many days have you felt
sad,  miserable or depressed/unable to enjoy or take an interest
in things?
4 days or more ............ 1
2 to 3 days .................. 2
1 day ........................... 3
(a)            (b)
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G9 In the past week when you felt
sad, miserable or depressed/unable to enjoy or take an interest in things,
did you ever become happier when something nice happened,
or when you were in company?
Yes, at least once........................... 2
No .................................................. 1
G10 How long have you been feeling
 sad, miserable or depressed/unable to enjoy or take an
 interest in things  as you have described?
less than 2 weeks.............................................. 1
Show card 6
2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
G11 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at G5, G6, G7 and G9.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on Check card,
enter score then go to
section H
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H Depressive Ideas
H1 Informants who scored 1 or more at section G, Depression
DNA: Others (coded O or blank at G11) .............. 1 Go to
section I
I would now like to ask you about when you have been feeling
sad, miserable or depressed/unable to enjoy or take an interest
in things. In the past week, was this worse in the morning
or in the evening, or did this make no difference?
in the morning ............ 1
in the evening ............. 2
no difference/other ..... 3
H2  Ask or use card 7
Many people find that feeling sad, miserable or depressed/unable
to enjoy or take an interest in things can affect their interest in sex.
Over the past month, do you think your interest in sex has
increased ....................................... 1
Running
prompt decreased ....................................... 2
or has it stayed the same? .................. 3
Spontaneous Not applicable ............................... 4
H3 When you have felt sad, miserable or depressed/unable to
enjoy or take an interest in things in the past seven days, Yes No
have you been so restless that you
couldn't sit still? ....................................... 1 2
have you been doing things more slowly,
for example, walking more slowly? ........ 1 2
have you been less talkative than normal? 1 2
H4 Now, thinking about the past seven days have you
on at least one occasion felt guilty or blamed yourself
when things went wrong when it hasn't been your fault?
Yes, at least once ........ 1
No ............................... 2
H5 During the past week, have you been feeling you
are not as good as other people?
Yes ............................. 1
No ............................... 2
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H7 Interviewer check
Informant felt guilty, not as good as others
or hopeless (coded 1 at H4 or H5 or H6 ) ................. 1 H8
Others (coded 2 at H4, H5 and H6) .................................... 2 read H10
H8 Ask or use card 8
In the past week have you felt that life isn't worth living?
Yes ............................. 1 H9
           Spontaneous: Yes, but not in the past week ........ 2
No ............................... 3
H9 Ask or use card 9
In the past week, have you thought of killing yourself?
Yes ............................. 1 (a)
                              Spontaneous: Yes, but not in the past week ........ 2
read H10
No ............................... 3
(a) Have you talked to your doctor about these
thoughts (of killing yourself)?
Yes ............................. 1 read H10
             Spontaneous: No, but has talked to other people ................... 2
read (b)
No ............................... 3
(b) (You have said that you are thinking about committing suicide.)
Since this is a very serious matter it is important that
you talk to your doctor about these thoughts.
read H10
H10 (Thank you for answering those questions on how you have
been feeling. I would now like to ask you a few questions
about worrying.)
H11 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at H4, H5, H6, H8 and H9.
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I Worry
I 1 (The next few questions are about worrying.)
In the past month, did you find yourself worrying more than
you needed to about things?
Yes, worrying ............. 1 I3
No/concerned ............. 2 I2
I 2 Have you had any worries at all in the past month?
Yes ............................. 1 I3
No ............................... 2 Go to
section J
I 3 (a) Can you look at this card and tell me what sorts
of things you worried about in the past month?
Ring code(s) in column (a). Code all Code one
that apply only
Members of the family .................... 01 01
Relationship with spouse/partner .... 02 02
Show card 10 Relationships with friends .............. 03 03
Housing ........................................... 04 04
Money/bills ..................................... 05 05
Own physical health (inc. pregnancy) 06 06
Own mental health .......................... 07 07
Work or lack of work (inc student) . 08 08
Legal difficulties ............................. 09 09
Political issues/the news ................. 10 10
Other ............................................... 11 11
Don't know/no main thing............... 99 99
(b) DNA : Only one item coded at (a) .......................... 1 I4
Ring code in column (b).
I 4 Interviewer check:
See instruction
Informant worries about physical health (coded 06 at I3(a)) 1 below, then go
to I5
Others (not coded 06 at I3(a)) ............................................ 2 I6
Make a note on Check flap to go to section F to record this
worry about physical health,  if not already recorded.





  (a)         (b)
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I 5 Interviewer check:
Informant is only worried about physical health
   (only code 06 is rung at I3(a)) ......................................... 1 Go to
section J
Informant had other worries (I3(a) is multi-coded) ............ 2 read (a)
(a) For the next few questions, I want you to think
about the worries you have had other than those
about your physical health.
I 6 On how many of the past seven days have you been
worrying about things (other than your physical health)?
4 days or more ............ 1
I7
1 to 3 days .................. 2
None ........................... 3 I 11
I 7 In your opinion, have you been worrying too much
in view of your circumstances?
Yes ............................. 1
Refer to worries other than
those about physical health No ............................... 2
I 8 In the past week, has this worrying been:
very unpleasant ............................. 1
Running prompt
a little unpleasant .......................... 2
Refer to worries other than or not unpleasant?.............................. 3
those about physical health
I 9 Have you worried for more than 3 hours in total
on any one of the past seven days?
Yes ............................. 1
Refer to worries other than
those about physical health No ............................... 2
A Study of Two Models of Primary Mental Health Care Provisions in Yogyakarta, Indonesia 
190  Sabrina Gabrielle Anjara – August 2018 
 
  
30 1361 A 2/93 LC V5
I 10 How long have you been worrying about things
in the way that you have described?
less than 2 weeks.............................................. 1
Show card 11
2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
I 11 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at I6, I7, I8 and I9.
Ring ‘0’ if sum of codes is zero .. 0
or  Insert score
on Check card,
enter score then go to
section J
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J Anxiety
J1 Have you been feeling anxious or nervous in the
past month?
Yes, anxious or nervous ................ 1 J3
No.................................................. 2 J2
J2 In the past month, did you ever find your muscles
felt tense or that you couldn't relax?
Yes ............................. 1
No ............................... 2
J3 Some people have phobias; they
get nervous or uncomfortable about specific things
or situations when there is no real danger. For instance they
may get nervous when speaking or eating in front of strangers,
when they are far from home or in crowded rooms, or they may
have a fear of heights. Others become nervous at the sight of
things like blood or spiders.
In the past month have you felt anxious, nervous or tense about




Informant reports anxiety and also a phobia
   (coded 1 at J1 or J2, and coded 1 at J3) ................ 1 J5
Informant reports only general anxiety
   (coded 1 at J1 or J2, and coded 2 at J3) ................ 2 J7
Others ........................................................................ 3 Go to
section K
J5 In the past month, when you felt anxious/nervous/tense, was this always
brought on by the phobia about some specific situation or thing
or did you sometimes feel generally anxious/nervous/tense?
Always brought on by phobia ................................... 1 Go to
section K
Sometimes felt generally anxious ............................. 2 J6
*
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J6 The next questions are concerned with general
anxiety/nervousness/tension only.
I will ask you about the anxiety which is brought
on by the phobia about specific things or situations later.
On how many of the past seven days
have you felt generally anxious/nervous/tense?
4 days or more ............ 1
J8
1 to 3 days .................. 2
None ........................... 3 J12
J7 On how many of the past seven days have you felt
generally anxious/nervous/tense?
4 days or more ............ 1
J8
1 to 3 days .................. 2
None ........................... 3 J12
J8 In the past week, has your
anxiety/nervousness/tension been:
very unpleasant ............................. 1
Running
prompt a little unpleasant .......................... 2
or not unpleasant?.............................. 3
J9 In the past week, when you've been anxious/nervous/tense,
have you had any of the symptoms shown on this card?
Yes ............................. 1 (a)
Show card 12
No ............................... 2 J10
(a) Which of these symptoms did you have when you felt
anxious/nervous/tense?
Heart racing or pounding .............. 1
Code all Hands sweating or shaking ........... 2
that apply
Feeling dizzy ................................. 3
Difficulty getting your breath ....... 4
Butterflies in stomach ................... 5
Dry mouth ..................................... 6
Nausea or feeling as though you
wanted to vomit ............................. 7
If informant had any of these symptoms,
check J9 is coded 1, ‘Yes’.
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J10 Have you felt anxious/nervous/tense for more
       than 3 hours in total on any one of the past seven days?
Yes ............................. 1
No ............................... 2
J11 How long have you had these feelings of general
anxiety/nervousness/tension as you described?
less than 2 weeks.............................................. 1
Show card 11
2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
J12 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at J6, J7, J8, J9 and J10.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on Check card,
enter score then go to
section K
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K Phobias
K1 Interviewer check:
Informants who had phobic anxiety in the past month (coded 1 at J3) ......... 1 K3(a)
Others ............................................................................................................ 2 K2
K2 Sometimes people avoid a specific situation or thing  because
the have a phobia about it. For instance, some people avoid
eating in public or avoid going to busy places because it
would make them feel nervous or anxious.
In the past month, have you avoided any situation or
thing because it would have made you feel nervous
or anxious, even though there was no real danger?
Yes ............................. 1 K3(b)
No ............................... 2 See section L
K3(a)  Can you look at this card and tell me which of
     the situations or things listed made you the most
     anxious/nervous/tense in the past month?
     Ring code at (b), then go to K4
Show card 13
     (b)  Can you look at this card and tell me,  which of
     these situations or things did you avoid the most
     in the past month?
Crowds or public places, including travelling
   alone or being far from home ................................. 1
Code Enclosed spaces ......................................................... 2
one
only Social situations, including eating or speaking
   in public, being watched or stared at ...................... 3
The sight of blood or injury....................................... 4
Any specific single cause
   including insects, spiders and heights .................... 5
Other (specify) .......................................................... 6
K4 Informants who had phobic anxiety in past month
DNA: others (coded 2 at K1) ...... 1 K7
In the past seven days, how many times have you
felt nervous or anxious about (SITUATION/THING)?
4 times or more .......... 1
K5
1 to 3 times ................. 2
None ........................... 3 K6
*
Show card 13
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K5 In the past week, on those occasions when you felt
anxious/nervous/tense did you have any of the
symptoms on this card?
Yes ............................. 1 (a)
Show card 12 No ............................... 2 K6
(a) Which of these symptoms did you have when you felt
anxious/nervous/tense?
Heart racing or pounding .............. 1
Code all Hands sweating or shaking ........... 2
that apply
Feeling dizzy ................................. 3
Difficulty getting your breath ....... 4
Butterflies in stomach ................... 5
Dry mouth ..................................... 6
Nausea or feeling as though
you wanted to vomit...................... 7
K6 In the past week, have you avoided any situation or thing because
it would have made you feel anxious/nervous/tense even though
there was no real danger?
Yes ............................. 1 K7
No ............................... 2 K8
K7 How many times have your avoided such situations or things
in the past seven days?
1 to 3 times ................. 1
4 times or more .......... 2
None ........................... 3
K8 Informants who had phobic anxiety/avoidance in the
past week  (coded 1 or 2 at K4 or K7)
DNA: others ................................. 1 K9
How long have you been having these feelings about these
situations/things as you have just described?
less than 2 weeks.............................................. 1
Show card 14
2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
K9 Interviewer check:
  Sum codes which you have ringed in the
  shaded boxes at K4, K5 and K7.
Ring ‘0’ if sum of codes is zero .. 0
or
enter score
If informant had any of
these symptoms, check
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L Panic
L1 Informants who felt anxious in the past month
DNA: Others (coded 3 at J4, page 31) ................... 1
section M
Thinking about the past month, did your anxiety or tension ever get so
bad that you got in a panic, for instance make you feel that you might
collapse or lose control unless you did something about it?
Yes ............................. 1 L2
No ............................... 2 Go to
section M
L2 How often has this happened in the past week?
Once ........................... 1
L3
More than once........... 2
Not at all ..................... 3 L8
L3 In the past week, have these feelings of panic been:
Running a little uncomfortable or unpleasant ................. 2
prompt
or have they been very unpleasant or
   unbearable? ................................................... 1
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L6 Informants who had phobic anxiety
DNA: Others (coded 2 at K1) ........................ 1   L7
Refer to situation/thing at K3.
Is this panic always brought on by (SITUATION/THING)?
Yes ............................. 1
No ............................... 2
L7 How long have you been having these feelings of panic
as you have described?
less than 2 weeks.............................................. 1
Show card 14
2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
L8 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at L2, L3, and L4.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on Check card,
enter score then go to
section M
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M Compulsions
M1 In the past month, did you find that you kept on doing
things over and over again when you knew you had already
done them, for instance checking things like taps
or washing yourself when you had already done so?
Yes ............................. 1 M2
No ............................... 2 Go to
section N
M2 On how many days in the past week did you find yourself
doing things over again that you had already done?
4 days or more ............ 1
M3
1 to 3 days .................. 2
None ........................... 3 M9
M3 Since last (DAY OF WEEK) what sorts of things
have you done over and over again?
M4 During the past week, have you tried to stop yourself
repeating  (BEHAVIOUR)/doing any of these things over again?
Yes ............................. 1
No ............................... 2
M5 Has repeating (BEHAVIOUR)/doing any of these things over again
made you upset or annoyed with yourself in the past week?
Yes, upset or annoyed ................... 1
No, not at all .................................. 2
*
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Refer to BEHAVIOUR
at M6, if applicable
M6 If more than one thing is repeated at M3
DNA : others ................................. 1 M7
Thinking about the past week, which of the things you
mentioned did you repeat the most times?
Describe here ............................................................. M7
M7 Since last (DAY OF WEEK), how many times did you
repeat (BEHAVIOUR) when you had already done it?
3 or more repeats .................................... 1
2 repeats .................................................. 2
1 repeat ................................................... 3
M8 How long have you been repeating
(BEHAVIOUR)/any of the things you mentioned
in the way which you have described?
less than 2 weeks.............................................. 1
Show card 14
2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
M9 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at M2, M4, M5 and M7.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on Check card,
enter score then go to
section N
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N Obsessions
N1 In the past month did you have any thoughts or ideas
over and over again that you found unpleasant
and would prefer not to think about, that still kept
on coming into your mind?
Yes ............................. 1 N2
No ............................... 2 Go to
section O
N2 Can I check, is this the same thought or idea over and over
again or are you worrying about something in general?
Same thought ....................... 1 N3
Worrying in general ............. 2 See
instruction
Make a note on check flap to go to section I below, then
to record this worry, if not already recorded. go to
section O
N3 What are these unpleasant thoughts or ideas that keep coming into
your mind?
Do not probe
Do not press for answer
N4 Since last (DAY OF WEEK), on how many days have you
had these unpleasant thoughts?
4 days or more ............ 1
N5
1 to 3 days .................. 2
None ........................... 3 N9
N5 During the past week, have you tried to stop yourself thinking
any of these thoughts?
Yes ............................. 1
No ............................... 2
N6 Have you become upset or annoyed with yourself when you
have had these thoughts in the past week?
Yes, upset or annoyed ................... 1
Not at all ........................................ 2
*
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N7 In the past week, was the longest episode of having such
thoughts :
Running a quarter of an hour or longer .......................... 1
prompt
or was it less than this?......................................... 2
N8 How long have you been having these thoughts
in the way which you have just described?
less than 2 weeks.............................................. 1
Show card 14
2 weeks but less than 6 months ........................ 2
6 months but less than 1 year ........................... 3
1 year but less than 2 years .............................. 4
2 years or more ................................................ 5
N9 Interviewer check:
Sum codes which you have ringed in the
shaded boxes at N4, N5, N6 and N7.
Ring ‘0’ if sum of codes is zero .. 0
or Insert score
on Check card,
enter score then go to
section O
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Informants who scored 2 or more
on any section, A to N.
DNA: Others (All section scores 0 or 1 on check card) ...... 1
Now I would like to ask you how all of these things
that you have told me about have affected you overall.
In the past week, has the way you have been feeling
ever actually stopped you from getting on with things
you used to do or would like to do?
Yes ............................. 1 (a)
No ............................... 2 (b)
(a) In the past week, has the way you have been
feeling stopped you doing things once or more
than once?
Once ........................... 1
More than once........... 2
(b) Has the way you have been feeling made
things more difficult even though you
have got everything done?
Yes .............................. 1
No ................................ 2
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APPENDIX M: PUBLISHED WHO MHGAP LITERATURE 
Table 26. Summary of Literature Describing WHO mhGAP Training (Keynejad et al., 2018) 
Authors/ 
Country 




study. 3-day training 
course developed 
from mhGAP-IG. 






& Substance abuse, 




Knowledge and skills 
to diagnose and treat 
mental health case 
vignettes assessed 










4 PHC workers nominated 
by 20 localgovernment areas, 
based on 
interest.Collaboration with 
mental health professionals 
interested in PHC from 
Lancashire Care NHS 
Foundation Trust/University 
of Manchester under a 
British Council Health Link 
Scheme. 
Written support materials 
included locally adapted 
assessment flow charts, case 
records, follow-up sheets to 
guide and record practice. 
3 day training course 
delivered as a 1 day 
introductory lecture and four 
2 day regional training 
sessions, by Aro Hospital 
and Lancashire faculty. 
Didactic and participatory 
methods included lectures, 
videos, role plays, 
discussions. 
Knowledge tests pre- 
and post-course 
Caseloads of patients 
seen over the 
following 12 months 
Post-training rates of 
accurate diagnosis by PHC 
workers significantly 
improved: 12.5% for 
psychosis(p=0.018), 12.5% 
for substance 
abuse(p=0.018), 30% for 
OSEC (p=0.001). 
Mean scores for appropriate 
intervention improved by 
114% for psychosis 
(p=0.001), 109% for 
depression (p=0.001), 78% 
for substance abuse 
(p=0.001), 103% for 
epilepsy (p=0.001) and 92% 
for OSEC (p=0.001). 
473 patients were treated in 
the following 12months 
(46% psychosis, 10% 
depression, 3% OSEC, 




Analysis of test 






2 separate cycles of training: 
mhGAP Base Course: 5 day 
sequential training, followed 
by 6 months' supervision and 
mentorship, before the 
mhGAP Standard Course, 
which builds on the Base 
Course with revision and 
addition of further mhGAP-
IG modules and building 





closely related to per 
diem payments for 
attendance, which was 
low despite needing to 
cover accommodation 








A formal introduction 
to familiarize trainers 
with the mhGAP-IG 






scores post-training on the 
WHO standardised 
knowledge test from the 
mhGAP monitoring and 
evaluation toolkit. 
A table of 592 MNS cases 
detected and treated or 
referred following training, 


















1038 + 290 
10 months' mhGAP training 
(groups of 7-50+) and 
supervision on assessment 
and management of common 
mental health conditions and 
conditions specifically 
related to stress for non-
specialized health workers. 
Existing training module for 
community workers 
reviewed and training 
materials piloted. Modules 
modified for midwives and 
health workers. 
3-point Likert scale 
survey of training 
quality, duration, 
trainer, participation, 
confidence to assess 
and manage priority 
conditions. 
Acceptability was 
noted as government 
and health 
stakeholders were 
motivated to improve 
local mental health 
services. 
155 of 159 (98%) PHC 
units, 21 of 24 District 
Hospitals (88%) and all 8 
provincial hospitals had a 
doctor and nurse trained in 
mental health assessment 
and management. 
Variable confidence of 
participants in mental health 
assessment and 
management post-course. 
Higher confidence among 
community workers than 
non-specialized staff. 
Local services increased 
inpatient, pharmacy and 
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Descriptive account Nurses, social 
workers, GPs 
at 50 PHC; 




106 + staff at 
30 PHC  
mhGAP-IG training of 
health workers in PHC. 
Psychological first aid 
training for staff in a further 
30 centres. 
4Ws (Who’s doing What, 
Where, and until When) 
assessment to map existing 
resources. 
Training modules on suicide 
risk management for 
frontline healthcare staff. 
Supervision unit will support 
>100 PHC in Lebanon. 
 Lebanon’s mental health 
system is growing, despite 
challenges, due to: 
Momentum and interest 
created by the Syrian crisis. 
Policy to avoid parallel care 
systems. Collaboration 
between Ministry, UN, 
national and international 
NGOs. National consensus 
mental health strategy 
involving all stakeholders. 
High level Ministry support 

























Mean age 20.2 
years 
2 day training (3 hours/day) 
course by clinical staff. 
Focus Group Discussions 
informed training, aimed at 
identification and referral of 
students having mental 
health problems, counselling 
and psychosocial support. 
Training covered epilepsy, 
psychosis, bipolar disorder, 
stress, alcohol and drugs, 
principles of care, 
communication, emergencies 
and peer counselling. 
Relaxation techniques were 
taught, record keeping, roles 
and responsibilities and an 
emphasis on commitment 
and altruism. 
 The mean knowledge pre-
test score was 24/30 (±2.3) 
points while the mean 
knowledge post-test score 
was 27.5/30 (±1.2) points. 





IG cascade training 
model delivered over 
18 months in 8 local 
government areas in 
Osun state. Training 
focused on detection 
and management of 
moderate to severe 
depression, 
psychosis, epilepsy 






training for front-line 
PHC workers. Initial 
training was 
supervised and 
mentored by Master 
Trainers. Refresher 
training was 
provided after 9 
months. 
PHC workers 
from 68 PHC. 
 
198 
3 planning workshops of key 
mental health stakeholders, 
including PHC workers and 
policy makers occurred, 
before a pilot training course 
to test methods including 
role plays. Facilitators were 
trained in all 9 modules of 
the mhGAP-IG, teaching 
skills, role play organisation 
and conduct. 
Training materials were 
contextualized and adapted 
by Master Trainers before 
giving them to Facilitators 
and delivering 2 day 
workshops. Facilitators 
attended de-briefing 
following initial, supervised 
training, to receive training 
observations and discuss 
areas for clarification. 
Midway refresher workshop 
reinforced knowledge and 
skills, with reference to 
clinical challenges and 
experiences. 
1) Clinical notes 




of clinical assessments 





contextualized for the 
Nigerian setting, were 
conducted midway and 
at the end of the 
project, alongside 
mhGAP-IG fidelity, 
patient flow and 
referral information. 
Markedly improved 
knowledge and skills of 
health workers (mean 
difference pre/post: -4.90, 
p<0.001). 
Significant increase in 
numbers identified and 
treated for MNS disorders 
(0 in 2011 versus 96 in 
2013), and number of 
referrals (0 versus 45). 
Substantial retention of 
gained knowledge observed 
nine months after initial 
training but some 
knowledge loss with time, 
so the refresher training was 




Pilot service for 
children with 
developmental 














tablet-based training and 
delivery tool developed. 
mhGAP-IG guidelines for 
developmental disorders 
incorporated into animated, 
interactive ‘avatar’ narratives 
about 3 children and 
families, divided into 







Pre-post training child 
and family outcome 
evaluation: Strengths 
Significant improvement in 
trained family member 
knowledge scores (n= 24) 
from 23.29 +/-3.22 to 27.17 
+/- 2.11 (t = 8.36, P<.001). 
Significant decrease in 
WHO-DAS global 
disability score from 
baseline (56.89 +/- 22.02 to 
50.57 +/-24.62, 95% CI 
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70 families training scenarios on 
psychoeducation, parent 
skills training, community 
participation, stigma, rights. 
Master’s level psychologist 
trainer delivered 8 days’ 
training for champions using 
ACT, to cascade the same 8 
days’ training to 5-7 
families, each. Champions 
received monthly 
supervision and met families 









Summary table of 
steps to replicate the 
innovation in other 
settings. 
3.63 to 9.0; P< .001) in 




difficulties scores in 
children (19.67 +/-5.24 to 
13.40 +/- 4.76, 95% CI –
7.68 to 4.87; P<.001). 
Hughes 2015 
Sierra Leone 





20 + 150 
mhGAP-IG and PFA used 
for training. 






Reflective comments that: 
1) PFA seems to be an 
effective tool; 2) Just one 
support session can reduce 
staff anxiety and 
depression; 3) mhGAP-IG 
is useful for screening and 
management, and receives 
positive feedback from field 
work; 4) In Sierra Leone, 
psychosocial care, 
encompassing culturally 
appropriate local support 








6 months' monthly 
mental health 
‘camps’ assessed 785 
cases. Joint specialist 
and non-specialist 
staff provided 
advocacy and needs 
assessment in camps, 
in an apprenticeship 
model. 
mhGAP-IG adapted 
to local mental health 
needs and 
competence of PHC 
staff. mhGAP-IG 
interface simplified 
as too complex. 
Most training in 











tribal area (5). 






Three 2-day training 
workshops over 3 months, 
featuring: Large and small 
group discussions, individual 
exercises, seminars, role-
play demonstrations. 
3 psychiatrists adapted 
modules to local needs. 
Master trainer supervised 
guideline adaptation for use 
in the camps. 
1 day training of trainers 
(ToT) workshop on 
rationale, content, method of 
mhGAP-IG. 
2 external reviewers gave 
independent feedback on 
course, trainers and 
materials, before review by 
senior staff. 
Supervision: formal and 
informal case discussion, 
emphasising holistic 
assessment, psychosocial 
intervention, timely referral. 
Following camps, a local 
psychiatrist continued to 
supervise PHC staff 
informally and follow up 
difficult cases. 
Feedback on: what 
was useful? What was 
not useful? Any 
suggestions? 
Summary of responses 
without description of 
collation. 
Mean pre- and post-test 
knowledge scores were 
15.43, 62% (p value 0.000, 
S.D. 4.05) and 19.48, 78% 
(p value 0.000, S.D. 3.13) 
respectively. 
mhGAP-IG was 
implemented to train PHC 
doctors in Pakistan. 
Lack of PHC resources 
hindered complete 
integration of mental health 
services into PHC. 
Pilot implementation of 
mhGAP-IG in PHC was 















Intervention: initial 3 hour 
training; 1.5 hour booster 
session 2 weeks later. 
Used mhGAP-IG module on 
behavioural disorders, 
focusing on ADHD, plus 
classroom management 
strategies for ADHD. 
Delivered using PowerPoint 
presentations, clinical 
vignettes, role plays, small 
group discussions and 
videos. 
Outcome measures: 
knowledge of ADHD, 
attitude towards ADHD, 
Pre- and post- training 
knowledge and 
attitude scores. 
Controlling for baseline 
scores, intervention group 
had significantly higher 
post-intervention scores on 
ADHD (SRAQ) and 
intervention knowledge 
(KBIQ) and less negative 
attitudes towards ADHD, 
compared with the control 
group.  
Intervention showed 
moderate to large effect 
sizes. 
Booster training was 
associated with a 
statistically significant 
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knowledge of behavioural 
intervention. 
Control: waiting list. 




Descriptive Account Health 
Professionals 
Training course using 
mhGAP-IG delivered by UK 
trainee psychiatrists who had 
attended a two-day ‘train the 
trainer’ course in the UK. 
Duration and training 
methods not described 
(conference abstract). 
 UK trainees gained 
experience of global mental 
health: cultural factors, 
stigma, differences in 
resources and health 
systems. 
Trainees developed 
competencies relevant to 
UK practice, by teaching 




















Intervention arm: structured 
training based on mhGAP-
IG depression, medically 
unexplained symptoms, 
alcohol abuse, and suicide 
modules. 5 full consecutive 
days' training by 2 
psychiatrists. Control: 
waiting list. Initial 3 month 
monitoring from the date of 
recruitment pre-training. All 
patients with common 
mental disorders (CMD) 
reported to study 
coordinator. After training, 
both arms monitored again 
for 3 months. Intervention 
arm will use mhGAP-IG to 
diagnose, treat, and refer 
suspected CMD seen in 
routine PHC. Control arm 
will continue current 
practice. Both arms will 
report CMD diagnoses to 
coordinator. Consenting 
identified patients will be 
reassessed by the study 
psychiatrist, who will also 
assess them using mhGAP-
IG. 
A qualitative study 
exploring the attitudes, 
views, and 
perspectives of PCP on 
integrating mental 
health and primary 
care will be nested 
within the pilot study. 
An economic 
evaluation will be 




Primary outcomes: rates of 
correct identification, 
adequate management 





Pilot and qualitative 
study with curtailed 
training duration and 



















substance misuse and suicide 
modules, a 24 hour training 
programme was held over 3 
days. Modules were selected 
as relevant to the setting 
based on prior research into 
priority conditions, conflict-
related context and 
participant backgrounds. 
WHO materials and videos 
were used. 
Training was delivered by a 
mhGAP-trained trainer and a 
local psychiatrist with 
clinical and research 
experience. 
mhGAP-IG pre- and 
post-training 
knowledge tests. 
Feedback on training, 
materials and content 
gathered after each 
module. A small-scale 
qualitative evaluation 
highlighted 
experiences of conflict 
and displacement, 
discussed health needs 
of post-conflict 
populations and 
provided insight into 
mental health care and 
training needs in PHC 
 
 
